Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor

文档序号:1219508 发布日期:2020-09-04 浏览:29次 中文

阅读说明:本技术 用于调节腺苷a2b受体和腺苷a2a受体的化合物和方法 (Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor ) 是由 Z·李 L·K·菲洛诺娃 E·K·布拉德利 E·弗纳 于 2018-08-31 设计创作,主要内容包括:本文尤其公开用于调节腺苷受体的组合物和方法。在一方面中,提供一种抑制腺苷A2B受体活性和腺苷A2A受体活性的方法,所述方法包含使所述腺苷A2B受体和腺苷A2A受体与如包含实施例的本文所描述的化合物接触。(Disclosed herein, inter alia, are compositions and methods for modulating adenosine receptors. In one aspect, there is provided a method of inhibiting adenosine A2B receptor activity and adenosine A2A receptor activity, the method comprising contacting the adenosine A2B receptor and adenosine A2A receptor with a compound as described herein, including the examples.)

1. A compound having the formula:

wherein

L1Is substituted or unsubstituted C1-C3Alkylene or substituted or unsubstituted 2-to 3-membered heteroalkylene;

ring a is aryl or heteroaryl;

R1independently of one another is halogen, -CX1 3、-CHX1 2、-CH2X1、-OCX1 3、-OCH2X1、-OCHX1 2、-CN、-SR1D、-NR1AR1B、-C(O)R1C、-C(O)OR1C、-C(O)NR1AR1B、-OR1D、-NR1AC(O)R1C、-NR1AC(O)OR1C、-SO2R1D、-SO2NR1AR1B、-NR1ASO2R1DSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl;

z1 is an integer from 0 to 5;

R2independently is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

R3independently is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

R2and R3Can optionally join to form a substituted or unsubstituted heterocycloalkyl;

R4independently hydrogen, halogen, -CX4 3、-CHX4 2、-CH2X4、-OCX4 3、-OCH2X4、-OCHX4 2、-CN、-SR4D、-NR4AR4B、-C(O)R4C、-C(O)OR4C、-C(O)NR4AR4B、-OR4D、-NR4AC(O)R4C、-NR4AC(O)OR4CSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl;

R5independently hydrogen, halogen, -CX5 3、-CHX5 2、-CH2X5、-OCX5 3、-OCH2X5、-OCHX5 2、-CN、-SR5D、-NR5AR5B、-C(O)R5C、-C(O)OR5C、-C(O)NR5AR5B、-OR5D、-NR5AC(O)R5C、-NR5AC(O)OR5CSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl;

each R1A、R1B、R1C、R1D、R4A、R4B、R4C、R4D、R5A、R5B、R5CAnd R5DIndependently hydrogen, halogen, -CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H. -NHC (O) H, -NHC (O) OH, -NHOH, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl or unsubstituted heteroaryl;

with the same nitrogenAtom-bonded R1BAnd R1BSubstituents can optionally join to form a substituted or unsubstituted heterocycloalkyl;

r bound to the same nitrogen atom4BAnd R4BSubstituents can optionally join to form a substituted or unsubstituted heterocycloalkyl;

r bound to the same nitrogen atom5BAnd R5BSubstituents can optionally join to form a substituted or unsubstituted heterocycloalkyl;

each X1、X4And X5Independently is-F, -Cl, -Br or-I; and

wherein said compound is not

Figure FDA0002599820770000021

2. The compound of claim 1, wherein

When R is2And R3R forms unsubstituted heterocycloalkyl and z1 is 04Is not hydrogen;

when R is2Or R3Is hydrogen and L1When it is an unsubstituted methylene group, R4Is not hydrogen; or

When R is2When is hydrogen, R3Is not unsubstituted cyclopropyl.

3. The compound of claim 1, wherein R2Is hydrogen, substituted or unsubstituted C1-C6Alkyl, substituted or unsubstituted 2-to 6-membered heteroalkyl, substituted or unsubstituted C3-C6Cycloalkyl, substituted or unsubstituted 3-to 6-membered heterocycloalkyl, substituted or unsubstituted phenyl, or substituted or unsubstituted 5-to 6-membered heteroaryl.

4. The compound of claim 1, wherein R2Is substituted or unsubstituted C1-C6An alkyl group.

5. The compound of claim 1, wherein R2Is substituted or unsubstituted C3-C6A cycloalkyl group.

6. The compound of claim 1, wherein R2Is hydrogen.

7. The compound of claim 1, wherein R3Is hydrogen, substituted or unsubstituted C1-C6Alkyl, substituted or unsubstituted 2-to 6-membered heteroalkyl, substituted or unsubstituted C3-C6Cycloalkyl, substituted or unsubstituted 3-to 6-membered heterocycloalkyl, substituted or unsubstituted phenyl, or substituted or unsubstituted 5-to 6-membered heteroaryl.

8. The compound of claim 1, wherein R3Is substituted or unsubstituted C1-C6An alkyl group.

9. The compound of claim 1, wherein R3Is substituted or unsubstituted C3-C6A cycloalkyl group.

10. The compound of claim 1, wherein R3Is hydrogen.

11. The compound of claim 1, wherein R2And R3To form a substituted or unsubstituted heterocycloalkyl.

12. The compound of claim 1, wherein ring a is phenyl or 5-to 6-membered heteroaryl.

13. The compound of claim 1, wherein ring a is phenyl, pyridyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, furyl, pyrrolyl, thienyl, pyrazinyl, pyridazinyl, or pyrimidinyl.

14. The compound of claim 1, wherein ring a is phenyl or pyridyl.

15. The compound of claim 1, wherein ring a is pyridyl.

16. The compound of claim 1, having the formula:

Figure FDA0002599820770000041

wherein

W1Is CH or N.

17. The compound of claim 1, having the formula:

18. the compound of claim 1, having the formula:

19. the compound of claim 1, having the formula:

20. the compound of claim 1, wherein L1Is substituted or unsubstituted C1-C3An alkylene group.

21. The compound of claim 1, wherein L1Is a substituted or unsubstituted methylene group.

22. The compound of claim 1, wherein R4Is hydrogen, halogen, -CX4 3、-CHX4 2、-CH2X4、-OCX4 3、-OCH2X4、-OCHX4 2、-CN、-SR4D、-NR4AR4BOr substituted or unsubstituted C1-C6An alkyl group.

23. The compound of claim 1, wherein R4Is hydrogen, halogen, -CX3、-NR4AR4BOr substituted or unsubstituted C1-C6An alkyl group.

24. The compound of claim 1, wherein R4Is hydrogen, halogen, -CF3、-NH2、-NH(CH3) Or unsubstituted C1-C6An alkyl group.

25. The compound of claim 1, wherein R4Is hydrogen or unsubstituted methyl.

26. The compound of claim 1, wherein R5Is hydrogen, halogen, -CX5 3、-CHX5 2、-CH2X5、-OCX5 3、-OCH2X5、-OCHX5 2、-CN、-SR5D、-NR5AR5BOr substituted or unsubstituted C1-C6An alkyl group.

27. The compound of claim 1, wherein R5Is hydrogen, halogen, -CX3、-NR5AR5BOr substituted or unsubstituted C1-C6An alkyl group.

28. The compound of claim 1, wherein R5Is hydrogen, halogen, -CF3、-NH2、-NH(CH3) Or unsubstituted C1-C6An alkyl group.

29. The compound of claim 1, wherein R5Is hydrogen or unsubstituted methyl.

30. The compound of claim 1, having the formula:

Figure FDA0002599820770000061

wherein

Ring B is heterocycloalkyl;

R6independently of one another is halogen, -CX6 3、-CHX6 2、-CH2X6、-OCX6 3、-OCH2X6、-OCHX6 2、-CN、-SR6D、-SO2R6D、-NR6AR6B、-C(O)R6C、-C(O)OR6C、-C(O)NR6AR6B、-C(O)NR6AOR6B、-OR6D、-NR6AC(O)R6C、-NR6AC(O)OR6CSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl;

z6 is an integer from 0 to 10;

each R6A、R6B、R6CAnd R6DIndependently hydrogen, halogen, -CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H. -nhc (o) H, -nhc (o) OH, -NHOH, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

r bound to the same nitrogen atom6AAnd R6BSubstituents can optionally join to form a substituted or unsubstituted heterocycloalkyl; and

X6independently is-F, -Cl, -Br or-I.

31. The compound of claim 30, having the formula:

wherein W1Is CH or N.

32. The compound of claim 30, having the formula:

33. the compound of claim 30, having the formula:

34. the compound of claim 30, having the formula:

35. the compound of claim 30, wherein ring B is 4-to 8-membered heterocycloalkyl.

36. The compound of claim 30, wherein ring B is 4-to 6-membered heterocycloalkyl.

37. The compound of claim 30, wherein ring B is azetidinyl.

38. The compound of claim 30, wherein z6 is 1.

39. The compound of claim 30, wherein R6Independently of one another is halogen, -CX6 3、-CHX6 2、-CH2X6、-OCX6 3、-OCH2X6、-OCHX6 2、-NR6AR6B、-C(O)R6CC substituted or unsubstituted1-C6Alkyl or substituted or unsubstituted 2 to 6 membered heteroalkyl.

40. The compound of claim 30, wherein R6Independently of one another is halogen, -CX6 3、-CHX6 2、-CH2X6、-OCX6 3、-OCH2X6、-OCHX6 2、-CN、-SR6D、-SO2R6D、-NR6AR6B、-C(O)R6C、-C(O)OR6C、-C(O)NR6AR6B、-C(O)NR6AOR6B、-OR6D、-NR6AC(O)R6C、-NR6AC(O)OR6CC substituted or unsubstituted1-C6Alkyl or substituted or unsubstituted 2 to 6 membered heteroalkyl.

41. The compound of claim 30, wherein R6Independently is-C (O) R6C、-C(O)OR6C、-C(O)NR6AR6B、-OR6D、-NR6AC(O)R6C、-NR6AC(O)OR6CC substituted or unsubstituted1-C6Alkyl, substituted or unsubstituted 2 to 6 membered heteroalkyl.

42. The compound of claim 30, wherein R6is-F, -OH, -OCH3、-OCH2CH3、-CH2OH、-CH2OCH3、-NHC(O)CH3、-CH3、-N(CH3)2、-CH2NH2、-CH2N(CH3)2、-NH2、-NHCH3-COOH or-SO2CH3

43. The compound of claim 30, wherein R6is-OH, -OCH3、-OCH2CH3、-CH2OH or-CH2OCH3

44. The compound of claim 30, wherein R6Is substituted or unsubstituted C1-C8Alkyl or substituted or unsubstituted 2 to 8 membered heteroalkyl.

45. The compound of claim 30, wherein R6Is by R35Substituted or unsubstituted C1-C8Alkyl or by R35Substituted or unsubstituted 2 to 8 membered heteroalkyl;

R35is oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F. Substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

46. The compound of claim 30, wherein R6Is that

Figure FDA0002599820770000101

Wherein z16 is an integer from 1 to 8; and

R35is oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F. Substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

47. The compound of claim 30, having the formula:

48. the compound of claim 30, having the formula:

49. the compound of claim 30, having the formula:

50. the compound of claim 30, having the formula:

Figure FDA0002599820770000113

51. the compound of claim 30, having the formula:

52. the compound of claim 30, having the formula:

53. the compound of claim 30, having the formula:

wherein

R35Is oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F. Substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkaneA substituted or unsubstituted heterocycloalkyl, a substituted or unsubstituted aryl, or a substituted or unsubstituted heteroaryl.

54. A compound according to claim 53, wherein R35Is a substituted or unsubstituted heteroalkyl or substituted or unsubstituted heterocycloalkyl.

55. A compound according to claim 53, wherein R35The method comprises the following steps:

56. the compound of claim 1, having the formula:

Figure FDA0002599820770000142

57. a pharmaceutical composition comprising a compound according to any one of claims 1 to 56 and a pharmaceutically acceptable excipient.

58. A method of inhibiting adenosine A2B receptor activity and adenosine A2A receptor activity, the method comprising contacting the adenosine A2B receptor and adenosine A2A receptor with a compound according to any one of claims 1 to 56.

59. A method of inhibiting adenosine A2B receptor activity, comprising contacting the adenosine A2B receptor with a compound according to any one of claims 1 to 56.

60. A method of treating cancer, comprising administering to a subject in need thereof an effective amount of a compound according to any one of claims 1 to 56.

61. The method of claim 57, wherein the cancer is breast cancer, lung cancer, colon cancer, bladder cancer, kidney cancer, liver cancer, pancreas cancer, melanoma, leukemia, lymphoma, or prostate cancer.

62. A method of treating a neurodegenerative disease, the method comprising administering to a subject in need thereof an effective amount of a compound of any one of claims 1-56.

63. A method of treating a fibrotic disorder, the method comprising administering to a subject in need thereof an effective amount of a compound according to any one of claims 1 to 56.

64. The method of claim 63, wherein the fibrotic disorder is pulmonary fibrosis.

Background

G protein-coupled receptors constitute a large transmembrane protein superfamily that represents the target for almost half of all drugs on sale. Two GPCR family members, the adenosine A2B receptor and the adenosine A2A receptor, are involved in a number of physiological functions. Thus, there is a need in the art for adenosine A2B receptor modulators and adenosine A2A receptor modulators. Provided herein, among other things, are solutions to these and other problems in the art.

Disclosure of Invention

In one aspect, a compound is provided having the formula:

L1is substituted or unsubstitutedAlkylene or substituted or unsubstituted heteroalkylene. Ring a is aryl or heteroaryl. R1Independently of one another is halogen, -CX1 3、-CHX1 2、-CH2X1、-OCX1 3、-OCH2X1、-OCHX1 2、-CN、-SR1D、-NR1AR1B、-C(O)R1C、-C(O)OR1C、-C(O)NR1AR1B、-OR1D、-NR1AC(O)R1C、-NR1AC(O)OR1C、-SO2R1D、-SO2NR1AR1B、-NR1ASO2R1DSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl. The symbol z1 is an integer from 0 to 5. R2Independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. R3Independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. R2And R3May optionally be joined to form a substituted or unsubstituted heterocycloalkyl group. R4Independently hydrogen, halogen, -CX4 3、-CHX4 2、-CH2X4、-OCX4 3、-OCH2X4、-OCHX4 2、-CN、-SR4D、-NR4AR4B、-C(O)R4C、-C(O)OR4C、-C(O)NR4AR4B、-OR4D、-NR4AC(O)R4C、-NR4AC(O)OR4CSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl. R5Independently hydrogen, halogen, -CX5 3、-CHX5 2、-CH2X5、-OCX5 3、-OCH2X5、-OCHX5 2、-CN、-SR5D、-NR5AR5B、-C(O)R5C、-C(O)OR5C、-C(O)NR5AR5B、-OR5D、-NR5AC(O)R5C、-NR5AC(O)OR5CSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl. Each R1A、R1B、R1C、R1D、R4A、R4B、R4C、R4D、R5A、R5B、R5CAnd R5DIndependently hydrogen, halogen, -CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H. -NHC (O) H, -NHC (O) OH, -NHOH, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. R bound to the same nitrogen atom1AAnd R1BThe substituents may optionally join to form a substituted or unsubstituted heterocycloalkyl. R bound to the same nitrogen atom4AAnd R4BThe substituents may optionally join to form a substituted or unsubstituted heterocycloalkyl. R bound to the same nitrogen atom5AAnd R5BThe substituents may optionally join to form a substituted or unsubstituted heterocycloalkyl. Each one ofX1、X4And X5Independently is-F, -Cl, -Br or-I.

In one aspect, there is provided a pharmaceutical composition comprising a compound as described herein and a pharmaceutically acceptable excipient.

In one aspect, there is provided a method of inhibiting adenosine A2B receptor activity and adenosine A2A receptor activity, the method comprising contacting the adenosine A2B receptor and adenosine A2A receptor with a compound as described herein, including the examples.

In another aspect, there is provided a method of inhibiting the activity of the adenosine A2B receptor, comprising contacting the adenosine A2B receptor with a compound as described herein, including the examples.

In one aspect, there is provided a method of treating cancer, the method comprising administering to a subject in need thereof an effective amount of a compound as described herein, including the examples.

In one aspect, there is provided a method of treating a fibrotic disease, the method comprising administering to a subject in need thereof an effective amount of a compound as described herein, including the examples.

In one aspect, there is provided a method of treating a neurodegenerative disease, the method comprising administering to a subject in need thereof an effective amount of a compound as described herein, including the examples.

In one aspect, there is provided a method of inhibiting adenosine receptor activity, the method comprising contacting the adenosine receptor (e.g., a1, A2A, A2B, or A3) with a compound as described herein, including the examples.

Detailed Description

I. Definition of

The abbreviations used herein have their conventional meaning in the chemical and biological arts. The chemical structures and chemical formulae set forth herein are constructed according to standard rules of chemical valency known in the chemical art.

When substituents are illustrated by conventional formulas written from left to right, the substituents are equally intended to encompass the chemically identical result from writing the structure from right to leftSubstituents, e.g. -CH2O-is equivalent to-OCH2-。

Unless otherwise specified, the term "alkyl" alone or as part of another substituent means a straight (i.e., unbranched) or branched carbon chain (or carbon), or combination thereof, which may be fully saturated, mono-unsaturated, or polyunsaturated, and may contain monovalent, divalent, and multivalent groups. The alkyl group may contain a specified number of carbons (e.g., C)1-C10Meaning one to ten carbons). Alkyl is an acyclic chain. Examples of saturated hydrocarbon groups include (but are not limited to) groups such as: methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, isobutyl, sec-butyl, methyl, homologs and isomers of, for example, n-pentyl, n-hexyl, n-heptyl, n-octyl, and the like. Unsaturated alkyl is alkyl having one or more double or triple bonds. Examples of unsaturated alkyl groups include, but are not limited to, ethenyl, 2-propenyl, crotyl, 2-isopentenyl, 2- (butadienyl), 2, 4-pentadienyl, 3- (1, 4-pentadienyl), ethynyl, 1-and 3-propynyl, 3-butynyl, and higher homologs and isomers. An alkoxy group is an alkyl group attached to the rest of the molecule through an oxygen linker (-O-). The alkyl moiety may be an alkenyl moiety. The alkyl moiety may be an alkynyl moiety. The alkyl moiety may be fully saturated. In addition to one or more double bonds, an alkenyl group may contain more than one double bond and/or one or more triple bonds. In addition to one or more triple bonds, an alkynyl group may contain more than one triple bond and/or one or more double bonds.

Unless otherwise specified, the term "alkylene" alone or as part of another substituent means a divalent group derived from an alkyl group, such as (but not limited to) -CH2CH2CH2CH2-. Typically, the alkyl (or alkylene) groups will have from 1 to 24 carbon atoms, with those groups having 10 or fewer carbon atoms being preferred herein. "lower alkyl" or "lower alkylene" is a short chain alkyl or alkylene group typically having eight or fewer carbon atoms. The term "alkenylene", alone or as part of another substituent, means, unless otherwise stated, derivedA divalent group derived from an olefin.

Unless otherwise specified, the term "heteroalkyl," alone or in combination with another term, means a stable straight or branched chain comprising at least one carbon atom and at least one heteroatom (e.g., O, N, P, Si and S, and wherein the nitrogen and sulfur atoms may optionally be oxidized, and the nitrogen heteroatom may optionally be quaternized), or a combination thereof. The heteroatom (e.g., N, S, Si or P) may be located at any internal position of the heteroalkyl group or at the position where the alkyl group is attached to the remainder of the molecule. Heteroalkyl is an acyclic chain. Examples include (but are not limited to): -CH2-CH2-O-CH3、-CH2-CH2-NH-CH3、-CH2-CH2-N(CH3)-CH3、-CH2-S-CH2-CH3、-CH2-S-CH2、-S(O)-CH3、-CH2-CH2-S(O)2-CH3、-CH=CH-O-CH3、-Si(CH3)3、-CH2-CH=N-OCH3、-CH=CH-N(CH3)-CH3、-O-CH3、-O-CH2-CH3and-CN. Up to two or three heteroatoms may be consecutive, e.g. -CH2-NH-OCH3and-CH2-O-Si(CH3)3. The heteroalkyl moiety may include one heteroatom (e.g., O, N, S, Si or P). The heteroalkyl moiety may comprise two optionally different heteroatoms (e.g., O, N, S, Si or P). The heteroalkyl moiety may comprise three optionally different heteroatoms (e.g., O, N, S, Si or P). The heteroalkyl moiety may comprise four optionally different heteroatoms (e.g., O, N, S, Si or P). The heteroalkyl moiety may comprise five optionally different heteroatoms (e.g., O, N, S, Si or P). The heteroalkyl moiety may contain up to 8 optionally different heteroatoms (e.g., O, N, S, Si or P). Unless otherwise specified, the term "heteroalkenyl" means, alone or in combination with another term, a heteroalkyl group that includes at least one double bond. In addition to one or more double bonds, a heteroalkenyl group can optionally include more than one double bond and/or one or more triple bonds. Unless otherwise indicated, alone or in combination with another term,the term "heteroalkynyl" means a heteroalkyl group containing at least one triple bond. In addition to one or more triple bonds, a heteroalkynyl group can optionally contain more than one triple bond and/or one or more double bonds.

Similarly, unless otherwise specified, the term "heteroalkylene," alone or as part of another substituent, means a divalent radical derived from a heteroalkyl group, such as (but not limited to) -CH2-CH2-S-CH2-CH2-and-CH2-S-CH2-CH2-NH-CH2-. For heteroalkylene groups, heteroatoms can also occupy either or both of the chain ends (e.g., alkyleneoxy, alkylenedioxy, alkyleneamino, alkylenediamino, and the like). In addition, for alkylene and heteroalkylene linking groups, the written direction of the formula for the linking group does not imply orientation of the linking group. For example, of the formula-C (O)2R' -represents-C (O)2R '-and-R' C (O)2-two. As described above, heteroalkyl, as used herein, includes those groups attached to the remainder of the molecule through a heteroatom, such as-C (O) R ', -C (O) NR ', -NR ' R ", -OR ', -SR ', and/OR-SO2R' is provided. When "heteroalkyl" is recited, followed by a particular heteroalkyl, such as-NR 'R "or the like, it is understood that the terms heteroalkyl and-NR' R" are not redundant or mutually exclusive. Rather, specific heteroalkyl groups are recited for added clarity. Thus, the term "heteroalkyl" should not be construed herein to exclude a particular heteroalkyl, such as-NR' R "or the like.

Unless otherwise specified, the terms "cycloalkyl" and "heterocycloalkyl", alone or in combination with other terms, mean the cyclic forms of "alkyl" and "heteroalkyl", respectively. Cycloalkyl and heterocycloalkyl groups are not aromatic. In addition, for heterocycloalkyl, a heteroatom may occupy the position at which the heterocycle is attached to the rest of the molecule. Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, 1-cyclohexenyl, 3-cyclohexenyl, cycloheptyl, and the like. Examples of heterocycloalkyl include, but are not limited to, 1- (1,2,5, 6-tetrahydropyridyl), 1-piperidinyl, 2-piperidinyl, 3-piperidinyl, 4-morpholinyl, 3-morpholinyl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydrothiophen-2-yl, tetrahydrothiophen-3-yl, 1-piperazinyl, 2-piperazinyl, and the like. By "cycloalkylene" and "heterocycloalkylene", alone or as part of another substituent, is meant a divalent radical derived from a cycloalkyl and a heterocycloalkyl, respectively.

The term "halo" or "halogen", alone or as part of another substituent, means, unless otherwise stated, a fluorine, chlorine, bromine or iodine atom. Additionally, terms such as "haloalkyl" are meant to encompass monohaloalkyl and polyhaloalkyl. For example, the term "halo (C)1-C4) Alkyl "includes, but is not limited to, fluoromethyl, difluoromethyl, trifluoromethyl, 2,2, 2-trifluoroethyl, 4-chlorobutyl, 3-bromopropyl, and the like.

Unless otherwise indicated, the term "acyl" means-c (o) R, wherein R is substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

Unless otherwise indicated, the term "aryl" means a polyunsaturated aromatic hydrocarbon substituent which may be a single ring or multiple rings (preferably 1 to 3 rings) which are fused together (i.e., a fused ring aryl) or covalently linked. Fused ring aryl refers to multiple rings fused together, wherein at least one of the fused rings is an aryl ring. The term "heteroaryl" refers to an aryl (or ring) containing at least one heteroatom, such as N, O or S, wherein the nitrogen and sulfur atoms are optionally oxidized and the nitrogen atoms are optionally quaternized. Thus, the term "heteroaryl" encompasses fused ring heteroaryl groups (i.e., multiple rings fused together wherein at least one of the fused rings is a heteroaromatic ring). A 5, 6-fused ring heteroarylene refers to two rings fused together, wherein one ring has 5 members and the other ring has 6 members, and wherein at least one ring is a heteroaryl ring. Likewise, a 6, 6-fused ring heteroarylene refers to two rings fused together, wherein one ring has 6 members and the other ring has 6 members, and wherein at least one ring is a heteroaryl ring. And 6, 5-fused ring heteroarylene refers to two rings fused together, wherein one ring has 6 members and the other ring has 5 members, and wherein at least one ring is a heteroaryl ring. The heteroaryl group may be attached to the rest of the molecule through a carbon or heteroatom. Non-limiting examples of aryl and heteroaryl groups include: phenyl, naphthyl, pyrrolyl, pyrazolyl, pyridazinyl, triazinyl, pyrimidinyl, imidazolyl, pyrazinyl, purinyl, oxazolyl, isoxazolyl, thiazolyl, furyl, thienyl, pyridyl, pyrimidinyl, benzothiazolyl, benzoxazolyl, benzimidazolyl, benzofuran, isobenzofuryl, indolyl, isoindolyl, benzothienyl, isoquinolyl, quinolyl, 1-naphthyl, 2-naphthyl, 4-biphenyl, 1-pyrrolyl, 2-pyrrolyl, 3-pyrazolyl, 2-imidazolyl, 4-imidazolyl, pyrazinyl, 2-oxazolyl, 4-oxazolyl, 2-phenyl-4-oxazolyl, 5-oxazolyl, 3-isoxazolyl, 4-isoxazolyl, pyridazinyl, triazinyl, pyrimidinyl, imidazolyl, pyrazinyl, purinyl, quinoxalyl, 2-naphthyl, 4-biphenyl, 4-oxazolyl, 5-oxazolyl, 3-isoxazolyl, 4-isoxazolyl, etc, 5-isoxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidyl, 4-pyrimidyl, 5-benzothiazolyl, purinyl, 2-benzimidazolyl, 5-indolyl, 1-isoquinolyl, 5-isoquinolyl, 2-quinolyl, 5-quinolyl, 3-quinolyl and 6-quinolyl. The substituents for each of the above-indicated aryl and heteroaryl ring systems are selected from the group of acceptable substituents described below. By "arylene" and "heteroarylene", alone or as part of another substituent, is meant a divalent radical derived from an aryl and heteroaryl group, respectively. The heteroaryl substituent may be-O-bonded to the nitrogen ring heteroatom.

A spiro ring is two or more rings in which adjacent rings are connected by a single atom. The individual rings within a spiro ring may be the same or different. Individual rings in the spiro ring may be substituted or unsubstituted, and may have different substituents than other individual rings in the spiro ring group. Possible substituents for individual rings in a spiro ring are possible substituents for the same ring when not part of a spiro ring (e.g., substituents for cycloalkyl or heterocycloalkyl rings). The spirocyclic ring can be substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkyl, or substituted or unsubstituted heterocycloalkylene, and individual rings within the spirocyclic group can be any of the immediately preceding list, including all rings having one type (e.g., all rings of a substituted heterocycloalkylene, where each ring can be the same or different substituted heterocycloalkylene). When referring to a spiro ring system, heterocyclic spiro ring means a spiro ring in which at least one ring is heterocyclic and in which each ring may be a different ring. When referring to a spiro ring system, substituted spirocyclic means that at least one ring is substituted and each substituent may optionally be different.

SymbolDenotes the point of attachment of a chemical moiety to the rest of the molecule or formula.

As used herein, the term "oxo" means an oxygen double bonded to a carbon atom.

The term "alkylarylene" is an arylene moiety covalently bonded to an alkylene moiety (also referred to herein as an alkylene linker). In embodiments, the alkylarylene group has the formula:

the alkylarylene moiety may be substituted (e.g., by a substituent) on the alkylene moiety or the arylene linker (e.g., at carbon 2, 3, 4, or 6) by: halogen, oxo, -N3、-CF3、-CCl3、-CBr3、-CI3、-CN、-CHO、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO2CH3-SO3H、-OSO3H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2C substituted or unsubstituted1-C5Alkyl or substituted or unsubstituted 2 to 5 membered heteroalkyl). In the examples, alkylarylene radicalsIs unsubstituted.

Each of the above terms (e.g., "alkyl," "heteroalkyl," "cycloalkyl," "heterocycloalkyl," "aryl," and "heteroaryl") encompasses both substituted and unsubstituted forms of the indicated group. Preferred substituents for each type of group are provided below.

Substituents for alkyl and heteroalkyl (including those commonly referred to as alkylene, alkenyl, heteroalkylene, heteroalkenyl, alkynyl, cycloalkyl, heterocycloalkyl, cycloalkenyl, and heterocycloalkenyl) can be one or more of a variety of groups selected from, but not limited to: -OR ', - (O), (NR ', - (N-OR ', - (NR ' R ", -SR ', halogen, -SiR ' R" R ' ", -oc (O) R ', -c (O) R ', -CO2R'、-CONR'R"、-OC(O)NR'R"、-NR"C(O)R'、-NR'-C(O)NR"R"'、-NR"C(O)2R'、-NR-C(NR'R"R"')=NR""、-NR-C(NR'R")=NR"'、-S(O)R'、-S(O)2R'、-S(O)2NR'R"、-NRSO2R'、-NR'NR"R"'、-ONR'R"、-NR'C(O)NR"NR"'R""、-CN、-NO2、-NR'SO2R ", -NR 'C (O) -OR", -NR' OR ", in a number ranging from zero to (2m '+1), where m' is the total number of carbon atoms in such a group. R, R ', R ", R'" and R "" each preferably independently mean hydrogen, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl (e.g., aryl substituted with 1-3 halogens), substituted or unsubstituted heteroaryl, substituted or unsubstituted alkyl, alkoxy, or thioalkoxy or aralkyl. When the compounds described herein comprise more than one R group, for example, each of the R groups is independently selected as are each R ', R ", R'" and R "" groups when more than one of these groups is present. When R' and R "are attached to the same nitrogen atom, they may combine with the nitrogen atom to form a 4-, 5-, 6-or 7-membered ring. For example, -NR' R "includes, but is not limited to, 1-pyrrolidinyl and 4-morpholinyl. From the above discussion of substituents, it will be understood by those skilled in the art that the term "alkyl" is intended to encompass groups containing carbon atoms bonded to groups other than hydrogen, such as haloAlkyl radicals (e.g., -CF)3and-CH2CF3) And acyl (e.g., -C (O) CH)3、-C(O)CF3、-C(O)CH2OCH3And the like).

Similar to the substituents described for alkyl, the substituents for aryl and heteroaryl are different and are selected, for example, from the following: -OR ', -NR ' R ", -SR ', -halo, -SiR ' R" R ' ", -OC (O) R ', -C (O) R ', -CO2R'、-CONR'R"、-OC(O)NR'R"、-NR"C(O)R'、-NR'-C(O)NR"R"'、-NR"C(O)2R'、-NR-C(NR'R"R"')=NR""、-NR-C(NR'R")=NR"'、-S(O)R'、-S(O)2R'、-S(O)2NR'R"、-NRSO2R'、-NR'NR"R"'、-ONR'R"、-NR'C(O)NR"NR"'R""、-CN、-NO2、-R'、-N3、-CH(Ph)2Fluorine (C)1-C4) Alkoxy, and fluorine (C)1-C4) Alkyl, -NR' SO2R ", -NR 'C (O) -OR", -NR' OR ", in an amount ranging from zero to the total number of open valences on the aromatic ring system; and wherein R ', R ", R'" and R "" are preferably independently selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl. When the compounds described herein comprise more than one R group, for example, each of the R groups is independently selected as are each R ', R ", R'" and R "" groups when more than one of these groups is present.

Substituents on a ring (e.g., cycloalkyl, heterocycloalkyl, aryl, heteroaryl, cycloalkylene, heterocycloalkylene, arylene, or heteroarylene) can be described as substituents on the ring (often referred to as floating substituents) other than the specified atoms on the ring. In this case, a substituent may be attached to any of the ring atoms (following the rules of chemical valency), and in the case of a fused ring or spiro ring, a substituent described as being bound to one member of the fused ring or spiro ring (floating substituent on a single ring), may be a substituent on any of the fused ring or spiro ring (floating substituent on multiple rings). When a substituent is attached to a ring other than a particular atom (a floating substituent) and the subscript of the substituent is an integer greater than one, multiple substituents can be on the same atom, the same ring, different atoms, different spiro rings of different fused rings, and each substituent can optionally be different. When the point of attachment of a ring to the rest of the molecule is not limited to a single atom (floating substituent), the point of attachment may be any atom of the ring, and in the case of a fused ring or spiro ring, may be any atom of either the fused ring or spiro ring while following the rules of chemical valency. When a ring, fused ring, or spiro ring contains one or more ring heteroatoms and the ring, fused ring, or spiro ring is shown to have yet another (one more) floating substituent (including, but not limited to, the point of attachment to the rest of the molecule), the floating substituent may be bonded to the heteroatom. When a ring heteroatom is shown bound to one or more hydrogens in a structure or formula with a floating substituent (e.g., two bonds are bound to the ring atom and the third bond is a ring nitrogen bound to a hydrogen), when the heteroatom is bound to a floating substituent, the substituent will be understood to replace the hydrogen while following the chemical valence rules.

Two or more substituents may optionally be joined to form an aryl, heteroaryl, cycloalkyl, or heterocycloalkyl group. Such so-called ring-forming substituents are typically, but not necessarily, found attached to a cyclic base structure. In one embodiment, the ring-forming substituent is attached to an adjacent member of the base structure. For example, two rings connected to adjacent members of a cyclic base structure form a substituent to produce a fused ring structure. In another embodiment, the ring-forming substituent is attached to a single member of the base structure. For example, two rings attached to a single member of a cyclic base structure form a substituent resulting in a spiro ring structure. In yet another embodiment, the ring-forming substituent is attached to a non-adjacent member of the base structure.

Two of the substituents on adjacent atoms of the aryl or heteroaryl ring may optionally form a compound of the formula-T-C (O) - (CRR')q-U-, wherein T and U are independently-NR-, -O-, -CRR' -or a single bond, and q is an integer of 0 to 3. Alternatively, two of the substituents on adjacent atoms of the aryl or heteroaryl ring may optionally be substituted with a group of formula-A- (CH)2)rSubstitution of the substituents of-B-,wherein A and B are independently-CRR' -, -O-, -NR-, -S (O)2-、-S(O)2NR' -or a single bond, and r is an integer of 1 to 4. One of the single bonds of the new ring thus formed may optionally be replaced with a double bond. Alternatively, two of the substituents on adjacent atoms of the aryl or heteroaryl ring may optionally be substituted with a compound of the formula- (CRR ') s-X ' - (C "R" R ' ")d-wherein S and d are independently integers from 0 to 3, and X 'is-O-, -NR' -, -S (O)2-or-S (O)2NR' -. Substituents R, R ', R ", and R'" are preferably independently selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl.

As used herein, "substituent" means a group selected from the following moieties:

(A) oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl or phenyl), or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl), and

(B) alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, said groups substituted with at least one substituent selected from the group consisting of:

(i) oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 9-membered heteroaryl6-membered heteroaryl), and

(ii) alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, said groups substituted with at least one substituent selected from the group consisting of:

(a) oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl), and

(b) alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, said groups substituted with at least one substituent selected from the group consisting of: oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

As used herein, "size-limited substituent group" means a group selected from all substituents described above for "substituent group", wherein each substituted or unsubstituted alkyl group is substituted or unsubstituted C1-C20Alkyl, each substituted or unsubstituted heteroalkyl is substituted or unsubstituted 2 to 20 membered heteroalkyl, each substituted or unsubstituted cycloalkyl is substituted or unsubstituted C3-C8Cycloalkyl, each substituted or unsubstituted heterocycloalkyl is substituted or unsubstituted 3 to 8 membered heterocycloalkyl, each substituted or unsubstituted aryl is substituted or unsubstituted C6-C10Aryl, and each substituted or unsubstituted heteroaryl is a substituted or unsubstituted 5-to 10-membered heteroaryl.

As used herein, "lower number substituent (lower substituent group)" means a group selected from all substituents described above for "substituent", wherein each substituted or unsubstituted alkyl group is substituted or unsubstituted C1-C8Alkyl, each substituted or unsubstituted heteroalkyl is substituted or unsubstituted 2 to 8 membered heteroalkyl, each substituted or unsubstituted cycloalkyl is substituted or unsubstituted C3-C7Cycloalkyl, each substituted or unsubstituted heterocycloalkyl is substituted or unsubstituted 3 to 7 membered heterocycloalkyl, each substituted or unsubstituted aryl is substituted or unsubstituted C6-C10Aryl, and each substituted or unsubstituted heteroaryl is a substituted or unsubstituted 5-to 9-membered heteroaryl.

In some embodiments, each substituted group described in the compounds herein is substituted with at least one substituent. More specifically, in some embodiments, each substituted alkyl, substituted heteroalkyl, substituted cycloalkyl, substituted heterocycloalkyl, substituted aryl, substituted heteroaryl, substituted alkylene, substituted heteroalkylene, substituted cycloalkylene, substituted heterocycloalkylene, substituted arylene, and/or substituted heteroarylene described herein is substituted with at least one substituent. In other embodiments, at least one or all of these groups are substituted with at least one size-limiting substituent. In other embodiments, at least one or all of these groups are substituted with at least one lower number substituent.

In other embodiments of the compounds herein, each substituted or unsubstituted alkyl may be substituted or unsubstituted C1-C20Alkyl, each substituted or unsubstituted heteroalkyl is substituted or unsubstituted 2 to 20 membered heteroalkyl, each substituted or unsubstituted cycloalkyl is substitutedSubstituted or unsubstituted C3-C8Cycloalkyl, each substituted or unsubstituted heterocycloalkyl is substituted or unsubstituted 3 to 8 membered heterocycloalkyl, each substituted or unsubstituted aryl is substituted or unsubstituted C6-C10Aryl, and/or each substituted or unsubstituted heteroaryl is a substituted or unsubstituted 5-to 10-membered heteroaryl. In some embodiments of the compounds herein, each substituted or unsubstituted alkylene is substituted or unsubstituted C1-C20Alkylene, each substituted or unsubstituted heteroalkylene being substituted or unsubstituted 2-to 20-membered heteroalkylene, each substituted or unsubstituted cycloalkylene being substituted or unsubstituted C3-C8Cycloalkylene, each substituted or unsubstituted heterocycloalkylene is substituted or unsubstituted 3-to 8-membered heterocycloalkylene, each substituted or unsubstituted arylene is substituted or unsubstituted C6-C10The arylene group, and/or each substituted or unsubstituted heteroarylene group is a substituted or unsubstituted 5-to 10-membered heteroarylene group.

In some embodiments, each substituted or unsubstituted alkyl is substituted or unsubstituted C1-C8Alkyl, each substituted or unsubstituted heteroalkyl is substituted or unsubstituted 2 to 8 membered heteroalkyl, each substituted or unsubstituted cycloalkyl is substituted or unsubstituted C3-C7Cycloalkyl, each substituted or unsubstituted heterocycloalkyl is substituted or unsubstituted 3 to 7 membered heterocycloalkyl, each substituted or unsubstituted aryl is substituted or unsubstituted C6-C10Aryl, and/or each substituted or unsubstituted heteroaryl is a substituted or unsubstituted 5-to 9-membered heteroaryl. In some embodiments, each substituted or unsubstituted alkylene is substituted or unsubstituted C1-C8Alkylene, each substituted or unsubstituted heteroalkylene being substituted or unsubstituted 2-to 8-membered heteroalkylene, each substituted or unsubstituted cycloalkylene being substituted or unsubstituted C3-C7Cycloalkylene, each substituted or unsubstituted heterocycloalkylene is substituted or unsubstituted 3-to 7-membered heterocycloalkylene, each substituted or unsubstituted arylene is substituted or unsubstituted C6-C10The arylene group, and/or each substituted or unsubstituted heteroarylene group is a substituted or unsubstituted 5-to 9-membered heteroarylene group. In some embodiments, the compound is a chemical species set forth in the examples section, figures, or tables below.

In embodiments, a substituted or unsubstituted moiety (e.g., substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkylene, substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, and/or substituted or unsubstituted heteroarylene) is unsubstituted (e.g., unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, unsubstituted heteroaryl, unsubstituted alkylene, substituted or unsubstituted heteroarylene, respectively) is unsubstituted (e.g., unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, unsubstituted heteroaryl, unsubstituted alkylene, substituted or unsubstituted heteroarenyl, respectively), Unsubstituted heteroalkylene, unsubstituted cycloalkylene, unsubstituted heterocycloalkylene, unsubstituted arylene, and/or unsubstituted heteroarylene). In embodiments, a substituted or unsubstituted moiety (e.g., substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkylene, substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, and/or substituted or unsubstituted heteroarylene) is substituted (e.g., substituted alkyl, substituted heteroalkyl, substituted cycloalkyl, substituted heterocycloalkyl, substituted aryl, substituted heteroaryl, substituted alkylene, substituted heteroalkylene, substituted heteroaryl, substituted, Substituted cycloalkylene, substituted heterocycloalkylene, substituted arylene, and/or substituted heteroarylene).

In embodiments, a substituted moiety (e.g., substituted alkyl, substituted heteroalkyl, substituted cycloalkyl, substituted heterocycloalkyl, substituted aryl, substituted heteroaryl, substituted alkylene, substituted heteroalkylene, substituted cycloalkylene, substituted heterocycloalkylene, substituted arylene, and/or substituted heteroarylene) is substituted with at least one substituent, wherein if the substituted moiety is substituted with multiple substituents, each substituent may optionally be different. In embodiments, if a substituted moiety is substituted with multiple substituents, each substituent is different.

In embodiments, a substituted moiety (e.g., substituted alkyl, substituted heteroalkyl, substituted cycloalkyl, substituted heterocycloalkyl, substituted aryl, substituted heteroaryl, substituted alkylene, substituted heteroalkylene, substituted cycloalkylene, substituted heterocycloalkylene, substituted arylene, and/or substituted heteroarylene) is substituted with at least one size-limiting substituent, wherein each size-limiting substituent may optionally be different if the substituted moiety is substituted with multiple size-limiting substituents. In embodiments, if a substituted moiety is substituted with multiple size-limited substituents, each size-limited substituent is different.

In embodiments, a substituted moiety (e.g., substituted alkyl, substituted heteroalkyl, substituted cycloalkyl, substituted heterocycloalkyl, substituted aryl, substituted heteroaryl, substituted alkylene, substituted heteroalkylene, substituted cycloalkylene, substituted heterocycloalkylene, substituted arylene, and/or substituted heteroarylene) is substituted with at least one lower carbon number substituent, wherein if the substituted moiety is substituted with a plurality of lower carbon number substituents, each lower carbon number substituent may optionally be different. In embodiments, if the substituted moiety is substituted with a plurality of lower carbon number substituents, each lower carbon number substituent is different.

In embodiments, a substituted moiety (e.g., substituted alkyl, substituted heteroalkyl, substituted cycloalkyl, substituted heterocycloalkyl, substituted aryl, substituted heteroaryl, substituted alkylene, substituted heteroalkylene, substituted cycloalkylene, substituted heterocycloalkylene, substituted arylene, and/or substituted heteroarylene) is substituted with at least one substituent, size-limiting substituent, or lower number substituent; wherein if the substituted moiety is substituted with a plurality of groups selected from substituents, size-limiting substituents and lower-number substituents, each substituent, size-limiting substituent and/or lower-number substituent may optionally be different. In embodiments, if the substituted moiety is substituted with a plurality of groups selected from substituents, size-limiting substituents, and lower-number substituents, each substituent, size-limiting substituent, and/or lower-number substituent is different.

Certain compounds of the present invention possess asymmetric carbon atoms (optical or chiral centers) or double bonds; defined in terms of absolute stereochemistry as enantiomers, racemates, diastereomers, tautomers, geometric isomers, stereoisomeric forms, and individual isomers in (R) -or (S) -or (D) -or (L) for amino acids are encompassed within the scope of the present invention. The compounds of the present invention do not include those known in the art to be too unstable to synthesize and/or isolate. The present invention is meant to encompass the compounds in racemic and optically pure form. Optically active (R) -and (S) -, or (D) -and (L) -isomers can be prepared using chiral synthons or chiral reagents, or resolved using conventional techniques. When the compounds described herein contain an olefinic bond or other geometric asymmetric center, and unless otherwise specified, it is intended that the compounds contain both the E and Z geometric isomers.

As used herein, the term "isomer" refers to compounds having the same number and kind of atoms, and thus the same molecular weight, but having different structural arrangements or atom configurations.

As used herein, the term "tautomer" refers to one of two or more structural isomers that exist in equilibrium and are readily converted from one isomeric form to another.

It will be apparent to those skilled in the art that certain compounds of the invention may exist in tautomeric forms, all such tautomeric forms of the compounds being within the scope of the invention.

Unless otherwise specified, the structures depicted herein are also meant to encompass all stereochemical forms of the structures; i.e., the R and S configuration of each asymmetric center. Thus, single stereochemical isomers as well as enantiomeric and diastereomeric mixtures of the compounds of the present invention are within the scope of the invention.

Unless otherwise indicated, the structures depicted herein are also meant to include compounds that differ only in the presence of one or more isotopically enriched atoms. For example, except that hydrogen is replaced by deuterium or tritium or carbon is replaced by13C or14In addition to carbon substitution by C enrichment, compounds having the structure of the present invention are within the scope of the present invention.

The compounds of the present invention may also contain unnatural proportions of atomic isotopes at one or more of the atoms that constitute such compounds. For example, the compound may be radiolabeled with a radioisotope, such as tritium (A)3H) Iodine-125 (125I) Or carbon-14 (14C) In that respect All isotopic variations of the compounds of the present invention, whether radioactive or not, are intended to be encompassed within the scope of the present invention.

It should be noted that throughout the application, substitutes are written in the Markush group, e.g., each amino acid position containing more than one possible amino acid. It is specifically contemplated that each member of the Markush group should be considered separately, thereby including another embodiment, and that the Markush group should not be read as a single unit.

"Analog/Analog" is used according to its usual meaning in chemistry and biology and refers to a compound that is structurally similar to another compound (i.e., a so-called "reference" compound) but differs in composition, for example, in that one atom is replaced by a different element atom, or a particular functional group is present, or one functional group is replaced by another functional group, or the absolute stereochemistry of one or more chiral centers of the reference compound. Thus, an analog is a compound that is similar or equivalent in function and appearance to a reference compound, but not in structure or origin.

The terms "a" and "an," as used herein, mean one or more. Further, as used herein, the phrase "being a [ n ]]Substituted means that the specified group may be substituted with any or all of one or more of the proposed substituents. For example, when a group, such as alkyl or heteroaryl, "is unsubstituted C1-C20When alkyl or unsubstituted 2-to 20-membered heteroalkyl is substituted ", the group may contain one or more unsubstituted C1-C20Alkyl, and/or one or more unsubstituted 2-to 20-membered heteroalkyl.

Further, when a moiety is substituted with an R substituent, the group may be referred to as "R-substituted". When a moiety is substituted with R, the moiety is substituted with at least one R substituent, and each R substituent is optionally different. When a particular R group is present in the description of a chemical species (as in formula (I)), a roman alphabet symbol may be used to distinguish each occurrence of the particular R group. For example, when multiple R' s13When a substituent is present, each R13The substituent may be R13A、R13B、R13C、R13DAre distinguished wherein R13A、R13B、R13C、R13DEach of which is defined in R13Within the defined ranges, and optionally different.

The term "pharmaceutically acceptable salt" is intended to encompass salts of the active compounds prepared with relatively nontoxic acids or bases, depending on the particular substituents found on the compounds described herein. When the compounds of the present invention contain relatively acidic functional groups, base addition salts can be obtained by contacting the neutral forms of such compounds with a sufficient amount of the desired base, neat or in a suitable inert solvent. Examples of pharmaceutically acceptable base addition salts include sodium, potassium, calcium, ammonium, organic ammonium or magnesium salts or the like. When the compounds of the present invention contain relatively basic functional groups, acid addition salts can be obtained by contacting the neutral form of such compounds with a sufficient amount of the desired acid, neat or in a suitable inert solvent. Examples of pharmaceutically acceptable acid addition salts include those derived from inorganic acids such as hydrochloric acid, hydrobromic acid, nitric acid, carbonic acid, monohydrogencarbonic acid, phosphoric acid, monohydrogenphosphoric acid, dihydrogenphosphoric acid, sulfuric acid, monohydrogensulfuric acid, hydroiodic acid, or phosphorous acid and the like; and salts derived from relatively nontoxic organic acids such as acetic, propionic, isobutyric, maleic, malonic, benzoic, succinic, suberic, fumaric, lactic, mandelic, phthalic, benzenesulfonic, p-tolylsulfonic, citric, tartaric, oxalic, methanesulfonic, and the like. Also included are salts of amino acids such as arginine salts and the like; and Salts of organic acids, such as glucuronic acid or galacturonic acid, and the like (see, e.g., Berge et al, "Pharmaceutical Salts," Journal of Pharmaceutical Science, 1977,66, 1-19.) certain specific compounds of the invention contain both basic and acidic functional groups that convert the compound to a base or acid addition salt.

Thus, the compounds of the present invention may exist in the form of a salt, such as a salt with a pharmaceutically acceptable acid. The present invention encompasses such salts. Non-limiting examples of such salts include hydrochloride, hydrobromide, phosphate, sulfate, methanesulfonate, nitrate, maleate, acetate, citrate, fumarate, propionate, tartrate (e.g., (+) -tartrate, (-) -tartrate, or mixtures thereof comprising racemic mixtures), succinate, benzoate, and salts formed with amino acids such as glutamic acid and quaternary ammonium salts (e.g., methyl iodide, ethyl iodide, etc.). These salts can be prepared by methods known to those skilled in the art.

The neutral form of the compound is preferably regenerated by contacting the salt with a base or acid and isolating the parent compound in a conventional manner. The parent form of the compound may differ from the various salt forms by certain physical characteristics, such as solubility in polar solvents.

In addition to salt forms, the present invention provides compounds in prodrug form. Prodrugs of the compounds described herein are those compounds that readily undergo chemical changes under physiological conditions to provide the compounds of the present invention. Prodrugs of the compounds described herein may be converted in vivo after administration. In addition, prodrugs can be converted to the compounds of the present invention in an ex vivo environment by chemical or biochemical means, for example, when contacted with a suitable enzyme or chemical reagent.

Certain compounds of the present invention may exist in unsolvated forms as well as solvated forms, including hydrated forms. In general, the solvated forms are equivalent to unsolvated forms and are intended to be encompassed within the scope of the present invention. Certain compounds of the present invention may exist in a variety of crystalline or amorphous forms. In general, all physical forms are equivalent for the uses contemplated by the present invention and are intended to be within the scope of the present invention.

"pharmaceutically acceptable excipient" and "pharmaceutically acceptable carrier" refer to a substance that facilitates administration and absorption of an active agent to a subject, and may be included in the compositions of the present invention without causing a significant adverse toxicological effect to the patient. Non-limiting examples of pharmaceutically acceptable excipients include water, NaCl, standard saline solution, lactated Ringer's solution, common sucrose, common glucose, binders, fillers, disintegrants, lubricants, coatings, sweeteners, flavors, salt solutions (e.g., Ringer's solution), alcohols, oils, gelatin, carbohydrates (e.g., lactose, amylose, or starch), fatty acid esters, hydroxymethylcellulose, polyvinylpyrrolidine, pigments, and the like. Such preparations can be sterilized and, if desired, mixed with auxiliary agents which do not deleteriously react with the compounds of the invention, such as lubricants, preservatives, stabilizers, wetting agents, emulsifiers, salts for influencing osmotic pressure, buffers, coloring and/or perfuming substances, etc. One skilled in the art will recognize that other pharmaceutical excipients are suitable for use in the present invention.

The term "preparing" is intended to encompass formulating the active compound as an encapsulating material with a carrier, resulting in a capsule in which the active component, with or without other carriers, is surrounded by, and thus associated with, the carrier. Similarly, cachets and lozenges were included. Lozenges, powders, capsules, pills, cachets, and troches can be used as solid dosage forms suitable for oral administration.

An "adenosine A2B receptor inhibitor" refers to a compound (e.g., a compound described herein) that reduces the activity of the adenosine A2B receptor when compared to a control, such as in the absence of the compound or a compound known to be inactive. An "adenosine A2A receptor inhibitor" refers to a compound (e.g., a compound described herein) that reduces the activity of the adenosine A2A receptor when compared to a control, such as in the absence of the compound or a compound known to be inactive. An adenosine A2B receptor inhibitor can preferentially bind to the adenosine A2B receptor (i.e., an adenosine A2B receptor inhibitor inhibits adenosine A2B receptor activity, more than an adenosine A2B receptor inhibitor inhibits a different adenosine receptor (e.g., A2A, a1, or A3)).

"contacting" is used in accordance with its ordinary meaning and refers to the process of bringing at least two different species (e.g., chemical compounds comprising biomolecules, or cells) into sufficient proximity to react, interact, or physically touch. However, it will be appreciated that the resulting reaction product may be produced directly from the reaction between the added reagents or from an intermediate from one or more of the added reagents, which may be produced in the reaction mixture.

The term "contacting" may comprise reacting, interacting or physically touching two species, wherein the two species may be a compound and a protein or enzyme as described herein. In some embodiments, contacting comprises interacting a compound described herein with a protein or enzyme involved in the signal transduction pathway.

As defined herein, with reference to a protein, the term "activation/activate/activating, etc." refers to the conversion of a protein from an initial inactive or inactivated state to a biologically active derivative. The term refers to a protein whose activation (activation) or causes it to activate (activating), sensitize or up-regulate signal transduction or enzymatic activity or the amount of the protein, which is reduced in a disease.

As defined herein, the term "activation/active/activating/activator, etc." in reference to a protein-inhibitor interaction means that the activity or function of a protein is positively affected (e.g., increased) relative to the activity or function of the protein in the absence of an activator. In embodiments, activation means positively affecting (e.g., increasing) the concentration or level of protein relative to the concentration or level of protein in the absence of the activating agent. The terms may refer to activation of a protein or causing activation of a protein (activation), sensitizing, or up-regulating signal transduction, or enzymatic activity, or an amount of the protein, which is decreased in a disease-thus, activation may comprise, at least in part, partially or completely increasing stimulation, increasing activation, or causing activation of a protein associated with a disease (e.g., a protein decreased in a disease relative to a non-diseased control), sensitizing, or up-regulating signal transduction, or enzymatic activity, or an amount of the protein. Activation may comprise at least partially or completely increasing stimulation of the protein, increasing activation or causing activation thereof (sensitization activation), sensitizing or up-regulating signal transduction or enzymatic activity or the amount of the protein. The terms "agonist," "activator," "upregulator" and the like refer to a substance that is capable of detectably increasing the expression or activity of a given gene or protein relative to the absence of the agonist. The agonist can increase expression or activity by 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% or more compared to a control in the absence of agonist. In certain instances, the expression or activity is 1.5-fold, 2-fold, 3-fold, 4-fold, 5-fold, 10-fold or more greater than the expression or activity in the absence of an agonist.

As defined herein, the term "inhibit (inhibition/inhibiting, etc.)" with reference to protein-inhibitor interactions means negatively affecting (e.g., decreasing) the activity or function of a protein relative to the activity or function of a protein in the absence of an inhibitor. In embodiments, inhibiting means negatively affecting (e.g., reducing) the concentration or level of the protein relative to the concentration or level of the protein in the absence of the inhibitor. In embodiments, inhibition refers to a reduction in a disease or symptom of a disease. In embodiments, inhibition refers to a decrease in the activity of a particular protein target. Thus, inhibiting comprises at least partially or completely blocking the stimulation of the protein, reducing, preventing or delaying activation, or inactivating, desensitizing, or down-regulating signal transduction or enzymatic activity or the amount of said protein. In embodiments, inhibition refers to a reduction in the activity of a target protein caused by a direct interaction (e.g., binding of an inhibitor to the target protein). In embodiments, inhibition refers to a decrease in the activity of a protein of interest due to an indirect interaction (e.g., binding of an inhibitor to a protein that activates the protein of interest, thereby preventing activation of the protein of interest). An "adenosine A2B receptor inhibitor" is a compound that negatively affects (e.g., reduces) the activity or function of the adenosine A2B receptor relative to the activity or function of the adenosine A2B receptor in the absence of the inhibitor. An "adenosine A2A receptor inhibitor" is a compound that negatively affects (e.g., reduces) the activity or function of the adenosine A2A receptor relative to the activity or function of the adenosine A2A receptor in the absence of the inhibitor.

The terms "inhibitor", "repressor" or "antagonist" or "downregulator" interchangeably refer to a substance capable of detectably reducing the expression or activity of a given gene or protein. An antagonist can reduce expression or activity by 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% or more compared to a control in the absence of the antagonist. In certain instances, the expression or activity is 1.5-fold, 2-fold, 3-fold, 4-fold, 5-fold, 10-fold or less lower than the expression or activity in the absence of the antagonist.

The terms "adenosine A2A receptor" and "AA 2A receptor" and "A2A" and "ADORA 2A" refer to proteins (including homologs, isoforms and functional fragments thereof) having adenylate cyclase activity. The term encompasses any recombinant or naturally occurring variant form of the adenosine A2A receptor thereof that maintains adenosine A2A receptor activity (e.g., within at least 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or 100% activity compared to the wild-type adenosine A2A receptor). In embodiments, the adenosine A2A receptor protein encoded by the ADORA2A gene has an amino acid sequence set forth in or corresponding to Entrez 135, UniProt P29274, or RefSeq (protein) NP _ 000666. In embodiments, the ADORA2A gene has a nucleic acid sequence set forth in refseq (mrna) NM _000675. In embodiments, the amino acid sequence or nucleic acid sequence is a sequence known at the time of filing the present application. In an embodiment, the sequence corresponds to GI: 156142194. in an embodiment, the sequence corresponds to NM _ 000675.5. In an embodiment, the sequence corresponds to NP _ 000667.2. In an embodiment, the sequence corresponds to GI: 4501949. in the examples, the A2A protein corresponds to the sequence:

MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS(SEQ ID NO:1)

the terms "adenosine A2B receptor" and "AA 2B receptor" and "A2B" and "ADORA 2B" refer to proteins (including homologs, isoforms and functional fragments thereof) having adenylate cyclase activity. The term encompasses any recombinant or naturally occurring variant form of the adenosine A2B receptor thereof that maintains adenosine A2B receptor activity (e.g., within at least 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or 100% activity compared to the wild-type adenosine A2B receptor). In an embodiment, the adenosine A2B receptor protein encoded by the ADORA2B gene has an amino acid sequence set forth in or corresponding to Entrez 136, UniProt P29275 or RefSeq (protein) NP _000667. In embodiments, the ADORA2B gene has a nucleic acid sequence set forth in refseq (mrna) NM _000676. In embodiments, the amino acid sequence or nucleic acid sequence is a sequence known at the time of filing the present application. In an embodiment, the sequence corresponds to GI: 4501950. in an embodiment, the sequence corresponds to NM _ 000676.2. In an embodiment, the sequence corresponds to NP _ 000667.1. In the examples, the A2B protein corresponds to the sequence:

MLLETQDALYVALELVIAALSVAGNVLVCAAVGTANTLQTPTNYFLVSLAAADVAVGLFAIPFAITISLGFCTDFYGCLFLACFVLVLTQSSIFSLLAVAVDRYLAICVPLRYKSLVTGTRARGVIAVLWVLAFGIGLTPFLGWNSKDSATNNCTEPWDGTTNESCCLVKCLFENVVPMSYMVYFNFFGCVLPPLLIMLVIYIKIFLVACRQLQRTELMDHSRTTLQREIHAAKSLAMIVGIFALCWLPVHAVNCVTLFQPAQGKNKPKWAMNMAILLSHANSVVNPIVYAYRNRDFRYTFHKIISRYLLCQADVKSGNGQAGVQPALGVGL(SEQ ID NO:2)。

the terms "adenosine a1 receptor" and "a 1 receptor" refer to proteins (including homologs, isoforms, and functional fragments thereof) having adenylate cyclase activity. The term encompasses any recombinant or naturally occurring variant form of the adenosine a1 receptor thereof that maintains adenosine a1 receptor activity (e.g., within at least 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or 100% activity compared to the wild-type adenosine a1 receptor). In an example, the adenosine a1 receptor protein encoded by the ADORA1 gene has an amino acid sequence set forth in or corresponding to Entrez 134, UniProt P30542 or RefSeq (protein) NP _ 000665. In embodiments, the ADORA1 gene has the nucleic acid sequence set forth in refseq (mrna) NM _ 000674. In embodiments, the amino acid sequence or nucleic acid sequence is a sequence known at the time of filing the present application.

The terms "adenosine A3 receptor" and "A3 receptor" refer to proteins (including homologs, isoforms, and functional fragments thereof) having adenylate cyclase activity. The term encompasses any recombinant or naturally occurring variant form of the adenosine A3 receptor thereof that maintains adenosine A3 receptor activity (e.g., within at least 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or 100% activity compared to the wild-type adenosine A3 receptor). In embodiments, the adenosine A3 receptor protein encoded by the ADORA3 gene has an amino acid sequence set forth in or corresponding to Entrez140, UniProt P0DMS8, or RefSeq (protein) NP _ 000668. In an embodiment, the ADORA3 gene has the nucleic acid sequence set forth in refseq (mrna) NM — 000677. In embodiments, the amino acid sequence or nucleic acid sequence is a sequence known at the time of filing the present application.

The term "expression" encompasses any step involved in the production of a polypeptide, including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification, and secretion. Expression can be detected using conventional techniques for detecting proteins (e.g., ELISA, western blot, flow cytometry, immunofluorescence, immunohistochemistry, etc.).

The term "disease" or "condition" refers to a state or health condition of a patient or individual that can be treated with a compound or method provided herein. The disease may be cancer. The disease may be an autoimmune disease. The disease may be a fibrotic disorder (e.g., fibrosis). The disease may be an inflammatory disease. The disease may be a neurodegenerative disease. In some other examples, "cancer" refers to human cancers and carcinomas, sarcomas, adenocarcinomas, lymphomas, leukemias, and the like, including solid and lymphocytic cancers, kidney, breast, lung, bladder, colon, ovary, prostate, pancreas, stomach, brain, head and neck, skin, uterus, testis, glioma, esophageal, and liver cancers (including hepatomas), lymphomas (including acute B lymphoblastic lymphomas), non-Hodgkin's (Hodgkin's) lymphomas (e.g., Burkitt's, small cell, and large cell lymphomas), Hodgkin's lymphomas, leukemias (including AML, ALL, and CML), or multiple myeloma.

As used herein, the term "cancer" refers to all types of cancers, neoplasms or malignancies found in mammals (e.g., humans), including leukemias, lymphomas, carcinomas and sarcomas. Exemplary cancers that can be treated with the compounds or methods provided herein include brain cancer, glioma, glioblastoma, neuroblastoma, prostate cancer, colorectal cancer, pancreatic cancer, cervical cancer, gastric cancer, ovarian cancer, lung cancer, and head cancer. Exemplary cancers that can be treated with the compounds or methods provided herein include: thyroid cancer, cancer of the endocrine system, brain cancer, breast cancer, cervical cancer, colon cancer, head and neck cancer, liver cancer, kidney cancer, lung cancer, non-small cell lung cancer, melanoma, mesothelioma, ovarian cancer, sarcoma, gastric cancer, uterine cancer, neural tube blastoma, colorectal cancer, pancreatic cancer. Other examples include: hodgkin's disease, non-hodgkin's lymphoma, multiple myeloma, neuroblastoma, glioma, glioblastoma multiforme, ovarian cancer, rhabdomyosarcoma, primary thrombocythemia, primary macroglobulinemia, primary brain tumor, cancer, malignant pancreatic cancer, malignant carcinoid cancer, bladder cancer, precancerous skin lesion, testicular cancer, lymphoma, thyroid cancer, neuroblastoma, esophageal cancer, genitourinary tract cancer, malignant hypercalcemia, endometrial cancer, adrenal cortex cancer, neoplasms of the endocrine or exocrine pancreas, medullary thyroid cancer, melanoma, colorectal cancer, papillary thyroid cancer, hepatocellular carcinoma, or prostate cancer.

The term "leukemia" broadly refers to a progressive malignant disease of the blood-forming organs and is generally characterized by the distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias are generally clinically classified based on: (1) duration and character of acute or chronic disease; (2) the cell type involved; bone marrow (myelogenous), lymphocytic (lymphoid) or monocytic; and (3) an increase or no increase in the number of abnormal cells in the blood of leukemia or leukopenia (sub-leukemia). Exemplary leukemias that can be treated with the compounds or methods provided herein include, for example: acute non-lymphocytic leukemia, chronic lymphocytic leukemia, acute myelocytic leukemia, chronic myelocytic leukemia, acute promyelocytic leukemia, adult T-cell leukemia, leukemia deficient in leukemia, basophilic leukemia, blastic leukemia, bovine leukemia, chronic myelocytic leukemia, skin leukemia, embryonic leukemia, eosinophilic leukemia, murine leukemia, hairy cell leukemia, hemoblastic leukemia, hemablastic leukemia, histiocytic leukemia, stem cell leukemia, acute monocytic leukemia, leukopenic leukemia, lymphoid leukemia, lymphoblastic leukemia, lymphocytic leukemia, lymphoid leukemia, lymphosarcoma cell leukemia, mast cell leukemia, megakaryocytic leukemia, human, Small myeloblastic leukemia, monocytic leukemia, myeloblastic leukemia, myelocytic leukemia, myeloblastic leukemia, myelomyeloblastic leukemia, myelomonocytic leukemia, Neglel leukemia (Naegeleukemia), plasma cell leukemia, multiple myeloma, plasma cell leukemia, promyelocytic leukemia, Reed's (Rieder) cell leukemia, Hill's leukemia, stem cell leukemia, sub-leukemia or undifferentiated cell leukemia.

As used herein, the term "lymphoma" refers to a type of cancer that affects both hematopoietic and lymphoid tissues. It begins with lymphocytes; found primarily in blood cells in the lymph nodes, spleen, thymus and bone marrow. The two major types of lymphoma are non-hodgkin's lymphoma and hodgkin's disease. Hodgkin's disease represents approximately 15% of all diagnosed lymphomas. This is a cancer associated with Reed-Sternberg malignant B lymphocytes (Reed-Sternberg malignant B lymphocytes). Non-Hodgkin's lymphomas (NHL) can be classified based on the rate of cancer growth and the cell types involved. Aggressive (higher) and indolent (lower) NHL types exist. Based on the cell type involved, there are B-cells and T-cells NHL. Exemplary B-cell lymphomas that can be treated with the compounds or methods provided herein include, but are not limited to, small lymphocytic lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, extranodal (MALT) lymphoma, nodal (mononuclear B cell) lymphoma, splenic lymphoma, diffuse large cell B lymphoma, burkitt's lymphoma, lymphoblastic lymphoma, immunoblastic large cell lymphoma, or precursor B-lymphoblastic lymphoma. Exemplary T cell lymphomas that can be treated with the compounds or methods provided herein include, but are not limited to, cutaneous T cell lymphoma, peripheral T cell lymphoma, large cell lymphoma multiforme, mycosis fungoides, and precursor T-lymphoid cell lymphoma.

The term "sarcoma" generally refers to a tumor that is composed of a substance such as embryonic connective tissue and generally includes tightly packed cells embedded in a fibrous or homogeneous substance. Sarcomas that can be treated with the compounds or methods provided herein comprise: chondrosarcoma, fibrosarcoma, lymphosarcoma, melanoma, myxosarcoma, osteosarcoma, Abelmoschi sarcoma (Abemethyl ' ssarcoma), liposarcoma, alveolar soft tissue tumor, amelogenic sarcoma, botryoid sarcoma, chloromonosarcoma, choriocarcinoma, embryosarcoma, Wilms ' tumor (Wilms ' sarcoma), endometrioma, stromal tumor, Ewing's sarcoma, myosarcoma, fibrosarcoma, giant cell sarcoma, granulocytic sarcoma, Hodgkin's sarcoma, idiopathic polychrome sarcoma, B-cell immunoblastic sarcoma, lymphoma, T-cell immunoblastic sarcoma, Jensen's sarcoma, Kaposi's sarcoma, Kupffer cell sarcoma (Kupffer cell sarcoma), angiosarcoma, white sarcoma, desmoplastic sarcoma, osteosarcoma, Abelmoschi sarcoma, osteosarcoma, Abelmoschi's sarcoma, liposarcoma, and Epstein-Barr's sarcoma, Reticulocytic sarcoma, Rous sarcoma (Rous sarcoma), serous (serositic) sarcoma, synovial sarcoma, or capillary-expansive sarcoma.

The term "melanoma" refers to tumors produced by the melanocytic system of the skin and other organs. Melanoma that may be treated with the compounds or methods provided herein include, for example: acral freckle melanoma, leucoma, benign juvenile melanoma, cloudlan melanoma (Cloudman' S melanoma), S91 melanoma, hadrine-paschen melanoma (Harding-Passey melanoma), juvenile melanoma, lentigo melanoma, malignant nodular melanoma, scrotal melanoma, or superficial spreading melanoma.

The term "carcinoma" refers to a malignant new growth made up of epithelial cells that tends to infiltrate the surrounding tissues and cause metastasis of the cancer. Exemplary carcinomas that can be treated with the compounds or methods provided herein include, for example: medullary thyroid carcinoma, familial medullary thyroid carcinoma, acinar carcinoma, alveolar carcinoma, adenoid cystic carcinoma (adenocystic carcinoma), adenoid cystic carcinoma (adenoid cystic carcinoma), adenocarcinoma, adrenocortical carcinoma, alveolar cell carcinoma, basal-like cytoma, basal-like carcinoma, basal squamous cell carcinoma, bronchioloalveolar carcinoma, bronchiolobronchial carcinoma, bronchial carcinoma, cerebroma, cholangiocellular carcinoma, choriocarcinoma, jelly-like carcinoma, acne carcinoma, uterine corpus carcinoma, ethmoid carcinoma, armor-like carcinoma, skin carcinoma, columnar cell carcinoma, tubular carcinoma, hard carcinoma, embryonic carcinoma, medullary carcinoma, epidermoid carcinoma, adenoid epithelial carcinoma, explanted carcinoma, ulcerative carcinoma, fibrocarcinoma, gelatininiformenia carcinoma, glioma, giant cell carcinoma, granuloma, adenocarcinoma, stratified cell carcinoma, maternal cell carcinoma, schlecular cell carcinoma, polycystic cell carcinoma (hepatocellular carcinoma), choriocarcinoma, squamous cell carcinoma, and squamous cell carcinoma (hepatocellular carcinoma), squamous cell carcinoma (hepatocellular carcinoma), squamous cell carcinoma, squamous cell, Hyaluronan cancer, adrenocarcinoid tumor, juvenile embryonal carcinoma, carcinoma in situ, carcinoma in epidermis, carcinoma in epithelium, Klompecher's carcinoma, Kulchitzky-cell carcinoma, large cell carcinoma, lenticular carcinoma, lipomatoid carcinoma, lymphatic epithelial carcinoma, medullary carcinoma, melanoma, soft carcinoma, mucinous cell carcinoma, mucoepidermoid carcinoma, mucinous-like carcinoma, nasopharyngeal carcinoma, oat cell carcinoma, ossified carcinoma, sclerotic-like carcinoma, papillary carcinoma, periportal carcinoma, invasive carcinoma, echinocytic carcinoma, limphoid carcinoma, renal tumor cell carcinoma, storage cell carcinoma, schciencoderma, cinoma (genital-like carcinoma), genital cell carcinoma, polima, simple potato cell carcinoma, or small-like carcinoma, simply A globular cell cancer, a spindle cell cancer, a medullary cancer, a squamous cell cancer, a tethered cancer, a vasodilatory cancer, a transitional cell cancer, a nodular skin cancer, a warty cancer, or a choriocarcinoma.

The term "treatment" refers to any indication of successful treatment or amelioration of an injury, disease, pathology, or condition, including any objective or subjective parameter, such as elimination; (iii) alleviating; reduce symptoms or make injuries, pathologies, or conditions more tolerable to the patient; slowing the rate of degeneration or decline; making the final denaturation point less debilitating; or improving the physical and mental health of the patient. Treatment or amelioration of symptoms can be based on objective or subjective parameters; including results of physical examination, neuropsychiatric examination, and/or mental evaluation. The term "treating" and morphological changes thereof can include preventing an injury, pathology, condition, or disease. In an embodiment, the treatment is prophylaxis. In embodiments, the treatment does not comprise prophylaxis.

As used herein, "treatment" (and as is well understood in the art) also broadly encompasses any method for obtaining a beneficial or desired result, including a clinical result, in a condition of an individual. Beneficial or desired clinical results can include, but are not limited to, alleviation or amelioration of one or more symptoms or conditions, diminishment of extent of disease, stabilization (i.e., not worsening) of disease state, prevention of disease metastasis or spread, delay or slowing of disease progression, amelioration or palliation of the disease state, diminishment of disease recurrence, and remission, whether partial or complete and whether detectable or undetectable. In other words, "treatment" as used herein encompasses any cure, amelioration or prevention of a disease. Treatment can prevent disease occurrence; inhibiting the spread of disease; alleviating the symptoms of the disease; completely or partially remove the underlying cause of the disease; shortening the duration of the disease; or a combination of these. As used herein, "treatment" includes prophylactic treatment. The method of treatment comprises administering to the subject a therapeutically effective amount of the active agent. The step of administering may consist of a single administration, or may comprise a series of administrations. The length of treatment depends on a variety of factors, such as the severity of the condition, the age of the patient, the concentration of the active agent, the activity of the composition used in the treatment, or a combination thereof. It will also be appreciated that the effective dose of the agent used for treatment or prophylaxis can be increased or decreased over a particular course of treatment or prophylaxis regimen. Dose variation can result and become apparent by standard diagnostic assays known in the art. In some cases, long-term administration may be required. For example, the composition is administered to an individual in an amount sufficient to treat the patient for a sufficient time.

The term "preventing" refers to reducing the occurrence of a disease or disease symptom in a patient (e.g., an adenosine A2B receptor or adenosine A2A receptor-related disease or disease symptom in a patient). As indicated above, prevention may be complete (no detectable symptoms) or partial, such that fewer symptoms are observed or the severity of symptoms is reduced than would be possible without treatment.

"patient" or "subject in need thereof" refers to a living organism suffering from or predisposed to a disease or condition that can be treated by administration of a pharmaceutical composition as provided herein. Non-limiting examples include humans, other mammals, bovines, rats, mice, dogs, monkeys, goats, sheep, cattle, deer, and other non-mammals. In some embodiments, the patient is a human.

An "effective amount" is an amount of a compound sufficient to achieve the stated purpose (e.g., achieve its effect of administration, treat a disease, reduce enzyme activity, increase enzyme activity, decrease signaling pathways, or decrease one or more symptoms of a disease or condition) relative to the absence of the compound. An example of an "effective amount" is an amount sufficient to cause treatment, prevention, or reduction of one or more symptoms of a disease, which may also be referred to as a "therapeutically effective amount". "reducing" one or more symptoms (and grammatical equivalents of this phrase) means reducing the severity or frequency of the symptoms, or eliminating the symptoms. A "prophylactically effective amount" of a drug is an amount that will have the desired prophylactic effect when the drug is administered to an individual, e.g., to prevent or delay the onset (or recurrence) of an injury, disease, pathology, or condition, or to reduce the likelihood of the onset (or recurrence) of an injury, disease, pathology, or condition, or a symptom thereof. The full prophylactic effect does not necessarily occur by administration of one dose, and may occur after administration of only a series of doses. Thus, a prophylactically effective amount may be administered in one or more administrations. As used herein, "activity-reducing amount" refers to the amount of antagonist required to reduce the enzymatic activity relative to the absence of the antagonist. As used herein, "functionally disrupting amount" refers to the amount of antagonist required to disrupt the function of an enzyme or protein relative to the absence of the antagonist. The precise amount will depend on The purpose of The treatment and will be determined by those skilled in The Art using known techniques (see, e.g., Lieberman, Pharmaceutical Dosage Forms (volumes 1-3, 1992); Lloyd, Art, Science and Technology in Pharmaceutical Compounding (The Art, Science and Technology in Pharmaceutical Compounding (1999); Pickar dose calculation (Dosage Calculations) (1999) and Remington, Pharmaceutical Science and Practice (Remington: The Science and Practice of pharmacy), 20 th edition, 2003, Gennaro edition, Lippincott, Williams & Wilkins).

For any of the compounds described herein, a therapeutically effective amount can be initially determined according to cell culture analysis. The target concentration will be the concentration of active compound that is capable of achieving the methods described herein, as measured using the methods described herein or known in the art.

As is well known in the art, a therapeutically effective amount for use in humans can also be determined from animal models. For example, the doses useful in humans are formulated to achieve concentrations found to be effective in animals. The dosage in humans can be adjusted by monitoring the effect of the compound and adjusting the dosage up or down as described above. Adjusting the dose to achieve maximal efficacy in humans based on the methods described above and other methods is well within the ability of one of ordinary skill in the art.

The term "therapeutically effective amount" as used herein means an amount of a therapeutic agent sufficient to ameliorate a condition, as described above. For example, for a given parameter, a therapeutically effective amount will show an increase or decrease of at least 5%, 10%, 15%, 20%, 25%, 40%, 50%, 60%, 75%, 80%, 90%, or at least 100%. Therapeutic efficacy may also be expressed as a "fold" increase or decrease. For example, a therapeutically effective amount can have an effect of at least 1.2-fold, 1.5-fold, 2-fold, 5-fold, or more relative to a control.

The dosage may vary depending on the requirements of the patient and the compound employed. In the context of the present invention, the dose administered to a patient should be sufficient to achieve a beneficial therapeutic response in the patient over time. The size of the dose will also be determined by the presence, nature and extent of any adverse side effects. The determination of the appropriate dosage for a particular situation is within the skill of the physician. Generally, treatment is initiated at a dose that is less than the optimal dose of the compound. Thereafter, the dose is increased in small increments until the optimum effect under these circumstances is achieved. The dose and interval may be independently adjusted to achieve levels of the administered compound that are effective for the particular clinical indication being treated. This will provide a treatment regimen commensurate with the severity of the disease condition in the individual.

As used herein, the term "administering" means orally administering to a subject, in the form of a suppository, topically contacting, intravenously, intraperitoneally, intramuscularly, intralesionally, intrathecally, intranasally, or subcutaneously, or implanting a slow release device (e.g., a mini osmotic pump). Administration is by any route compatible with the formulation, including parenteral and transmucosal (e.g., buccal, sublingual, palatine, gingival, nasal, vaginal, rectal, or transdermal). Parenteral administration includes, for example, intravenous, intramuscular, intraarteriolar, intradermal, subcutaneous, intraperitoneal, intracerebroventricular, and intracranial. Other modes of delivery include, but are not limited to, the use of liposome formulations, intravenous infusion, transdermal patches, and the like.

By "co-administration" it is meant that the compositions described herein are administered simultaneously with, just before, or just after the administration of one or more additional therapies. The compounds of the invention may be administered alone or may be co-administered to a patient. Co-administration is meant to encompass the simultaneous or sequential administration of the compound(s), either alone or in combination. Thus, the formulations may also be combined with other active substances (e.g. to reduce metabolic degradation) when desired. The compositions of the present invention may be delivered transdermally, by a topical route, or formulated as application sticks, solutions, suspensions, emulsions, gels, creams, ointments, pastes, jellies, paints, powders, and aerosols.

As used herein, "cell" refers to a cell that performs a metabolic or other function sufficient to maintain or replicate its genomic DNA. Cells can be identified by methods well known in the art, including, for example, the presence of an intact membrane, staining with a particular dye, being capable of producing progeny, or in the case of a gamete being capable of combining with a second gamete to produce a live progeny. The cells may comprise prokaryotic and eukaryotic cells. Prokaryotic cells include, but are not limited to, bacteria. Eukaryotic cells include, but are not limited to, yeast cells and cells derived from plants and animals, such as mammalian, insect (e.g., noctuid), and human cells. It may be suitable when the cells are naturally non-adherent or have been treated (e.g., by trypsinization) so as not to adhere to the surface.

"control" or "control experiment" is used in its ordinary sense and refers to an experiment in which the individual or reagents of the experiment are treated as in a parallel experiment, except that the procedures, reagents, or variables of the experiment are omitted. In some cases, a control is used as a standard for comparison in evaluating the effect of an experiment. In some embodiments, a control is a measure of protein activity in the absence of a compound as described herein (including examples and examples).

The term "modulator" refers to a composition that increases or decreases the level of a target molecule or the function of a target molecule or the physical state of a target of a molecule. In some embodiments, the adenosine A2B receptor or adenosine A2A receptor-related disease modulator is a compound that reduces the severity of one or more symptoms of a disease (e.g., cancer) associated with the adenosine A2B receptor or the adenosine A2A receptor. An adenosine A2B receptor or adenosine A2A receptor modulator is a compound that increases or decreases the activity or function or level of activity or function of the adenosine A2B receptor or adenosine A2A receptor relative to the activity or function or level of activity or function of the adenosine A2B receptor or adenosine A2A receptor in the absence of the adenosine A2B receptor or adenosine A2A receptor modulator.

The term "modulate" is used in accordance with its ordinary meaning and is meant to act to alter or change one or more characteristics. "Modulation" refers to a method of altering or changing one or more characteristics. For example, as applied to the effect of a modulator on a target protein, modulation means alteration by increasing or decreasing the identity or function of the target molecule, or the amount of the target molecule.

In the context of a substance or substance activity or function associated with a disease (e.g., a protein-related disease, a cancer associated with adenosine A2B receptor activity, an adenosine A2B receptor-related cancer, an adenosine A2B receptor-related disease (e.g., cancer)), the term "associated with" or "associated with …" means that the disease (e.g., cancer) is caused (in whole or in part) by the substance or substance activity or function, or that a symptom of the disease is caused (in whole or in part) by the substance or substance activity or function. For example, a cancer associated with adenosine A2B receptor or adenosine A2A receptor activity or function may be a cancer arising (in whole or in part) from aberrant adenosine A2B receptor or adenosine A2A receptor function (e.g., enzymatic activity, protein-protein interactions, signaling pathways), or wherein a particular symptom of a disease is a cancer arising (in whole or in part) from aberrant adenosine A2B receptor or adenosine A2A receptor activity or function. As used herein, a pathogen is described as being associated with a disease if it can be the target of treatment of the disease. For example, in instances where increasing adenosine A2B receptor or adenosine A2A receptor activity or function (e.g., signaling pathway activity) results in a disease (e.g., cancer), a cancer associated with adenosine A2B receptor or adenosine A2A receptor activity or function or an adenosine A2B receptor or adenosine A2A receptor-associated disease (e.g., cancer) may be treated with an adenosine A2B receptor or adenosine A2A receptor modulator or adenosine A2B receptor or adenosine A2A receptor inhibitor.

As used herein, the term "abnormal" refers to something other than normal. When used to describe enzymatic activity or protein function, abnormal refers to an activity or function that is higher or lower than the average of normal control or normal non-diseased control samples. Abnormal activity can refer to an amount of activity that causes a disease, wherein returning abnormal activity to normal or a non-disease related amount (e.g., by administering a compound as described herein or using a method as described herein) causes a reduction in the disease or one or more symptoms of the disease.

As used herein, the term "signaling pathway" refers to a series of interactions between cellular components and optionally extracellular components (e.g., proteins, nucleic acids, small molecules, ions, lipids) that transmit changes in one component to one or more other components, which in turn may transmit changes to additional components, which optionally propagate to other signaling pathway components. For example, binding of an adenosine A2B receptor or an adenosine A2A receptor to a compound as described herein may reduce the level of a product of a reaction catalyzed by the adenosine A2B receptor or the adenosine A2A receptor or a downstream derivative of such a product, or binding may reduce the interaction between the adenosine A2B receptor or the adenosine A2A receptor or the adenosine A2B receptor or the adenosine A2A receptor reaction product and a downstream effector or signaling pathway component, thereby causing a change in cell growth, proliferation or survival.

As used herein, the term "fibrosis" refers to the formation of excess fibrous connective tissue. The term "fibrotic disease" refers to a disease or condition caused by abnormal fibrosis, or in which the symptoms are abnormal fibrosis (e.g., relative to a control individual without the disease). Examples of fibrotic diseases that may be treated with the compounds, pharmaceutical compositions or methods described herein include Idiopathic Pulmonary Fibrosis (IPF), myocardial infarction, myocardial hypertrophy, heart failure, cirrhosis, acetaminophen (Tylenol) hepatotoxicity, hepatitis C liver disease, fatty liver (hepatosteatosis/fatty liver disease), and liver fibrosis.

As used herein, the term "neurodegenerative disease" refers to a disease or condition in which the function of the nervous system of an individual is weakened (e.g., relative to a control individual not suffering from neurodegenerative disease). Examples of neurodegenerative diseases that can be treated with the compounds, pharmaceutical compositions, or methods described herein include: alexander's disease, Epstein-Barr's disease, Alzheimer's disease, amyotrophic lateral sclerosis, ataxia telangiectasia, Pasteur's disease (also known as Scheimer-Vogt-Sjogren-Batten disease), Bovine spongiform encephalopathy (Bovine spongiform encephalopathy; BSE), Karma disease (Canavan disease), Cockayne syndrome, corticobasal degeneration, Creutzfeldt-Jakob disease, temporal dementia, Gerstmann-Straussler syndrome (Gerstmann-Straussler-Scheinker)

Figure BDA0002469898950000351

-Scheinker syndrome), Huntington's disease, HIV-associated dementia, Kennedy's disease, Krabbe's disease, kuru (kuru), Lewy body dementia (Lewy body division), macyoto-Joseph disease (spinocerebellar type 3), multiple sclerosisChemosis, multiple systemic atrophy, narcolepsy, Neurobreiosis, Parkinson's Disease, Pemeus-Merzbacher Disease, Pick's Disease, primary lateral sclerosis, prion Disease, Refsum's Disease, Sandhoff's Disease, Schlder's Disease, subacute combined degeneration of subacute spinal cord secondary to pernicious anemia, schizophrenia, spinocerebellar disorders (of various types with different characteristics), spinal muscular atrophy, Spirot-Richardson-Olszewski Disease, WolRam Syndrome, transverse myelitis, Marchot-Mariothis, or tuberculosis. Examples of neurodegenerative diseases that can be treated with the compounds, pharmaceutical compositions, or methods described herein include: retinitis pigmentosa, amyotrophic lateral sclerosis, retinal degeneration, macular degeneration, Parkinson's disease, Alzheimer's disease, Huntington's disease, prion disease, Creutzfeldt-Jakob disease, or Kuru.

II. Compound

In one aspect, a compound is provided having the formula:

L1is a bond, substituted or unsubstituted alkylene, or substituted or unsubstituted heteroalkylene. In the examples, L1Is substituted or unsubstituted C1-C3Alkylene or substituted or unsubstituted 2-to 3-membered heteroalkylene. Ring a is aryl or heteroaryl. R1Independently of one another is halogen, -CX1 3、-CHX1 2、-CH2X1、-OCX1 3、-OCH2X1、-OCHX1 2、-CN、-SR1D、-NR1AR1B、-C(O)R1C、-C(O)OR1C、-C(O)NR1AR1B、-OR1D、-NR1AC(O)R1C、-NR1AC(O)OR1C、-SO2R1D、-SO2NR1AR1B、-NR1ASO2R1DSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl. The symbol z1 is an integer from 0 to 5.

R2Independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. R3Independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. R2And R3May optionally be joined to form a substituted or unsubstituted heterocycloalkyl group.

R4Independently hydrogen, halogen, -CX4 3、-CHX4 2、-CH2X4、-OCX4 3、-OCH2X4、-OCHX4 2、-CN、-SR4D、-NR4AR4B、-C(O)R4C、-C(O)OR4C、-C(O)NR4AR4B、-OR4D、-NR4AC(O)R4C、-NR4AC(O)OR4CSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl. R5Independently hydrogen, halogen, -CX5 3、-CHX5 2、-CH2X5、-OCX5 3、-OCH2X5、-OCHX5 2、-CN、-SR5D、-NR5AR5B、-C(O)R5C、-C(O)OR5C、-C(O)NR5AR5B、-OR5D、-NR5AC(O)R5C、-NR5AC(O)OR5CSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl.

Each R1A、R1B、R1C、R1D、R4A、R4B、R4C、R4D、R5A、R5B、R5CAnd R5DIndependently hydrogen, halogen, -CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H. -NHC (O) H, -NHC (O) OH, -NHOH, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. In the examples, each R1A、R1B、R1C、R1D、R4A、R4B、R4C、R4D、R5A、R5B、R5CAnd R5DIndependently hydrogen, halogen, -CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H. -NHC (O) H, -NHC (O) OH, -NHOH, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl or unsubstituted heteroaryl. R bound to the same nitrogen atom1AAnd R1BThe substituents may optionally join to form a substituted or unsubstituted heterocycloalkyl or a substituted or unsubstituted heteroaryl. R bound to the same nitrogen atom4AAnd R4BThe substituents may optionally join to form a substituted or unsubstituted heterocycloalkyl or a substituted or unsubstituted heteroaryl. R bound to the same nitrogen atom5AAnd R5BThe substituents may optionally join to form a substituted or unsubstituted heterocycloalkyl or a substituted or unsubstituted heteroaryl. Each X1、X4And X5Independently is-F, -Cl, -Br or-I.

In embodiments, the compound has the formula:

Figure BDA0002469898950000381

wherein ring B is heterocycloalkyl and R4、R5、L1Ring A, R1And z1 as described herein (including the examples). R6Independently of one another is halogen, -CX6 3、-CHX6 2、-CH2X6、-OCX6 3、-OCH2X6、-OCHX6 2、-CN、-SR6D、-SO2R6D、-NR6AR6B、-C(O)R6C、-C(O)OR6C、-C(O)NR6AR6B、-OR6D、-NR6AC(O)R6C-、-NR6AC(O)NR6C-、-NR6AC(O)OR6C、-SO2NR6AR6B、-NR6ASO2R6DSubstituted or unsubstituted alkyl, substituted or unsubstituted heteroalkylA substituted or unsubstituted heterocycloalkyl, a substituted or unsubstituted aryl, or a substituted or unsubstituted heteroaryl. The symbol z6 is an integer from 0 to 10.

Each R6A、R6B、R6CAnd R6DIndependently hydrogen, halogen, -CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H. -NHC (O) H, -NHC (O) OH, -NHOH, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. R bound to the same nitrogen atom6AAnd R6BThe substituents may optionally join to form a substituted or unsubstituted heterocycloalkyl or a substituted or unsubstituted heteroaryl. Symbol X6Independently is-F, -Cl, -Br or-I.

In embodiments, the compound has the formula:

Figure BDA0002469898950000391

wherein R is2、R3、R4、R5、L1、R1And z1 as described herein (including the examples). Symbol W1Is C (R)1) CH or N.

In embodiments, the compound has the formula:wherein R is2、R3、R4、R5、L1、R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:wherein R is2、R3、R4、R5、L1、R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:wherein R is2、R3、R4、R5、L1And R1As described herein, including the examples.

In embodiments, the compound has the formula:wherein R is2、R3、R4、R5、L1And R1As described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000402

wherein ring B is heterocycloalkyl and R4、R5、L1、R1Ring a and z1 are as described herein, including the examples.

In embodiments, the compound has the formula:wherein R is6、z6、R4、R5、L1、R1Ring a and z1 are as described herein, including the examples.

In the examples, compoundsThe compound has the formula:

Figure BDA0002469898950000411

wherein R is6、z6、R4、R5、L1、R1Ring a and z1 are as described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000412

wherein R is6、z6、R4、R5、L1、R1Ring a and z1 are as described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000413

wherein R is6、z6、R4、R5、L1、R1、W1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:wherein R is6、z6、R4、R5、L1、R1Ring B and z1 are as described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000421

wherein R is6、z6、R4、R5、L1、R1Ring B and z1 are as described herein, including the examples.

In embodiments, the compound has the formula:wherein R is6、z6、R4、R5、L1、R1And ring B as described herein (including the examples).

In embodiments, the compound has the formula:

Figure BDA0002469898950000423

wherein R is6、z6、R4、R5、L1、R1And ring B as described herein (including the examples).

In embodiments, the compound has the formula:

Figure BDA0002469898950000431

wherein R is6、z6、R4、L1、R1And ring B as described herein (including the examples).

In embodiments, the compound has the formula:wherein R is6、z6、R4、L1、R1And ring B as described herein (including the examples).

In embodiments, the compound has the formula:

wherein R is6A、R6B、R6C、R4、R5、L1Ring A, z1, R1And ring B as described herein (including the examples).

In embodiments, the compound has the formula:

Figure BDA0002469898950000442

wherein R is6A、R6B、R6C、R4、R5、L1Ring A, z1 and R1As described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000451

wherein R is6A、R6B、R6C、R4、R5、L1Ring A, z1 and R1As described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000453

wherein R is1、z1、R6A、R6B、R6C、R4And R5As described herein, including the examples. In embodiments, the compound has the formula:

Figure BDA0002469898950000462

wherein R is1、z1、R6A、R6B、R6C、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000463

wherein R is6A、R6B、R6C、R4And R5As described herein, including the examples. In embodiments, the compound has the formula:

Figure BDA0002469898950000472

wherein R is6A、R6B、R6C、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:

wherein R is4、R5、L1Ring A, R1And z1 as described herein (including the examples); and z16 is an integer from 0 to 8. R35Is oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F. Substituted or unsubstituted alkyl, substituted orUnsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

In embodiments, the compound has the formula:

Figure BDA0002469898950000482

wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples); and z16 is an integer from 1 to 8.

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples); and z16 is an integer from 1 to 8.

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples); and z16 is an integer from 1 to 8.

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples); and z16 is an integer from 1 to 8.

In embodiments, the compound has the formula:

Figure BDA0002469898950000501

wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples); and z16 is an integer from 1 to 8.

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples); and z16 is an integer from 1 to 8.

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples); and z16 is an integer from 1 to 8.

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples); and z16 is an integer from 1 to 8.

In embodiments, the compound has the formula:

Figure BDA0002469898950000512

wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples); and z16 is an integer from 1 to 8.

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples); and z16 is an integer from 1 to 8.

In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

Figure BDA0002469898950000523

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

Figure BDA0002469898950000531

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

Figure BDA0002469898950000534

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000542

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000551

wherein R is6、z6、R4、R5And R1As described herein, including the examples.

In embodiments, the compound has the formula:

wherein R is6、z6、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:

wherein R is6、z6、R4、R5And R1As described herein, including the examples.

In embodiments, the compound has the formula:

wherein R is6、z6、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:

wherein R is6、R4、R5And R1As described herein, including the examples.

In embodiments, the compound has the formula:

wherein R is6、R4、R5And R1As described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000571

wherein R is1、R4And R5As described herein.

In embodiments, the compound has the formula:

Figure BDA0002469898950000572

wherein R is1、R4And R5As described herein.

In embodiments, the compound has the formula:

Figure BDA0002469898950000573

wherein R is1、R4And R5As described herein.

In embodiments, the compound has the formula:

wherein R is6、z6、R1、R4And R5As described herein.

In embodiments, the compound has the formula:

Figure BDA0002469898950000582

wherein R is4、R5Z6 and R6As described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000583

wherein R is6、R1、R4And R5As described herein.

In embodiments, the compound has the formula:

Figure BDA0002469898950000591

wherein R is6、R4And R5As described herein.

In embodiments, the compound has the formula:

wherein R is1、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:

wherein R is1、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000601

wherein R is1、R4And R5As described herein (including the examples); and wherein R6.1And R6.2Each R at a fixed position on the bonded ring6。R6.1And R6.2Can independently be R as described herein (including any aspect, embodiment, example, drawing, or technical scheme)6Any substituent of (1). R6.1And R6.2May be hydrogen.

In embodiments, the compound has the formula:

wherein R is1、z1、R2And R4As described herein, including the examples. In embodiments, the compound has the formula:

Figure BDA0002469898950000603

wherein R is1、z1、R2And R4As described herein, including the examples. In embodiments, the compound has the formula:wherein R is1、z1、R2And R4As described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000612

wherein R is1Z1, ring A, L1、R3、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:wherein R is1、z1、W1、L1、R3、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:wherein R is1、z1、L1、R3、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000621

wherein R is1、z1、L1、R3、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000622

wherein R is1、L1、R3、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:wherein R is1、L1、R3、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:wherein L is1、R3、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:wherein L is1、R3、R4And R5As described herein, including the examples.

In embodiments, the compound has the formula:wherein R is1、z1、W1、L1And R3As described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000633

wherein R is1Z1, ring A, L1、R4And R5As described herein (including the examples); and wherein L2Is a bond, -S (O)2-、-S(O)2NH-、-NHS(O)2-, -C (O) -, -C (O) NH-, -NHC (O) -, -NHC (O) O-, -NHC (O) NH-, -C (O) O-, -OC (O) -, substituted or unsubstituted alkylene, substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene; ring C is cycloalkyl, heterocycloalkyl, aryl or heteroaryl; and z24 is an integer from 0 to 10. R24Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R25Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R25Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R25Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R25Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R25Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R25Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In an embodiment, z24 is 1. In an embodiment, z24 is 2. In an embodiment, z24 is 0.

In embodiments, the compound has the formula:wherein R is1、z1、L1、R4、R5、L2Ring C, R24And z24 as described herein (including the examples).

In the examplesThe compound has the formula:

Figure BDA0002469898950000642

wherein R is1、z1、L1、R4、R5、L2Ring C, R24And z24 as described herein (including the examples).

In embodiments, the compound has the formula:

Figure BDA0002469898950000651

wherein L is2、R4、R5、L1Ring A, z1, R1And ring B as described herein (including the examples). R36Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R37Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R37Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R37Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R37Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl,3-to 6-membered heterocycloalkyl or 5-to 6-membered heterocycloalkyl), with R37Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R37Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). The symbol z36 is an integer from 0 to 10. In an embodiment, z36 is 1. In an embodiment, z36 is 2. In the examples, when R35Is a substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl), R35May be referred to herein as (Ring D) - (R)36)z36. In the examples, L2Is that

Figure BDA0002469898950000662

Wherein z16 is as described herein, including the examples. In the examples, L2Is that

Figure BDA0002469898950000665

In the examples, L2Is that

Figure BDA0002469898950000668

In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:

Figure BDA0002469898950000672

wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:

Figure BDA0002469898950000683

wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:

Figure BDA0002469898950000691

wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:

Figure BDA0002469898950000693

wherein R is35、R4、R5、L1Ring A, R1And z1 as described herein (including the examples).

In embodiments, the compound has the formula:

Figure BDA0002469898950000701

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

Figure BDA0002469898950000702

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

Figure BDA0002469898950000713

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as defined in (A), (B), (CIncluding the examples). In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples. In embodiments, the compound has the formula:

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples.

In embodiments, the compound has the formula:

Figure BDA0002469898950000723

wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples.

In embodiments, the compound has the formula:wherein R is35、R4、R5、L1Ring A, R1Z16 and z1 are as described herein, including the examples.

In the examples, the compounds areWherein R is35、R1And z1 as described hereinThe above-mentioned processes are described.

In the examples, the compounds are

Figure BDA0002469898950000734

Wherein R is35、R1And z1 are as described herein.

In the examples, the compounds areWherein R is35、R1And z1 are as described herein.

In the examples, the compounds areWherein R is35And R1As described herein.

In the examples, the compounds areWherein R is35And X1As described herein.

In the examples, the compounds are

Figure BDA0002469898950000744

Wherein R is35As described herein.

In the examples, the compounds areWherein R is35As described herein.

In the examples, the compounds areWherein R is1And R35As described herein.

In the examples, the compounds are

Figure BDA0002469898950000753

Wherein R is1And R35As described herein.

In the examples, the compounds areWherein R is1And R35As described herein.

In the examples, the compounds are

Figure BDA0002469898950000761

Wherein X1And R35As described herein.

In the examples, the compounds areWherein R is35As described herein.

In the examples, the compounds are

Figure BDA0002469898950000763

Wherein R is35As described herein.

In the examples, the compounds areWherein R is1Z1 and R35As described herein.

In the examples, the compounds areWherein R is1And R35As described herein.

In the examples, the compounds areWherein R is1And R35As described herein.

In the examples, the compounds areWherein R is1And R35As described herein.

In the examples, the compounds areWherein R is1And R35As described herein.

In the examples, the compounds areWherein z1, R1And R35As described herein.

In the examples, the compounds areWherein R is1Z1 and R35As described herein.

In the examples, the compounds are

Figure BDA0002469898950000783

Wherein z1, R1And R35As described herein.

In the examples, the compounds are

Figure BDA0002469898950000784

Wherein R is1And R35As described herein.

In the examples, the compounds areWherein R is1And R35As described herein.

In the examples, the compounds are

Figure BDA0002469898950000792

Wherein R is1And R35As described herein.

In the examples, L2Is a substituted or unsubstituted alkylene (e.g., C)1-C8Alkylene, or a mixture thereof,C1-C6Alkylene or C1-C4Alkylene). In the examples, L2Is a substituted alkylene group (e.g. C)1-C8Alkylene radical, C1-C6Alkylene or C1-C4Alkylene). In the examples, L2Is unsubstituted alkylene (e.g. C)1-C8Alkylene radical, C1-C6Alkylene or C1-C4Alkylene). In the examples, L2Is a substituted or unsubstituted heteroalkylene group (e.g., 2-to 8-membered heteroalkylene, 2-to 6-membered heteroalkylene, or 2-to 4-membered heteroalkylene). In the examples, L2Is a substituted heteroalkylene group (e.g., a 2-to 8-membered heteroalkylene group, a 2-to 6-membered heteroalkylene group, or a 2-to 4-membered heteroalkylene group). In the examples, L2Is unsubstituted heteroalkylene (e.g., 2-to 8-membered heteroalkylene, 2-to 6-membered heteroalkylene, or 2-to 4-membered heteroalkylene). In the examples, L2Is substituted or unsubstituted C1-C6An alkylene group. In the examples, L2Is substituted or unsubstituted C1-C4An alkylene group. In the examples, L2Is substituted or unsubstituted C1-C3An alkylene group. In the examples, L2Is substituted or unsubstituted C1-C2An alkylene group.

In the examples, L2Is that

Figure BDA0002469898950000793

Figure BDA0002469898950000802

Wherein z16 is as described herein, including the examples.

In the examples, L2Is that

Figure BDA0002469898950000803

In the examples, L2Is that

Figure BDA0002469898950000805

In the examples, L2Is that

Figure BDA0002469898950000806

In the examples, L2Is that

Figure BDA0002469898950000807

In the examples, L2Is thatIn the examples, L2Is that

Figure BDA0002469898950000809

In the examples, L2Is that

Figure BDA00024698989500008010

In the examples, L2Is that

Figure BDA00024698989500008011

In the examples, L2Is thatIn the examples, L2Is thatIn the examples, L2Is that

Figure BDA0002469898950000813

In the examples, L2Is thatIn the examples, L2Is that

Figure BDA0002469898950000815

In the examples, L2Is that

Figure BDA0002469898950000816

In the examples, L2Is thatIn the examples, L2Is thatIn the examples, L2Is thatIn the examples, L2Is thatIn the examples, L2Is that

Figure BDA00024698989500008111

In the examples, L2Is that

Figure BDA00024698989500008112

In the examples, L2Is thatIn the examples, L2Is that

Figure BDA00024698989500008114

In the examples, L2Is thatIn the examples, L2Is that

Figure BDA00024698989500008116

In the implementation ofIn the examples, R1Is substituted or unsubstituted C1-C6Alkyl or substituted or unsubstituted 2 to 6 membered heteroalkyl.

In the examples, R1Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R20Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl) or by R20Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl).

In the examples, R1Is by R20Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R1Is by R20Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R1Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R1Is by R20Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl)). In the examples, R1Is by R20Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R1Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl).

In the examples, R1A、R1B、R1CAnd R1DIndependently hydrogen, halogen, -CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2Quilt R20Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl) or by R20Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl).

In the examples, R1A、R1B、R1C、R1DIndependently is by R20Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R1A、R1B、R1CAnd R1DIndependently is by R20Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R1A、R1B、R1CAnd R1DIndependently is unsubstitutedAlkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R1A,R1B,R1C,R1Dare independentlyR20-a substitated or unsubstitated heteroalkyi (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R1A、R1B、R1CAnd R1DIndependently is by R20Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R1A、R1B、R1CAnd R1DIndependently an unsubstituted heteroalkyl group (e.g., a 2-to 8-membered heteroalkyl group, a 2-to 6-membered heteroalkyl group, or a 2-to 4-membered heteroalkyl group).

In the examples, R1A、R1B、R1CAnd R1DIndependently is by R20Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R20Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R20Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R20Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

R20Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R21Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R21Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R21Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R21Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R21Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R21Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

R21Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R22Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical、C1-C6Alkyl or C1-C4Alkyl), by R22Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R22Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R22Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R22Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R22Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R1Is by R20Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R1Is by R20Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R1Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R1Is by R20Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R1Is by R20Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R1Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R1Is by R20Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R1Is by R20SubstitutionCycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R1Is unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R1Is by R20Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R1Is by R20Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R1Is unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R1Is by R20Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R1Is by R20Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R1Is unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R1Is by R20Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R1Is by R20Substituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R1Is unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R1is-SO2R1D、-SO2NR1AR1Bor-NR1ASO2R1D. In the examples, R1is-SO2R1D. In the examples, R1is-SO2NR1AR1B. In the examples, R1is-NR1ASO2R1D

In the examples, R1Independently is-OH. In the examples, R1Independently is-OCH3. In the examples, R1Independently is-OCH2CH3. In the examples, R1Independently is unsubstituted C1-C4An alkoxy group. In the examples, R1Independently is-Cl. In the examples, R1Independently is-F. In the examples, R1Independently a halogen. In the examples, R1Independently is-CH3. In the examples, R1Independently is-CH2CH3. In the examples, R1Independently is unsubstituted C1-C4An alkyl group. In the examples, R1Independently is-CF3. In the examples, R1Independently is-CX1 3. In the examples, R1Independently is-OCH3or-F. In the examples, R1Independently is unsubstituted C1-C4Alkoxy or halogen. In the examples, R1Independently is-CN. In the examples, R1Independently is-C (O) NH2. In the examples, R1Independently is-C (O) NR1AR1B. In the examples, R1AIndependently hydrogen. In the examples, R1AIndependently is unsubstituted C1-C4An alkyl group. In the examples, R1AIndependently is-CH3. In the examples, R1AIndependently is-CH2CH3. In the examples, R1BIndependently hydrogen. In the examples, R1BIndependently is unsubstituted C1-C4An alkyl group. In the examples, R1BIndependently is-CH3. In the examples, R1BIndependently is-CH2CH3. In the examples, R1CIndependently hydrogen. In the examples, R1CIndependently is unsubstituted C1-C4An alkyl group. In the examples, R1CIndependently is-CH3. In the examples, R1CIndependently is-CH2CH3. In the examples, R1DIndependently hydrogen. In the examples, R1DIndependently is unsubstituted C1-C4An alkyl group. In the examples, R1DIndependently is-CH3. In the examples, R1DIndependently is-CH2CH3

In the examples, R2Is hydrogen, substituted or unsubstituted C1-C6Alkyl, substituted or unsubstituted 2-to 6-membered heteroalkyl, substituted or unsubstituted C3-C6Cycloalkyl, substituted or unsubstituted 3-to 6-membered heterocycloalkyl, substituted or unsubstituted phenyl, or substituted or unsubstituted 5-to 6-membered heteroaryl.

In the examples, R2Independently is hydrogen, is R23Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R23Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R23Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R23Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R23Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R23Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R2Independently hydrogen.

In the examples, R2Is by R23Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R2Is by R23Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R2Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R2Is by R23Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R2Is by R23Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R2Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R2Is by R23Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R2Is by R23Substituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R2Is unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R2Is by R23Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R2Is by R23Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R2Is unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R2Is by R23Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R2Is by R23Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R2Is unsubstitutedAryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R2Is by R23Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R2Is by R23Substituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R2Is unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, when R2When divalent, it may be referred to herein as L2

R23Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R24Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R24Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R24Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R24Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkylHeterocyclic alkyl radical) by R24Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R24Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, when R23Is by R24Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R24Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R24Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R24When substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl), it may be referred to herein as being (R)24)z4Substituted ring C.

In the examples, R23Independently an oxo group. In the examples, R23Independently a halogen. In the examples, R23Independently is-CCl3. In the examples, R23Independently is-CBr3. In the examples, R23Independently is-CF3. In the examples, R23Independently is-CI3. In the examples, R23Independently is CHCl2. In the examples, R23Independently is-CHBr2. In the examples, R23Independently is-CHF2. In the examples, R23Independently is-CHI2. In the examples, R23Independently is-CH2And (4) Cl. In the examples, R23Independently is-CH2Br is added. In the examples, R23Independently is-CH2F. In the examples, R23Independently is-CH2I. In the examples, R23Independently is-CN. In the examples, R23Independently is-OH. In the examples, R23Independently is-NH2. In the examples, R23Independent of each otherAnd ground is-COOH. In the examples, R23Independently is-CONH2. In the examples, R23Independently is-NO2. In the examples, R23Independently is-SH. In the examples, R23Independently is-SO3H. In the examples, R23Independently is-SO4H. In the examples, R23Independently is-SO2NH2. In the examples, R23Independently is-NHNH2. In the examples, R23Independently is-ONH2. In the examples, R23Independently is-NHC (O) NHNH2. In the examples, R23Independently is-NHC (O) NH2. In the examples, R23Independently is-NHSO2H. In the examples, R23independently-NHC (O) H. In the examples, R23independently-NHC (O) OH. In the examples, R23independently-NHOH. In the examples, R23Independently is-OCCl3. In the examples, R23Independently is-OCF3. In the examples, R23Independently is-OCBr3. In the examples, R23Independently is-OCI3. In the examples, R23Independently is-OCHCl2. In the examples, R23Independently is-OCHBr2. In the examples, R23Independently is-OCHI2. In the examples, R23Independently is-OCHF2. In the examples, R23Independently is-OCH2And (4) Cl. In the examples, R23Independently is-OCH2Br is added. In the examples, R23Independently is-OCH2I. In the examples, R23Independently is-OCH2F. In the examples, R23Independently is-N3

In the examples, R23Is by R24Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R23Is by R24Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R23Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups).

In the examples, R23Is by R24Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R23Is by R24Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R23Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl).

In the examples, R23Is by R24Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R23Is by R24Substituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R23Is unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups).

In the examples, R23Is by R24Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R23Is by R24Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R23Is unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl).

In the examples, R23Is by R24Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl radicalsOr phenyl). In the examples, R23Is by R24Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R23Is unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl).

In the examples, R23Is by R24Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R23Is by R24Substituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R23Is unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R23Is by R24Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R23Is a substituted or unsubstituted pyridyl group. In the examples, R23Is by R24A substituted pyridyl group. In the examples, R23Is an unsubstituted pyridyl group. In the examples, R23Is a substituted or unsubstituted pyrimidinyl group. In the examples, R23Is by R24A substituted pyrimidinyl group. In the examples, R23Is an unsubstituted pyrimidinyl group. In the examples, R23Is methoxy. In the examples, R23Is a substituted or unsubstituted phenyl group. In the examples, R23Is by R24A substituted phenyl group. In the examples, R23Is unsubstituted phenyl. In the examples, R23Is a substituted or unsubstituted pyridazinyl group. In the examples, R23Is by R24A substituted pyridazinyl group. In the examples, R24Is an unsubstituted pyridazinyl group.

In the examples, R24Independently is-OH. In the examples, R24Independently is-OCH3. In the examples, R24Independently is-OCH2CH3. In the examples, R24Independently is-F. In the examples, R24Independently is-NHC (O) CH3. In the examples, R24independently-COOH. In the examples, R24Independently is-SO2NH2

In the examples, R24Is by R25Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R24Is a substituted or unsubstituted pyridyl group. In the examples, R24Is by R25A substituted pyridyl group. In the examples, R24Is an unsubstituted pyridyl group. In the examples, R24Is a substituted or unsubstituted pyrimidinyl group. In the examples, R24Is by R25A substituted pyrimidinyl group. In the examples, R24Is an unsubstituted pyrimidinyl group. In the examples, R24Is methoxy. In the examples, R24Is a substituted or unsubstituted phenyl group. In the examples, R24Is by R25A substituted phenyl group. In the examples, R24Is unsubstituted phenyl. In the examples, R24Is a substituted or unsubstituted pyridazinyl group. In the examples, R24Is by R25A substituted pyridazinyl group. In the examples, R24Is an unsubstituted pyridazinyl group.

In the examples, R2Is by R23Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R2Is by R23Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R2Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R2Is by R23Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl)Alkyl or 2 to 4 membered heteroalkyl). In the examples, R2Is by R23Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R2Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R2Is by R23Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R2Is by R23Substituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R2Is unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R2Is by R23Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R2Is by R23Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R2Is unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R2Is by R23Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R2Is by R23Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R2Is unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R2Is by R23Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R2Is by R23Substituted heteroaryl (e.g., 5 to 10 membered)Heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R2Is unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R2Is substituted or unsubstituted C1-C6An alkyl group. In the examples, R2Is substituted or unsubstituted C3-C6A cycloalkyl group. In the examples, R2Is hydrogen.

In the examples, R2Is ethyl substituted with substituted or unsubstituted pyridyl. In the examples, R2Is ethyl substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl. In the examples, R2Is ethyl substituted with substituted or unsubstituted heteroaryl. In the examples, R2Is C substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R2Is C substituted by substituted or unsubstituted heteroaryl1-C4An alkyl group. In the examples, R2Is ethyl substituted with a substituted pyridyl group. In the examples, R2Is ethyl substituted with a substituted 5-to 6-membered heteroaryl. In the examples, R2Is ethyl substituted with a substituted heteroaryl group. In the examples, R2Is substituted with a substituted 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R2Is substituted with substituted heteroaryl1-C4An alkyl group. In the examples, R2Is substituted C1-C4An alkyl group. In the examples, R2Is a substituted ethyl group. In the examples, R2Is an ethyl group substituted with an unsubstituted pyridyl group. In the examples, R2Is an unsubstituted 5-to 6-membered heteroaryl substituted ethyl group. In the examples, R2Is an unsubstituted heteroaryl substituted ethyl. In the examples, R2Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted heteroaryl substituted C1-C4An alkyl group.

In the examples, R2Is methyl substituted by substituted or unsubstituted pyrimidinyl. In the examples, R2Is methyl substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl. In the examples, R2Is methyl substituted with substituted or unsubstituted heteroaryl. In the examples, R2Is a substituted methyl group. In the examples, R2Is methyl substituted with a substituted pyrimidinyl group. In the examples, R2Is methyl substituted with a substituted 5-to 6-membered heteroaryl group. In the examples, R2Is methyl substituted with a substituted heteroaryl group. In the examples, R2Is unsubstituted methyl. In the examples, R2Is substituted C1-C4An alkyl group. In the examples, R2Is an unsubstituted pyrimidinyl-substituted methyl group. In the examples, R2Is an unsubstituted 5-to 6-membered heteroaryl substituted methyl. In the examples, R2Is methyl substituted with unsubstituted heteroaryl.

In the examples, R2Is methyl substituted by substituted or unsubstituted pyridyl. In the examples, R2Is methyl substituted by methoxy substituted pyridyl. In the examples, R2Is methyl substituted with a substituted pyridyl group. In the examples, R2Is methyl substituted with a substituted pyridyl group. In the examples, R2Is methyl substituted by unsubstituted pyridyl.

In the examples, R2Is C substituted by methoxy-substituted pyridyl1-C4An alkyl group. In the examples, R2Is substituted by a substituted pyridyl group1-C4An alkyl group. In the examples, R2Is substituted with a substituted 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R2Is substituted with substituted heteroaryl1-C4An alkyl group. In the examples, R2Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted heteroaryl substituted C1-C4An alkyl group.

In the examplesWherein R2 is unsubstituted methyl. In the examples, R2Is unsubstituted C1-C4An alkyl group. In the examples, R2Is cyclopentyl substituted by methyl. In the examples, R2Is a quilt C1-C4Alkyl-substituted cyclopentyl. In the examples, R2Is C substituted by methyl3-C6A cycloalkyl group. In the examples, R2Is substituted C3-C6A cycloalkyl group. In the examples, R2Is a substituted cyclopentyl group.

In the examples, R2Is propyl substituted with substituted or unsubstituted pyridyl. In the examples, R2Is a substituted or unsubstituted 5-to 6-membered heteroaryl substituted propyl. In the examples, R2Is propyl substituted with substituted or unsubstituted heteroaryl. In the examples, R2Is a substituted propyl group. In the examples, R2Is C substituted by substituted or unsubstituted pyridyl1-C6An alkyl group. In the examples, R2Is C substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl group1-C6An alkyl group. In the examples, R2Is C substituted by substituted or unsubstituted heteroaryl1-C6An alkyl group. In the examples, R2Is propyl substituted with a substituted pyridyl group. In the examples, R2Is a substituted 5-to 6-membered heteroaryl substituted propyl. In the examples, R2Is a substituted heteroaryl substituted propyl. In the examples, R2Is unsubstituted propyl. In the examples, R2Is substituted by a substituted pyridyl group1-C6An alkyl group. In the examples, R2Is substituted with a substituted 5-to 6-membered heteroaryl group1-C6An alkyl group. In the examples, R2Is substituted with substituted heteroaryl1-C6An alkyl group. In the examples, R2Is substituted C1-C6An alkyl group. In the examples, R2Is propyl substituted with unsubstituted pyridyl. In the examples, R2Is unsubstituted 5-to 6-membered heteroaryl substitutedPropyl group of (2). In the examples, R2Is an unsubstituted heteroaryl substituted propyl. In the examples, R2Is a substituted propyl group. In the examples, R2Is unsubstituted pyridyl substituted C1-C6An alkyl group. In the examples, R2Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C6An alkyl group. In the examples, R2Is unsubstituted heteroaryl substituted C1-C6An alkyl group.

In the examples, R2Is methyl substituted with substituted or unsubstituted phenyl. In the examples, R2Is methyl substituted with substituted or unsubstituted aryl. In the examples, R2Is a substituted methyl group. In the examples, R2Is C substituted by substituted or unsubstituted phenyl1-C4An alkyl group. In the examples, R2Is C substituted by substituted or unsubstituted aryl1-C4An alkyl group. In the examples, R2Is substituted C1-C4An alkyl group. In the examples, R2Is methyl substituted by unsubstituted phenyl. In the examples, R2Is an unsubstituted aryl-substituted methyl group. In the examples, R2Is unsubstituted phenyl-substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted aryl-substituted C1-C4An alkyl group. In the examples, R2Is methyl substituted with a substituted phenyl group. In the examples, R2Is methyl substituted with substituted aryl. In the examples, R2Is substituted by substituted phenyl1-C4An alkyl group. In the examples, R2Is substituted by substituted aryl1-C4An alkyl group.

In the examples, R2Is methyl substituted with a substituted or unsubstituted pyridazinyl group. In the examples, R2Is a substituted or unsubstituted pyridazinyl group1-C4An alkyl group. In the examples, R2Is a substituted pyridazinyl substituted methyl group. In the examples, R2Is substituted by a substituted pyridazinyl group C1-C4An alkyl group. In the examples, R2Is a methyl group substituted with an unsubstituted pyridazinyl group. In the examples, R2Is unsubstituted pyridazinyl substituted C1-C4An alkyl group.

In the examples, R2Is an unsubstituted ethyl group. In the examples, R2Is unsubstituted C1-C4An alkyl group.

In the examples, R2Is a pyridyl group substituted with a methoxy group. In the examples, R2Is a substituted pyridyl group. In the examples, R2Is a 5 to 6 membered heteroaryl substituted with methoxy. In the examples, R2Is a substituted 5-to 6-membered heteroaryl. In the examples, R2Is a substituted heteroaryl group.

In the examples, R2Is a methyl group substituted with a piperidinyl group substituted with a substituted or unsubstituted benzyl group. In the examples, R2Is a substituted benzyl-substituted piperidinyl-substituted methyl group. In the examples, R2Is an unsubstituted benzyl-substituted piperidinyl-substituted methyl group. In the examples, R2Is methyl substituted with a substituted piperidinyl group. In the examples, R2Is methyl substituted with a substituted or unsubstituted 5-to 6-membered heterocycloalkyl group. In the examples, R2Is a substituted 5-to 6-membered heterocycloalkyl substituted methyl group. In the examples, R2Is methyl substituted by substituted or unsubstituted heterocycloalkyl. In the examples, R2Is a substituted heterocycloalkyl substituted methyl group. In the examples, R2Is a substituted methyl group. In the examples, R2Is C substituted by a substituted or unsubstituted benzyl-substituted piperidinyl group1-C4An alkyl group. In the examples, R2Is a substituted benzyl-substituted piperidinyl-substituted C1-C4An alkyl group. In the examples, R2Is substituted with a substituted piperidinyl group1-C4An alkyl group. In the examples, R2Is C substituted by substituted or unsubstituted 5-to 6-membered heterocycloalkyl1-C4An alkyl group. In the examples, R2Is C substituted by substituted or unsubstituted heterocycloalkyl1-C4An alkyl group. In the examples, R2Is substituted C1-C4An alkyl group. In the examples, R2Is an unsubstituted benzyl-substituted piperidinyl-substituted methyl group. In the examples, R2Is methyl substituted with a substituted piperidinyl group. In the examples, R2Is a substituted 5-to 6-membered heterocycloalkyl substituted methyl group. In the examples, R2Is a substituted heterocycloalkyl substituted methyl group. In the examples, R2Is unsubstituted benzyl-substituted piperidinyl-substituted C1-C4An alkyl group. In the examples, R2Is substituted with a substituted piperidinyl group1-C4An alkyl group. In the examples, R2Is substituted with a substituted 5-to 6-membered heterocycloalkyl group1-C4An alkyl group. In the examples, R2Is substituted by a substituted heterocycloalkyl group1-C4An alkyl group.

In the examples, R2Is a 4-membered heteroalkyl group substituted with a substituted or unsubstituted pyridyl group. In the examples, R2Is a 4-membered heteroalkyl group substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl group. In the examples, R2Is a 4-membered heteroalkyl group substituted with a substituted or unsubstituted heteroaryl group. In the examples, R2Is a2 to 6 membered heteroalkyl group substituted with a substituted or unsubstituted pyridyl group. In the examples, R2Is a 2-to 6-membered heteroalkyl substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl. In the examples, R2Is a2 to 6 membered heteroalkyl group substituted with a substituted or unsubstituted heteroaryl group. In the examples, R2Is a 4-membered heteroalkyl group substituted with a substituted pyridyl group. In the examples, R2Is a substituted 5-to 6-membered heteroaryl substituted 4-membered heteroalkyl. In the examples, R2Is a substituted heteroaryl substituted 4-membered heteroalkyl. In the examples, R2Is a2 to 6 membered heteroalkyl substituted with a substituted pyridyl. In the examples, R2Is a 2-to 6-membered heteroalkyl substituted with a substituted 5-to 6-membered heteroaryl. In thatIn the examples, R2Is a2 to 6 membered heteroalkyl substituted with a substituted heteroaryl.

In the examples, R2Is a 4-membered heteroalkyl group substituted with an unsubstituted pyridyl group. In the examples, R2Is an unsubstituted 5-to 6-membered heteroaryl substituted 4-membered heteroalkyl. In the examples, R2Is an unsubstituted heteroaryl substituted 4 membered heteroalkyl. In the examples, R2Is a2 to 6 membered heteroalkyl substituted with an unsubstituted pyridyl. In the examples, R2Is an unsubstituted 5-to 6-membered heteroaryl substituted 2-to 6-membered heteroalkyl. In the examples, R2Is an unsubstituted heteroaryl substituted 2 to 6 membered heteroalkyl group.

In the examples, R2Is ethyl substituted with a substituted or unsubstituted imidazolyl. In the examples, R2Is ethyl substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl. In the examples, R2Is ethyl substituted with substituted or unsubstituted heteroaryl. In the examples, R2Is C substituted by a substituted or unsubstituted imidazolyl group1-C4An alkyl group. In the examples, R2Is C substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R2Is C substituted by substituted or unsubstituted heteroaryl1-C4An alkyl group. In the examples, R2Is ethyl substituted with a substituted imidazolyl group. In the examples, R2Is ethyl substituted with a substituted 5-to 6-membered heteroaryl. In the examples, R2Is ethyl substituted with a substituted heteroaryl group. In the examples, R2Is substituted by a substituted imidazolyl group1-C4An alkyl group. In the examples, R2Is substituted with a substituted 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R2Is substituted with substituted heteroaryl1-C4An alkyl group.

In the examples, R2Is an ethyl group substituted with an unsubstituted imidazolyl group. In the examples, R2Is an unsubstituted 5-to 6-membered heteroaryl substituted ethyl group. In the examples,R2Is an unsubstituted heteroaryl substituted ethyl. In the examples, R2Is unsubstituted imidazolyl-substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted heteroaryl substituted C1-C4An alkyl group.

In the examples, R2Is ethyl substituted by OH. In the examples, R2Is C substituted by OH1-C4An alkyl group. In the examples, R2Is a substituted ethyl group. In the examples, R2Is substituted C1-C4An alkyl group.

In the examples, R2Is unsubstituted 4-membered heteroalkyl-substituted piperidinyl-substituted methyl. In the examples, R2Is an unsubstituted heteroalkyl-substituted piperidinyl-substituted methyl group. In the examples, R2Is a substituted 5-to 6-membered heterocycloalkyl substituted methyl group. In the examples, R2Is unsubstituted 4-membered heteroalkyl-substituted piperidinyl-substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted heteroalkyl-substituted piperidinyl-substituted C1-C4An alkyl group. In the examples, R2Is substituted with a substituted 5-to 6-membered heterocycloalkyl group1-C4An alkyl group. In the examples, R2Is substituted by a substituted heterocycloalkyl group1-C4An alkyl group.

In the examples, R2Is pyrrolidinyl substituted with tert-butoxycarbonyl. In the examples, R2Is substituted 2 to 8 membered heteroalkyl substituted pyrrolidinyl. In the examples, R2Is a3 to 6 membered heterocycloalkyl substituted with tert-butoxycarbonyl. In the examples, R2Is a substituted 3-to 6-membered heterocycloalkyl group. In the examples, R2Is a substituted heterocycloalkyl group.

In the examples, R2Is unsubstituted 4-membered heteroalkyl. In the examples, R2Is unsubstituted 2-to 6-membered heteroalkyl. In the examples, R2Is unsubstituted heteroalkyl.

In the examples, R2Is unsubstituted cyclobutyl. In the examples, R2Is unsubstituted 3 to 6 membered cycloalkyl. In the examples, R2Is unsubstituted cycloalkyl.

In the examples, R2Is unsubstituted pyrrolidinyl. In the examples, R2Is unsubstituted 3-to 6-membered heterocycloalkyl. In the examples, R2Is unsubstituted heterocycloalkyl.

In the examples, R2Is cyclobutyl substituted by OH. In the examples, R2Is a substituted cyclobutyl group. In the examples, R2Is C substituted by OH3-C6A cycloalkyl group. In the examples, R2Is substituted C3-C6A cycloalkyl group.

In the examples, R2Is propyl substituted by OH. In the examples, R2Is C substituted by OH1-C6An alkyl group. In the examples, R2Is a substituted propyl group. In the examples, R2Is substituted C1-C6An alkyl group.

In the examples, R2Is azetidinyl substituted with tert-butoxycarbonyl. In the examples, R2Is 2 to 8 membered heteroalkyl substituted azetidinyl substituted with oxo. In the examples, R2Is an azetidinyl substituted with an oxo-substituted heteroalkyl. In the examples, R2Is a substituted 2-to 8-membered heteroalkyl substituted azetidinyl. In the examples, R2Is a substituted heteroalkyl substituted azetidinyl.

In the examples, R2Is unsubstituted cyclopentyl. In the examples, R2Is unsubstituted C3-C6A cycloalkyl group. In the examples, R2Is unsubstituted cyclopropyl.

In the examples, R2Is methyl substituted by unsubstituted cyclobutyl. In the examples, R2Is unsubstituted C3-C6Cycloalkyl-substituted methyl. In the examples, R2Is unsubstituted cyclobutyl substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted C3-C6Cycloalkyl-substituted C1-C4An alkyl group.

In the examples, R2Is unsubstituted oxetanyl. In the examples, R2Is unsubstituted 3-to 6-membered heterocycloalkyl.

In the examples, R2Is unsubstituted isopropyl. In the examples, R2Is unsubstituted propyl. In the examples, R2Is unsubstituted tert-butyl. In the examples, R2Is an unsubstituted butyl group. In the examples, R2Is unsubstituted C1-C6An alkyl group.

In the examples, R2Is a 4-membered heteroalkyl substituted with oxo. In the examples, R2Is a2 to 6 membered heteroalkyl substituted with oxo. In the examples, R2Is a substituted 4-membered heteroalkyl group. In the examples, R2Is a substituted 2-to 6-membered heteroalkyl group. In the examples, R2Is a substituted heteroalkyl group.

In the examples, R2Is methyl substituted with unsubstituted tetrahydropyran. In the examples, R2Is methyl substituted with tetrahydropyran. In the examples, R2Is an unsubstituted 5-to 6-membered heterocycloalkyl substituted methyl group. In the examples, R2Is unsubstituted tetrahydropyran substituted C1-C4An alkyl group. In the examples, R2Is C substituted by tetrahydropyran1-C4An alkyl group. In the examples, R2Is unsubstituted 5-to 6-membered heterocycloalkyl-substituted C1-C4An alkyl group.

In the examples, R2Is by CF3A substituted methyl group. In the examples, R2Is a quilt C (halogen base)3A substituted methyl group. In the examples, R2Is by CF3Substituted C1-C4An alkyl group. In the examples, R2Is a quilt C (halogen base)3Substituted C1-C4An alkyl group.

In the examples, R2Is methyl substituted with t-butoxycarbonyl substituted pyrrolidinyl. In the examples, R2Is a pyrrolidinyl substituted methyl substituted with a2 to 8 membered heteroalkyl substituted with oxo. In the examples, R2Is a substituted 2 to 8 membered heteroalkyl substituted pyrrolidinyl substituted methyl. In the examples, R2Is methyl substituted with a3 to 6 membered heterocycloalkyl substituted with tert-butoxycarbonyl. In the examples, R2Is C substituted by tert-butoxycarbonyl-substituted pyrrolidinyl1-C4An alkyl group. In the examples, R2Is substituted 2-to 8-membered heteroalkyl-substituted pyrrolidinyl-substituted C1-C4An alkyl group. In the examples, R2Is a 3-to 6-membered heterocycloalkyl substituted with a substituted 2-to 8-membered heteroalkyl1-C4An alkyl group. In the examples, R2Is substituted with a substituted 3-to 6-membered heterocycloalkyl group1-C4An alkyl group.

In the examples, R2Is butyl substituted by OH. In the examples, R2Is a substituted butyl group.

In the examples, R2Is ethyl substituted with OH substituted pyridyl. In the examples, R2Is ethyl substituted by OH. In the examples, R2Is an ethyl group substituted with an unsubstituted pyridyl group. In the examples, R2Is C substituted by OH and unsubstituted pyridyl1-C4An alkyl group. In the examples, R2Is C substituted by OH1-C4An alkyl group. In the examples, R2Is unsubstituted pyridyl substituted C1-C4An alkyl group. In the examples, R2Is ethyl substituted with OH and unsubstituted 5-to 6-membered heteroaryl. In the examples, R2Is a substituted ethyl group. In the examples, R2Is an unsubstituted 5-to 6-membered heteroaryl substituted ethyl group. In the examples, R2Is taken out by OHSubstituted and unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group. In the examples, R2Is substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group.

In the examples, R2Is methyl substituted with imidazolyl substituted with substituted or unsubstituted methyl. In the examples, R2Is methyl substituted with a 5 to 6 membered heteroaryl substituted with substituted or unsubstituted methyl. In the examples, R2Is methyl substituted by heteroaryl substituted by substituted or unsubstituted methyl. In the examples, R2Is methyl substituted with a substituted methyl substituted imidazolyl. In the examples, R2Is a 5 to 6 membered heteroaryl substituted methyl substituted with a substituted methyl. In the examples, R2Is a substituted methyl-substituted heteroaryl-substituted methyl. In the examples, R2Is unsubstituted C1-C4Alkyl substituted imidazolyl substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted C1-C4Alkyl substituted 5 to 6 membered heteroaryl substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted C1-C4Alkyl substituted heteroaryl substituted C1-C4An alkyl group.

In the examples, R2Is cyclobutyl substituted by methoxy. In the examples, R2Is cyclobutyl substituted by 2-to 4-membered heteroalkyl. In the examples, R2Is C substituted by methoxy3-C6A cycloalkyl group. In the examples, R2Is C substituted by 2-to 4-membered heteroalkyl3-C6A cycloalkyl group.

In the examples, R2Is unsubstituted phenyl. In the examples, R2Is unsubstituted aryl.

In the examples, R2Is methyl substituted with a substituted or unsubstituted imidazolyl. In the examples, R2Is substituted or not substitutedSubstituted 5-to 6-membered heteroaryl substituted methyl. In the examples, R2Is methyl substituted with substituted or unsubstituted heteroaryl. In the examples, R2Is methyl substituted with a substituted imidazolyl group. In the examples, R2Is methyl substituted with a substituted 5-to 6-membered heteroaryl group. In the examples, R2Is methyl substituted with a substituted heteroaryl group. In the examples, R2Is methyl substituted with unsubstituted imidazolyl. In the examples, R2Is an unsubstituted 5-to 6-membered heteroaryl substituted methyl. In the examples, R2Is methyl substituted with unsubstituted heteroaryl. In the examples, R2Is C substituted by a substituted or unsubstituted imidazolyl group1-C4An alkyl group. In the examples, R2Is C substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R2Is C substituted by substituted or unsubstituted heteroaryl1-C4An alkyl group. In the examples, R2Is unsubstituted imidazolyl-substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted heteroaryl substituted C1-C4An alkyl group.

In the examples, R2Is cyclopentyl substituted by OH. In the examples, R2Is C substituted by OH3-C6A cycloalkyl group. In the examples, R2Is a substituted cyclopentyl group. In the examples, R2Is substituted C3-C6A cycloalkyl group.

In the examples, R2Is ethyl substituted by OH-substituted phenyl. In the examples, R2Is ethyl substituted with an OH substituted aryl. In the examples, R2Is a substituted aryl substituted ethyl group. In the examples, R2Is C substituted by OH-substituted phenyl1-C4An alkyl group. In the examples, R2Is C substituted by OH-substituted aryl1-C4An alkyl group. In the examplesIn, R2Is substituted by substituted aryl1-C4An alkyl group.

In the examples, R2Is ethyl substituted with t-butoxycarbonyl substituted tetrahydropyran. In the examples, R2Is a substituted 2 to 8 membered heteroalkyl substituted tetrahydropyran substituted ethyl group. In the examples, R2Is ethyl substituted with a3 to 6 membered heterocycloalkyl substituted with tert-butoxycarbonyl. In the examples, R2Is C substituted by tetrahydropyran substituted by tert-butoxycarbonyl1-C4An alkyl group.

In the examples, R2Is an unsubstituted pyrrolidinyl-substituted ethyl group. In the examples, R2Is an unsubstituted 3-to 6-membered heterocycloalkyl substituted ethyl group. In the examples, R2Is unsubstituted pyrrolidinyl substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted 5-to 6-membered heterocycloalkyl-substituted C1-C4An alkyl group.

In the examples, R2Is ethyl substituted with t-butoxycarbonyl substituted pyrrolidinyl. In the examples, R2Is a substituted 2 to 8 membered heteroalkyl substituted pyrrolidinyl substituted ethyl. In the examples, R2Is ethyl substituted with a3 to 6 membered heterocycloalkyl substituted with tert-butoxycarbonyl.

In the examples, R2Is C substituted by tert-butoxycarbonyl-substituted pyrrolidinyl1-C4An alkyl group. In the examples, R2Is substituted 2-to 8-membered heteroalkyl-substituted pyrrolidinyl-substituted C1-C4An alkyl group. In the examples, R2Is C substituted by a 3-to 6-membered heterocycloalkyl group substituted by a tert-butoxycarbonyl group1-C4An alkyl group.

In the examples, R2Is methyl substituted by unsubstituted pyrrolidinyl. In the examples, R2Is an unsubstituted 3-to 6-membered heterocycloalkyl substituted methyl group.

In the examples, R2Is unsubstituted pyrrolidinyl substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted 3-to 6-membered heterocycloalkyl-substituted C1-C4An alkyl group.

In the examples, R2Is ethyl substituted with unsubstituted morpholinyl. In the examples, R2Is ethyl substituted with unsubstituted morpholinyl. In the examples, R2Is an unsubstituted 5-to 6-membered heterocycloalkyl substituted ethyl group. In the examples, R2Is unsubstituted morpholinyl substituted C1-C4An alkyl group.

In the examples, R2Is ethyl substituted by OH-substituted phenyl. In the examples, R2Is ethyl substituted with an OH substituted aryl. In the examples, R2Is substituted by substituted phenyl1-C4An alkyl group. In the examples, R2Is substituted by substituted aryl1-C4An alkyl group.

In the examples, R2Is unsubstituted piperidinyl substituted methyl. In the examples, R2Is an unsubstituted 5-to 6-membered heterocycloalkyl substituted methyl group. In the examples, R2Is an unsubstituted heterocycloalkyl substituted methyl group. In the examples, R2Is unsubstituted piperidinyl-substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted 5-to 6-membered heterocycloalkyl-substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted heterocycloalkyl-substituted C1-C4An alkyl group.

In the examples, R2Is an ethyl group substituted with an OH-substituted methyl-substituted phenyl group. In the examples, R2Is an ethyl group substituted with an aryl group substituted with an OH-substituted methyl group. In the examples, R2Is a substituted phenyl substituted ethyl group. In the examples, R2Is a substituted aryl substituted ethyl group. In the examples, R2Is substituted by substituted phenyl1-C4An alkyl group. In the examples, R2Is substituted by substituted aryl1-C4An alkyl group.

In the examples, R2Is ethyl substituted with Cl substituted phenyl. In the examples, R2Is an ethyl group substituted with an aryl group substituted with a halogen group. In the examples, R2Is ethyl substituted with phenyl substituted with halo. In the examples, R2Is C substituted by Cl-substituted phenyl1-C4An alkyl group. In the examples, R2Is C substituted by phenyl substituted by halogen1-C4An alkyl group. In the examples, R2Is aryl substituted by halogen1-C4An alkyl group.

In the examples, R2Is methyl substituted with unsubstituted tetrahydrofuranyl. In the examples, R2Is methyl substituted by tetrahydrofuranyl. In the examples, R2Is an unsubstituted 3-to 6-membered heterocycloalkyl substituted methyl group. In the examples, R2Is unsubstituted tetrahydrofuranyl-substituted C1-C4An alkyl group. In the examples, R2Is C substituted by tetrahydrofuranyl1-C4An alkyl group.

In the examples, R2Is an ethyl group substituted with an unsubstituted phenyl group. In the examples, R2Is an unsubstituted aryl substituted ethyl group. In the examples, R2Is unsubstituted phenyl-substituted C1-C4An alkyl group. In the examples, R2Is unsubstituted aryl-substituted C1-C4An alkyl group.

In the examples, R2Is unsubstituted azetidinyl. In the examples, R2Is unsubstituted 3-to 6-membered heterocycloalkyl

In the examples, R2Is methyl substituted by phenoxy substituted by methoxy. In the examples, R2Is methyl substituted with 2 to 4-membered alkoxy substituted phenoxy substituted pyridyl. In the examples, R2Is methyl substituted with 2 to 4-membered alkoxy-substituted aryloxy-substituted pyridyl. In the examples, R2Is methyl substituted with 5 to 6 membered heteroaryl substituted with 2 to 4 membered alkoxy substituted aryloxy. In the implementation ofIn the examples, R2Is C substituted with a 5-to 6-membered heteroaryl group substituted with a 2-to 4-membered alkoxy-substituted aryloxy group1-C4An alkyl group.

In the examples, R2Is ethyl substituted with methoxy substituted pyridyl. In the examples, R2Is ethyl substituted with 2 to 4 membered alkoxy substituted pyridyl. In the examples, R2Is ethyl substituted with a 5 to 6 membered heteroaryl substituted with a2 to 4 membered alkoxy. In the examples, R2Is C substituted with a 5-to 6-membered heteroaryl group substituted with a 2-to 4-membered alkoxy group1-C4An alkyl group. In the examples, R2Is C substituted by 2-to 4-membered alkoxy-substituted heteroaryl1-C4An alkyl group.

In the examples, R2Is ethyl substituted by methoxy substituted phenyl. In the examples, R2Is ethyl substituted with phenyl substituted with 2 to 4 membered alkoxy. In the examples, R2Is ethyl substituted with 2 to 4 membered alkoxy substituted aryl. In the examples, R2Is C substituted by aryl substituted by 2-to 4-membered alkoxy1-C4An alkyl group.

In the examples, R2Is ethyl substituted with phenyl substituted with a2 to 4 membered heteroalkyl substituted with oxo. In the examples, R2Is a substituted 2 to 4 membered heteroalkyl substituted phenyl substituted ethyl. In the examples, R2Is ethyl substituted with 2 to 4 membered heteroalkyl substituted aryl. In the examples, R2Is substituted 2-to 4-membered heteroalkyl-substituted aryl-substituted C1-C4An alkyl group.

In the examples, R2Is propyl substituted with methoxy substituted phenyl. In the examples, R2Is a propyl group substituted with a phenyl group substituted with a2 to 4-membered alkoxy group. In the examples, R2Is a propyl group substituted with a2 to 4-membered alkoxy-substituted aryl group. In the examples, R2Is C substituted by aryl substituted by 2-to 4-membered alkoxy1-C4An alkyl group.

In the examples, R2Is 2-to 4-membered heteroalkyl substituted with oxoPhenyl substituted ethyl. In the examples, R2Is a substituted 2 to 4 membered heteroalkyl substituted phenyl substituted ethyl. In the examples, R2Is ethyl substituted with 2 to 4 membered heteroalkyl substituted aryl. In the examples, R2Is substituted 2-to 4-membered heteroalkyl-substituted aryl-substituted C1-C4An alkyl group.

In the examples, R2Is an ethyl group substituted with an unsubstituted cyclopentyl group. In the examples, R2Is unsubstituted C3-C6Cycloalkyl-substituted ethyl. In the examples, R2Is unsubstituted C3-C6Cycloalkyl-substituted C1-C4An alkyl group.

In the examples, R2Is ethyl substituted with t-butoxycarbonyl substituted pyrrolidinyl. In the examples, R2Is a pyrrolidinyl substituted ethyl substituted with oxo substituted 4 to 8 membered heteroalkyl substituted. In the examples, R2Is a substituted 4 to 8 membered heteroalkyl substituted pyrrolidinyl substituted ethyl. In the examples, R2Is a3 to 6 membered heterocycloalkyl substituted ethyl substituted with a substituted 4 to 8 membered heteroalkyl. In the examples, R2Is a 3-to 6-membered heterocycloalkyl substituted with a substituted 4-to 8-membered heteroalkyl1-C4An alkyl group.

In the examples, R2Is ethyl substituted with t-butoxycarbonyl substituted azetidinyl. In the examples, R2Is an ethyl group substituted with an oxo-substituted 4 to 8 membered heteroalkyl-substituted azetidinyl group. In the examples, R2Is a substituted 4 to 8 membered heteroalkyl substituted azetidinyl substituted ethyl. In the examples, R2Is a substituted 4-to 8-membered heteroalkyl-substituted azetidinyl-substituted C1-C4An alkyl group.

In the examples, R2Is an ethyl group substituted with an unsubstituted azetidinyl group. In the examples, R2Is unsubstituted C3-C6Heterocycloalkyl substituted ethyl. In the examples, R2Is unsubstituted C3-C6Heterocycloalkyl-substituted C1-C4An alkyl group.

In the examples, R2Is ethyl substituted with phenyl substituted with CN. In the examples, R2Is a substituted phenyl substituted ethyl group. In the examples, R2Is ethyl substituted with aryl substituted with CN. In the examples, R2Is aryl substituted by CN1-C4An alkyl group. In the examples, R2Is substituted by substituted aryl1-C4An alkyl group.

In the examples, R2Is an unsubstituted phenyl-substituted ethyl-substituted piperidinyl-substituted methyl group. In the examples, R2Is an unsubstituted aryl-substituted ethyl-substituted piperidinyl-substituted methyl group. In the examples, R2Is unsubstituted aryl-substituted C1-C4Alkyl-substituted piperidinyl-substituted methyl. In the examples, R2Is unsubstituted aryl-substituted C1-C4Alkyl-substituted 3 to 6 membered heterocycloalkyl-substituted methyl. In the examples, R2Is unsubstituted aryl-substituted C1-C4Alkyl substituted 3 to 6 membered heterocycloalkyl substituted C1-C4An alkyl group.

In the examples, R2Is methyl substituted by methoxy substituted pyridyl. In the examples, R2Is methyl substituted with 2 to 4-membered alkoxy substituted pyridyl. In the examples, R2Is methyl substituted with a 5 to 6 membered heteroaryl substituted with a2 to 4 membered alkoxy. In the examples, R2Is C substituted with a 5-to 6-membered heteroaryl group substituted with a 2-to 4-membered alkoxy group1-C4An alkyl group.

In the examples, R2Is methyl substituted by unsubstituted 2-to 4-membered alkoxy-substituted pyridyl. In the examples, R2Is an unsubstituted 2-to 4-membered alkoxy-substituted 5-to 6-membered heteroaryl-substituted methyl group. In the examples, R2Is unsubstituted 2-to 4-membered alkoxy-substituted 5-to 6-membered heteroaryl-substituted C1-C4An alkyl group.

In the examples, R2Is methyl substituted by unsubstituted pyridyl. In the examples, R2Is an unsubstituted 5-to 6-membered heteroaryl substituted methyl. In the examples, R2Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group.

In the examples, R2Is ethyl substituted by phenyl substituted by carboxyl. In the examples, R2Is a substituted phenyl substituted ethyl group. In the examples, R2Is ethyl substituted with aryl substituted with carboxyl. In the examples, R2Is aryl substituted by carboxyl1-C4An alkyl group.

In the examples, R2Is by SO2NH2Substituted phenyl substituted ethyl. In the examples, R2Is by SO2NH2Substituted aryl substituted ethyl. In the examples, R2Is by SO2NH2Substituted aryl substituted C1-C4An alkyl group. In the examples, R2Is hydrogen.

In the examples, R2Is ethyl substituted with phenyl substituted with tert-butyl carbamate. In the examples, R2Is an ethyl group substituted with a phenyl group substituted with a 6 to 8 membered heteroalkyl group substituted with an oxo group. In the examples, R2Is a substituted 6 to 8 membered heteroalkyl substituted phenyl substituted ethyl. In the examples, R2Is a substituted 6 to 8 membered heteroalkyl substituted aryl substituted ethyl. In the examples, R2Is substituted 6-to 8-membered heteroalkyl-substituted aryl-substituted C1-C4An alkyl group.

In the examples, R2Is ethyl substituted with tert-butoxycarbonyl substituted piperidinyl. In the examples, R2Is a piperidinyl-substituted ethyl substituted with a 5 to 7 membered heteroalkyl substituted with oxo. In the examples, R2Is a substituted 5 to 7 membered heteroalkyl substituted piperidinyl substituted ethyl. In the examples, R2Is a 5 to 6 membered heterocycloalkyl substituted ethyl substituted with a substituted 5 to 7 membered heteroalkyl. In thatIn the examples, R2Is a 5-to 6-membered heterocycloalkyl substituted with a substituted 5-to 7-membered heteroalkyl1-C4An alkyl group.

In the examples, R2Is methyl substituted by unsubstituted thiazolyl. In the examples, R2Is an unsubstituted 5-to 6-membered heteroaryl substituted methyl. In the examples, R2Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group.

In the examples, R2Is by NH2Substituted phenyl substituted ethyl. In the examples, R2Is by NH2Substituted aryl substituted ethyl. In the examples, R2Is by NH2Substituted aryl substituted C1-C4An alkyl group. In the examples, R2Is substituted by substituted aryl1-C4An alkyl group.

In the examples, R2Is an unsubstituted piperidinyl-substituted ethyl group. In the examples, R2Is an unsubstituted 5-to 6-membered heterocycloalkyl substituted ethyl group. In the examples, R2Is unsubstituted 5-to 6-membered heterocycloalkyl-substituted C1-C4An alkyl group.

In the examples, R2Is ethyl substituted with phenyl substituted with a2 to 6 membered heteroalkyl substituted with oxo. In the examples, R2Is a substituted 2 to 6 membered heteroalkyl substituted phenyl substituted ethyl. In the examples, R2Is a substituted 2 to 6 membered heteroalkyl substituted aryl substituted ethyl. In the examples, R2Is substituted 2-to 6-membered heteroalkyl-substituted aryl-substituted C1-C4An alkyl group.

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001065

In the examples, R2Is that

Figure BDA0002469898950001066

In the examples, R2Is that

Figure BDA0002469898950001067

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010611

In the examples, R2Is that

Figure BDA00024698989500010612

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001071

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001073

In the examples, R2Is that

Figure BDA0002469898950001074

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010710

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010713

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010715

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010717

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010719

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010724

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010727

In the examples, R2Is that

Figure BDA00024698989500010728

In the examples, R2Is that

Figure BDA00024698989500010729

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001081

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001084

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001086

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001088

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010810

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010813

In the examples, R2Is that

Figure BDA00024698989500010814

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010816

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010820

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010822

In the examples, R2Is that

Figure BDA00024698989500010823

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010825

In the examples, R2Is that

Figure BDA00024698989500010826

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010829

In the examples, R2Is that

Figure BDA00024698989500010830

In the examples, R2Is that

Figure BDA0002469898950001091

In the examples, R2Is that

Figure BDA0002469898950001092

In the examplesIn, R2Is thatIn the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001096

In the examples, R2Is that

Figure BDA0002469898950001097

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001099

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010911

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010914

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010916

In the examples, R2Is that

Figure BDA00024698989500010917

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010921

In the examples, R2Is that

Figure BDA00024698989500010922

In the examples, R2Is that

Figure BDA00024698989500010923

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500010925

In the examples, R2Is that

Figure BDA00024698989500010926

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001102

In the examples, R2Is that

Figure BDA0002469898950001103

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001105

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001107

In the examples, R2Is that

Figure BDA0002469898950001108

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500011011

In the examples, R2Is that

Figure BDA00024698989500011012

In the examples, R2Is that

Figure BDA00024698989500011013

In the examples, R2Is that

Figure BDA00024698989500011014

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500011017

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500011020

In the examples, R2Is that

Figure BDA00024698989500011021

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500011023

In the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is thatIn the examples, R2Is that

Figure BDA00024698989500011027

In the examples, R2Is that

Figure BDA00024698989500011028

In the examples, R2Is that

Figure BDA0002469898950001111

In the examples, R2Is that

Figure BDA0002469898950001112

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001114

In the examples, R2Is that

Figure BDA0002469898950001115

In the examples, R2Is thatIn the examples, R2Is that

Figure BDA0002469898950001117

In the examples, R3Is hydrogen, substituted or unsubstituted C1-C6Alkyl, substituted or unsubstituted 2-to 6-membered heteroalkyl, substituted or unsubstituted C3-C6Cycloalkyl radicalsSubstituted or unsubstituted 3-to 6-membered heterocycloalkyl, substituted or unsubstituted phenyl, or substituted or unsubstituted 5-to 6-membered heteroaryl.

In the examples, R3Independently is hydrogen, is R26Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R26Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R26Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R26Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R26Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R26Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R3Independently hydrogen.

In the examples, R3Is by R26Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R3Is by R26Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R3Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R3Is by R26Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R3Is by R26Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R3Is not coveredSubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R3Is by R26Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R3Is by R26Substituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R3Is unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R3Is by R26Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R3Is by R26Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R3Is unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R3Is by R26Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R3Is by R26Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R3Is unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R3Is by R26Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R3Is by R26Substituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R3Is unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R26Independently an oxo group. In the examples, R26Independently a halogen. In the examples, R26Independently is-CCl3. In the examples, R26Independently is-CBr3. In the examples, R26Independently is-CF3. In the examples, R26Independently is-CI3. In the examples, R26Independently is CHCl2. In the examples, R26Independently is-CHBr2. In the examples, R26Independently is-CHF2. In the examples, R26Independently is-CHI2. In the examples, R26Independently is-CH2And (4) Cl. In the examples, R26Independently is-CH2Br is added. In the examples, R26Independently is-CH2F. In the examples, R26Independently is-CH2I. In the examples, R26Independently is-CN. In the examples, R26Independently is-OH. In the examples, R26Independently is-NH2. In the examples, R26independently-COOH. In the examples, R26Independently is-CONH2. In the examples, R26Independently is-NO2. In the examples, R26Independently is-SH. In the examples, R26Independently is-SO3H. In the examples, R26Independently is-SO4H. In the examples, R26Independently is-SO2NH2. In the examples, R26Independently is-NHNH2. In the examples, R26Independently is-ONH2. In the examples, R26Independently is-NHC (O) NHNH2. In the examples, R26Independently is-NHC (O) NH2. In the examples, R26Independently is-NHSO2H. In the examples, R26independently-NHC (O) H. In the examples, R26independently-NHC (O) OH. In the examples, R26independently-NHOH. In the examples, R26Independently is-OCCl3. In the examples, R26Independently is-OCF3. In the examples, R26Independently is-OCBr3. In the examples, R26Independently is-OCI3. In the examples, R26Independently is-OCHCl2. In the examples, R26Independently is-OCHBr2. In the examples, R26Independently is-OCHI2. In the examples, R26Independently is-OCHF2. In the examples, R26Independently is-OCH2And (4) Cl. In the examples, R26Independently is-OCH2Br is added. In the examples, R26Independently is-OCH2I. In the examples, R26Independently is-OCH2F. In the examples, R26Independently is-N3

In the examples, R26Is by R27Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R26Is by R27Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R26Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups).

In the examples, R26Is by R27Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R26Is by R27Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R26Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl).

In the examples, R26Is by R27Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6CycloalkanesA base). In the examples, R26Is by R27Substituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R26Is unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups).

In the examples, R26Is by R27Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R26Is by R27Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R26Is unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl).

In the examples, R26Is by R27Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R26Is by R27Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R26Is unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl).

In the examples, R26Is by R27Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R26Is by R27Substituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R26Is unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

R26Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R27Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R27Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R27Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R27Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R27Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R27Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

R27Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R28Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R28Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R28Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R28Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R28Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R28Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R27Independently is-OH. In the examples, R27Independently is-OCH3. In the examples, R27Independently is-OCH2CH3. In the examples, R27Independently is-F. In the examples, R27Independently is-NHC (O) CH3. In the examples, R27independently-COOH. In the examples, R27Independently is-SO2NH2

In the examples, R2And R3May optionally be joined to form a substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), which may be referred to herein as "ring B". In the examples, R2And R3May optionally be joined to form a substituted or unsubstituted 3-to 8-membered heterocycloalkyl. In the examples, R2And R3May optionally be joined to form a substituted or unsubstituted 3-membered heterocycloalkyl. In the examples, R2And R3May optionally be joined to form a substituted or unsubstituted 4-membered heterocycloalkyl. In the examples, R2And R3May optionally be joined to form a substituted or unsubstituted 5-membered heterocycloalkyl. In the examples, R2And R3May optionally be joined to form a substituted or unsubstituted 6-membered heterocycloalkyl. In the examples, R2And R3May optionally be joined to form a substituted or unsubstituted 7-membered heterocycloalkyl. In the examples, R2And R3May optionally be joined to form a substituted or unsubstituted 8-membered heterocycloalkyl.

In the examples, R2And R3May optionally be joined to form a substituted 3-to 8-membered heterocycloalkyl group. In the examples, R2And R3May optionally be joined to form a substituted 3-membered heterocycloalkyl group. In the examples, R2And R3May optionally be joined to form a substituted 4-membered heterocycloalkyl group. In the examples, R2And R3May optionally be joined to form a substituted 5-membered heterocycloalkyl group. In the examples, R2And R3May optionally be joined to form a substituted 6-membered heterocycloalkyl group. In the examples, R2And R3May optionally be joined to form a substituted 7-membered heterocycloalkyl group. In the examples, R2And R3May optionally be joined to form a substituted 8-membered heterocycloalkyl group. In the examples, R2And R3Optionally joined to form a quilt R6Substituted 3 to 8 membered heterocycloalkyl. In the examples, R2And R3Optionally joined to form a quilt R6Substituted 3-membered heterocycloalkyl. In the examples, R2And R3Optionally joined to form a quilt R6Substituted 4-membered heterocycloalkyl. In the examples, R2And R3Optionally joined to form a quilt R6Substituted 5-membered heterocycloalkyl. In the examples, R2And R3Optionally joined to form a quilt R6Substituted 6-membered heterocycloalkyl. In thatIn the examples, R2And R3Optionally joined to form a quilt R6Substituted 7-membered heterocycloalkyl. In the examples, R2And R3Optionally joined to form a quilt R6Substituted 8-membered heterocycloalkyl. In the examples, R2And R3May optionally be joined to form an unsubstituted 3-to 8-membered heterocycloalkyl group. In the examples, R2And R3May optionally be joined to form an unsubstituted 3-membered heterocycloalkyl group. In the examples, R2And R3May optionally be joined to form an unsubstituted 4-membered heterocycloalkyl group. In the examples, R2And R3May optionally be joined to form an unsubstituted 5-membered heterocycloalkyl group. In the examples, R2And R3May optionally be joined to form an unsubstituted 6-membered heterocycloalkyl group. In the examples, R2And R3May optionally be joined to form an unsubstituted 7-membered heterocycloalkyl group. In the examples, R2And R3May optionally be joined to form an unsubstituted 8-membered heterocycloalkyl group.

In the examples, R3Is hydrogen, substituted or unsubstituted C1-C6Alkyl, substituted or unsubstituted 2-to 6-membered heteroalkyl, substituted or unsubstituted C3-C6Cycloalkyl, substituted or unsubstituted 3-to 6-membered heterocycloalkyl, substituted or unsubstituted phenyl, or substituted or unsubstituted 5-to 6-membered heteroaryl. In the examples, R2And R3To form a substituted or unsubstituted heterocycloalkyl.

In the examples, R3Is by R26Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R3Is by R26Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R3Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R3Is by R26Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R3Is by R26Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R3Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R3Is by R26Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R3Is by R26Substituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R3Is unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R3Is by R26Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R3Is by R26Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R3Is unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R3Is by R26Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R3Is by R26Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R3Is unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R3Is by R26Substituted or unsubstituted heteroaryl (e.g.5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R3Is by R26Substituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R3Is unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R3Is substituted or unsubstituted C1-C6An alkyl group. In the examples, R3Is substituted or unsubstituted C3-C6A cycloalkyl group. In the examples, R3Is hydrogen.

In the examples, R3Is ethyl substituted with substituted or unsubstituted pyridyl. In the examples, R3Is ethyl substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl. In the examples, R3Is ethyl substituted with substituted or unsubstituted heteroaryl. In the examples, R3Is C substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R3Is C substituted by substituted or unsubstituted heteroaryl1-C4An alkyl group. In the examples, R3Is ethyl substituted with a substituted pyridyl group. In the examples, R3Is ethyl substituted with a substituted 5-to 6-membered heteroaryl. In the examples, R3Is ethyl substituted with a substituted heteroaryl group. In the examples, R3Is substituted with a substituted 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R3Is substituted with substituted heteroaryl1-C4An alkyl group. In the examples, R3Is substituted C1-C4An alkyl group. In the examples, R3Is a substituted ethyl group. In the examples, R3Is an ethyl group substituted with an unsubstituted pyridyl group. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted ethyl group. In the examples, R3Is an unsubstituted heteroaryl substituted ethyl. In the examples, R3Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group. In the examplesIn, R3Is unsubstituted heteroaryl substituted C1-C4An alkyl group.

In the examples, R3Is methyl substituted by substituted or unsubstituted pyrimidinyl. In the examples, R3Is methyl substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl. In the examples, R3Is methyl substituted with substituted or unsubstituted heteroaryl. In the examples, R3Is methyl substituted with a substituted pyrimidinyl group. In the examples, R3Is methyl substituted with a substituted 5-to 6-membered heteroaryl group. In the examples, R3Substituted heteroaryl substituted methyl. In the examples, R3Is a substituted methyl group. In the examples, R3Is substituted C1-C4An alkyl group. In the examples, R3Is an unsubstituted pyrimidinyl-substituted methyl group. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted methyl. In the examples, R3Is methyl substituted with unsubstituted heteroaryl.

In the examples, R3Is methyl substituted by substituted or unsubstituted pyridyl. In the examples, R3Is methyl substituted by methoxy substituted pyridyl. In the examples, R3Is methyl substituted with a substituted pyridyl group. In the examples, R3Is methyl substituted by unsubstituted pyridyl.

In the examples, R3Is C substituted by methoxy-substituted pyridyl1-C4An alkyl group. In the examples, R3Is substituted by a substituted pyridyl group1-C4An alkyl group. In the examples, R3Is unsubstituted pyridyl substituted C1-C4An alkyl group. In the examples, R3Is substituted with a substituted 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R3Is substituted with substituted heteroaryl1-C4An alkyl group.

In the examples, R3Is unsubstituted methyl. In the examples, R3Is unsubstitutedC1-C4An alkyl group. In the examples, R3Is cyclopentyl substituted with substituted or unsubstituted methyl. In the examples, R3Is substituted or unsubstituted C1-C4Alkyl-substituted cyclopentyl. In the examples, R3Is C substituted by substituted or unsubstituted methyl3-C6A cycloalkyl group. In the examples, R3Is a substituted methyl-substituted cyclopentyl group. In the examples, R3Is substituted C1-C4Alkyl-substituted cyclopentyl. In the examples, R3Is substituted by substituted methyl3-C6A cycloalkyl group. In the examples, R3Is substituted C3-C6A cycloalkyl group. In the examples, R3Is a substituted cyclopentyl group.

In the examples, R3Is propyl substituted with substituted or unsubstituted pyridyl. In the examples, R3Is a substituted or unsubstituted 5-to 6-membered heteroaryl substituted propyl. In the examples, R3Is propyl substituted with substituted or unsubstituted heteroaryl. In the examples, R3Is a substituted propyl group. In the examples, R3Is C substituted by substituted or unsubstituted pyridyl1-C6An alkyl group. In the examples, R3Is propyl substituted with a substituted pyridyl group. In the examples, R3Is a substituted 5-to 6-membered heteroaryl substituted propyl. In the examples, R3Is a substituted heteroaryl substituted propyl. In the examples, R3Is unsubstituted propyl. In the examples, R3Is substituted by a substituted pyridyl group1-C6An alkyl group. In the examples, R3Is propyl substituted with unsubstituted pyridyl. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted propyl. In the examples, R3Is an unsubstituted heteroaryl substituted propyl. In the examples, R3Is unsubstituted pyridyl substituted C1-C6An alkyl group.

In the examples, R3Is taken outSubstituted or unsubstituted 5-to 6-membered heteroaryl substituted C1-C6An alkyl group. In the examples, R3Is C substituted by substituted or unsubstituted heteroaryl1-C6An alkyl group. In the examples, R3Is substituted with a substituted 5-to 6-membered heteroaryl group1-C6An alkyl group. In the examples, R3Is substituted with substituted heteroaryl1-C6An alkyl group. In the examples, R3Is substituted with a substituted 5-to 6-membered heteroaryl group1-C6An alkyl group. In the examples, R3Is substituted with substituted heteroaryl1-C6An alkyl group. In the examples, R3Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C6An alkyl group. In the examples, R3Is unsubstituted heteroaryl substituted C1-C6An alkyl group. In the examples, R3Is substituted C1-C6An alkyl group. In the examples, R3Is propyl substituted with unsubstituted pyridyl. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted propyl. In the examples, R3Is an unsubstituted heteroaryl substituted propyl. In the examples, R3Is a substituted propyl group. In the examples, R3Is unsubstituted pyridyl substituted C1-C6An alkyl group. In the examples, R3Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C6An alkyl group. In the examples, R3Is unsubstituted heteroaryl substituted C1-C6An alkyl group.

In the examples, R3Is methyl substituted with substituted or unsubstituted phenyl. In the examples, R3Is methyl substituted with substituted or unsubstituted aryl. In the examples, R3Is a substituted methyl group. In the examples, R3Is C substituted by substituted or unsubstituted phenyl1-C4An alkyl group. In the examples, R3Is C substituted by substituted or unsubstituted aryl1-C4An alkyl group. In the examples, R3Is substitutedPhenyl-substituted methyl. In the examples, R3Is methyl substituted with substituted aryl. In the examples, R3Is unsubstituted methyl. In the examples, R3Is substituted by substituted phenyl1-C4An alkyl group. In the examples, R3Is substituted by substituted aryl1-C4An alkyl group. In the examples, R3Is substituted C1-C4An alkyl group. In the examples, R3Is methyl substituted by unsubstituted phenyl. In the examples, R3Is an unsubstituted aryl-substituted methyl group. In the examples, R3Is unsubstituted phenyl-substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted aryl-substituted C1-C4An alkyl group.

In the examples, R3Is methyl substituted with a substituted or unsubstituted pyridazinyl group. In the examples, R3Is a substituted or unsubstituted pyridazinyl group1-C4An alkyl group. In the examples, R3Is a substituted pyridazinyl substituted methyl group. In the examples, R3Is substituted by a substituted pyridazinyl group C1-C4An alkyl group. In the examples, R3Is a methyl group substituted with an unsubstituted pyridazinyl group. In the examples, R3Is unsubstituted pyridazinyl substituted C1-C4An alkyl group. In the examples, R3Is an unsubstituted ethyl group. In the examples, R3Is unsubstituted C1-C4An alkyl group. In the examples, R3Is a pyridyl group substituted with a methoxy group. In the examples, R3Is a substituted pyridyl group. In the examples, R3Is a 5 to 6 membered heteroaryl substituted with methoxy. In the examples, R3Is a substituted 5-to 6-membered heteroaryl. In the examples, R3Is a substituted heteroaryl group.

In the examples, R3Is a methyl group substituted with a piperidinyl group substituted with a substituted or unsubstituted benzyl group. In the examples, R3Is a substituted benzyl-substituted piperidinyl substituentA substituted methyl group. In the examples, R3Is an unsubstituted benzyl-substituted piperidinyl-substituted methyl group. In the examples, R3Is methyl substituted with a substituted piperidinyl group. In the examples, R3Is methyl substituted with a substituted or unsubstituted 5-to 6-membered heterocycloalkyl group. In the examples, R3Is methyl substituted by substituted or unsubstituted heterocycloalkyl. In the examples, R3Is a substituted 5-to 6-membered heterocycloalkyl substituted methyl group. In the examples, R3Is a substituted heterocycloalkyl substituted methyl group. In the examples, R3Is a substituted methyl group. In the examples, R3Is C substituted by a substituted or unsubstituted benzyl-substituted piperidinyl group1-C4An alkyl group. In the examples, R3Is substituted with a substituted piperidinyl group1-C4An alkyl group. In the examples, R3Is C substituted by substituted or unsubstituted 5-to 6-membered heterocycloalkyl1-C4An alkyl group. In the examples, R3Is C substituted by substituted or unsubstituted heterocycloalkyl1-C4An alkyl group. In the examples, R3Is a substituted benzyl-substituted piperidinyl-substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted piperidinyl-substituted C1-C4An alkyl group. In the examples, R3Is substituted with a substituted 5-to 6-membered heterocycloalkyl group1-C4An alkyl group. In the examples, R3Is substituted by a substituted heterocycloalkyl group1-C4An alkyl group. In the examples, R3Is substituted C1-C4An alkyl group. In the examples, R3Is an unsubstituted benzyl-substituted piperidinyl-substituted methyl group. In the examples, R3Is methyl substituted with a substituted piperidinyl group. In the examples, R3Is a substituted 5-to 6-membered heterocycloalkyl substituted methyl group. In the examples, R3Is a substituted heterocycloalkyl substituted methyl group. In the examples, R3Is unsubstituted benzyl-substituted piperidinyl-substituted C1-C4An alkyl group. In the examples, R3Is substituted with a substituted piperidinyl group1-C4An alkyl group. In the examples, R3Is substituted with a substituted 5-to 6-membered heterocycloalkyl group1-C4An alkyl group. In the examples, R3Is substituted by a substituted heterocycloalkyl group1-C4An alkyl group.

In the examples, R3Is a 4-membered heteroalkyl group substituted with a substituted or unsubstituted pyridyl group. In the examples, R3Is a 4-membered heteroalkyl group substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl group. In the examples, R3Is a 4-membered heteroalkyl group substituted with a substituted or unsubstituted heteroaryl group. In the examples, R3Is a2 to 6 membered heteroalkyl group substituted with a substituted or unsubstituted pyridyl group. In the examples, R3Is a 2-to 6-membered heteroalkyl substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl. In the examples, R3Is a2 to 6 membered heteroalkyl group substituted with a substituted or unsubstituted heteroaryl group. In the examples, R3Is a 4-membered heteroalkyl group substituted with a substituted pyridyl group. In the examples, R3Is a substituted 5-to 6-membered heteroaryl substituted 4-membered heteroalkyl. In the examples, R3Is a substituted heteroaryl substituted 4-membered heteroalkyl. In the examples, R3Is a2 to 6 membered heteroalkyl substituted with a substituted pyridyl. In the examples, R3Is a 2-to 6-membered heteroalkyl substituted with a substituted 5-to 6-membered heteroaryl. In the examples, R3Is a2 to 6 membered heteroalkyl substituted with a substituted heteroaryl. In the examples, R3Is a 4-membered heteroalkyl group substituted with an unsubstituted pyridyl group. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted 4-membered heteroalkyl. In the examples, R3Is an unsubstituted heteroaryl substituted 4 membered heteroalkyl. In the examples, R3Is a2 to 6 membered heteroalkyl substituted with an unsubstituted pyridyl. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted 2-to 6-membered heteroalkyl. In the examples, R3Is an unsubstituted heteroaryl substituted 2 to 6 membered heteroalkyl group.

In the examples, R3Is unsubstitutedPyridyl-substituted 4-membered heteroalkyl. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted 4-membered heteroalkyl. In the examples, R3Is an unsubstituted heteroaryl substituted 4 membered heteroalkyl. In the examples, R3Is a2 to 6 membered heteroalkyl substituted with an unsubstituted pyridyl. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted 2-to 6-membered heteroalkyl. In the examples, R3Is an unsubstituted heteroaryl substituted 2 to 6 membered heteroalkyl group.

In the examples, R3Is ethyl substituted with a substituted or unsubstituted imidazolyl. In the examples, R3Is ethyl substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl. In the examples, R3Is ethyl substituted with substituted or unsubstituted heteroaryl. In the examples, R3Is C substituted by a substituted or unsubstituted imidazolyl group1-C4An alkyl group. In the examples, R3Is C substituted with a substituted or unsubstituted 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R3Is C substituted by substituted or unsubstituted heteroaryl1-C4An alkyl group. In the examples, R3Is ethyl substituted with a substituted imidazolyl group. In the examples, R3Is ethyl substituted with a substituted 5-to 6-membered heteroaryl. In the examples, R3Is ethyl substituted with a substituted heteroaryl group. In the examples, R3Is substituted by a substituted imidazolyl group1-C4An alkyl group. In the examples, R3Is substituted with a substituted 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R3Is substituted with substituted heteroaryl1-C4An alkyl group. In the examples, R3Is an ethyl group substituted with an unsubstituted imidazolyl group. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted ethyl group. In the examples, R3Is an unsubstituted heteroaryl substituted ethyl. In the examples, R3Is unsubstituted imidazolyl-substituted C1-C4An alkyl group. In the examples, R3Is notSubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted heteroaryl substituted C1-C4An alkyl group.

In the examples, R3Is an ethyl group substituted with an unsubstituted imidazolyl group. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted ethyl group. In the examples, R3Is an unsubstituted heteroaryl substituted ethyl. In the examples, R3Is unsubstituted imidazolyl-substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted heteroaryl substituted C1-C4An alkyl group.

In the examples, R3Is ethyl substituted by OH. In the examples, R3Is C substituted by OH1-C4An alkyl group. In the examples, R3Is a substituted ethyl group. In the examples, R3Is substituted C1-C4An alkyl group.

In the examples, R3Is unsubstituted 4-membered heteroalkyl-substituted piperidinyl-substituted methyl. In the examples, R3Is an unsubstituted heteroalkyl-substituted piperidinyl-substituted methyl group. In the examples, R3Is a substituted 5-to 6-membered heterocycloalkyl substituted methyl group. In the examples, R3Is unsubstituted 4-membered heteroalkyl-substituted piperidinyl-substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted heteroalkyl-substituted piperidinyl-substituted C1-C4An alkyl group. In the examples, R3Is substituted with a substituted 5-to 6-membered heterocycloalkyl group1-C4An alkyl group. In the examples, R3Is substituted by a substituted heterocycloalkyl group1-C4An alkyl group.

In the examples, R3Is pyrrolidinyl substituted with tert-butoxycarbonyl. In the examples, R3Is a substituted 2-to 8-membered heteroalkyl-substituted pyrrolidineAnd (4) a base. In the examples, R3Is unsubstituted 2-to 8-membered heteroalkyl-substituted pyrrolidinyl. In the examples, R3Is a3 to 6 membered heterocycloalkyl substituted with tert-butoxycarbonyl. In the examples, R3Is a substituted 3-to 6-membered heterocycloalkyl group. In the examples, R3Is a substituted heterocycloalkyl group. In the examples, R3Is unsubstituted 4-membered heteroalkyl. In the examples, R3Is unsubstituted 2-to 6-membered heteroalkyl. In the examples, R3Is unsubstituted heteroalkyl.

In the examples, R3Is unsubstituted cyclobutyl. In the examples, R3Is unsubstituted 3 to 6 membered cycloalkyl. In the examples, R3Is unsubstituted cycloalkyl. In the examples, R3Is unsubstituted pyrrolidinyl. In the examples, R3Is unsubstituted 3-to 6-membered heterocycloalkyl. In the examples, R3Is unsubstituted heterocycloalkyl.

In the examples, R3Is cyclobutyl substituted by OH. In the examples, R3Is a substituted cyclobutyl group. In the examples, R3Is C substituted by OH3-C6A cycloalkyl group. In the examples, R3Is substituted C3-C6A cycloalkyl group.

In the examples, R3Is propyl substituted by OH. In the examples, R3Is C substituted by OH1-C6An alkyl group. In the examples, R3Is a substituted propyl group. In the examples, R3Is substituted C1-C6An alkyl group.

In the examples, R3Is azetidinyl substituted with tert-butoxycarbonyl. In the examples, R3Is 2 to 8 membered heteroalkyl substituted azetidinyl substituted with oxo. In the examples, R3Is an azetidinyl substituted with an oxo-substituted heteroalkyl. In the examples, R3Is a substituted 2-to 8-membered heteroalkyl substituted azetidinyl. In the examples, R3Is substituted by substituted heteroalkylAn azetidinyl group.

In the examples, R3Is unsubstituted cyclopentyl. In the examples, R3Is unsubstituted C3-C6A cycloalkyl group. In the examples, R3Is unsubstituted cyclopropyl.

In the examples, R3Is methyl substituted by unsubstituted cyclobutyl. In the examples, R3Is unsubstituted C3-C6Cycloalkyl-substituted methyl. In the examples, R3Is unsubstituted cyclobutyl substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted C3-C6Cycloalkyl-substituted C1-C4An alkyl group.

In the examples, R3Is unsubstituted oxetanyl. In the examples, R3Is unsubstituted 3-to 6-membered heterocycloalkyl.

In the examples, R3Is unsubstituted isopropyl. In the examples, R3Is unsubstituted propyl. In the examples, R3Is unsubstituted tert-butyl. In the examples, R3Is an unsubstituted butyl group. In the examples, R3Is unsubstituted C1-C6An alkyl group.

In the examples, R3Is a 4-membered heteroalkyl substituted with oxo. In the examples, R3Is a2 to 6 membered heteroalkyl substituted with oxo. In the examples, R3Is a substituted 4-membered heteroalkyl group. In the examples, R3Is a substituted 2-to 6-membered heteroalkyl group. In the examples, R3Is a substituted heteroalkyl group.

In the examples, R3Is methyl substituted with unsubstituted tetrahydropyran. In the examples, R3Is methyl substituted with tetrahydropyran. In the examples, R3Is an unsubstituted 5-to 6-membered heterocycloalkyl substituted methyl group. In the examples, R3Is unsubstituted tetrahydropyran substituted C1-C4An alkyl group. In the examples, R3Is substituted by tetrahydropyranC of (A)1-C4An alkyl group. In the examples, R3Is unsubstituted 5-to 6-membered heterocycloalkyl-substituted C1-C4An alkyl group.

In the examples, R3Is by CF3A substituted methyl group. In the examples, R3Is a quilt C (halogen base)3A substituted methyl group. In the examples, R3Is by CF3Substituted C1-C4An alkyl group. In the examples, R3Is a quilt C (halogen base)3Substituted C1-C4An alkyl group.

In the examples, R3Is methyl substituted with t-butoxycarbonyl substituted pyrrolidinyl. In the examples, R3Is a pyrrolidinyl substituted methyl substituted with a2 to 8 membered heteroalkyl substituted with oxo. In the examples, R3Is a substituted 2 to 8 membered heteroalkyl substituted pyrrolidinyl substituted methyl. In the examples, R3Is methyl substituted with a3 to 6 membered heterocycloalkyl substituted with tert-butoxycarbonyl. In the examples, R3Is C substituted by tert-butoxycarbonyl-substituted pyrrolidinyl1-C4An alkyl group. In the examples, R3Is substituted 2-to 8-membered heteroalkyl-substituted pyrrolidinyl-substituted C1-C4An alkyl group. In the examples, R3Is a 3-to 6-membered heterocycloalkyl substituted with a substituted 2-to 8-membered heteroalkyl1-C4An alkyl group. In the examples, R3Is substituted with a substituted 3-to 6-membered heterocycloalkyl group1-C4An alkyl group.

In the examples, R3Is butyl substituted by OH. In the examples, R3Is a substituted butyl group.

In the examples, R3Is ethyl substituted with OH and unsubstituted pyridyl. In the examples, R3Is ethyl substituted by OH. In the examples, R3Is an ethyl group substituted with an unsubstituted pyridyl group. In the examples, R3Is C substituted by OH and unsubstituted pyridyl1-C4An alkyl group. In the examples, R3Is substituted by OHC1-C4An alkyl group. In the examples, R3Is unsubstituted pyridyl substituted C1-C4An alkyl group. In the examples, R3Is ethyl substituted with OH and unsubstituted 5-to 6-membered heteroaryl. In the examples, R3Is a substituted ethyl group. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted ethyl group. In the examples, R3Is C substituted with OH-substituted and unsubstituted 5-to 6-membered heteroaryl1-C4An alkyl group. In the examples, R3Is substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group.

In the examples, R3Is methyl substituted with methyl-substituted imidazolyl. In the examples, R3Is methyl substituted with a 5 to 6 membered heteroaryl substituted with methyl. In the examples, R3Is methyl substituted by heteroaryl substituted by methyl. In the examples, R3Is unsubstituted C1-C4Alkyl substituted imidazolyl substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted C1-C4Alkyl substituted 5 to 6 membered heteroaryl substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted C1-C4Alkyl substituted heteroaryl substituted C1-C4An alkyl group.

In the examples, R3Is cyclobutyl substituted by methoxy. In the examples, R3Is cyclobutyl substituted by 2-to 4-membered heteroalkyl. In the examples, R3Is C substituted by methoxy3-C6A cycloalkyl group. In the examples, R3Is C substituted by 2-to 4-membered heteroalkyl3-C6A cycloalkyl group.

In the examples, R3Is unsubstituted phenyl. In the examples, R3Is unsubstituted aryl.

In the examples, R3Is methyl substituted by imidazolyl. In fact In the examples, R3Is methyl substituted with a 5 to 6 membered heteroaryl. In the examples, R3Is methyl substituted by heteroaryl. In the examples, R3Is methyl substituted with unsubstituted imidazolyl. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted methyl. In the examples, R3Is methyl substituted with unsubstituted heteroaryl. In the examples, R3Is C substituted by imidazolyl1-C4An alkyl group. In the examples, R3Is C substituted by a 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R3Is C substituted by heteroaryl1-C4An alkyl group. In the examples, R3Is unsubstituted imidazolyl-substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted heteroaryl substituted C1-C4An alkyl group.

In the examples, R3Is cyclopentyl substituted by OH. In the examples, R3Is C substituted by OH3-C6A cycloalkyl group. In the examples, R3Is a substituted cyclopentyl group. In the examples, R3Is substituted C3-C6A cycloalkyl group.

In the examples, R3Is ethyl substituted by OH-substituted phenyl. In the examples, R3Is ethyl substituted with an OH substituted aryl. In the examples, R3Is a substituted aryl substituted ethyl group. In the examples, R3Is C substituted by OH-substituted phenyl1-C4An alkyl group. In the examples, R3Is C substituted by OH-substituted aryl1-C4An alkyl group. In the examples, R3Is substituted by substituted aryl1-C4An alkyl group.

In the examples, R3Is ethyl substituted with t-butoxycarbonyl substituted tetrahydropyran. In the examples, R3Is a substituted 2-to 8-membered heteroalkyl-substituted tetrahydropyranA substituted ethyl group. In the examples, R3Is ethyl substituted with a 3 to 6 membered heterocycloalkyl substituted with tert-butoxycarbonyl. In the examples, R3Is C substituted by tetrahydropyran substituted by tert-butoxycarbonyl1-C4An alkyl group.

In the examples, R3Is an unsubstituted pyrrolidinyl-substituted ethyl group. In the examples, R3Is an unsubstituted 3-to 6-membered heterocycloalkyl substituted ethyl group. In the examples, R3Is unsubstituted pyrrolidinyl substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted 5-to 6-membered heterocycloalkyl-substituted C1-C4An alkyl group.

In the examples, R3Is ethyl substituted with t-butoxycarbonyl substituted pyrrolidinyl. In the examples, R3Is a substituted 2 to 8 membered heteroalkyl substituted pyrrolidinyl substituted ethyl. In the examples, R3Is ethyl substituted with a 3 to 6 membered heterocycloalkyl substituted with tert-butoxycarbonyl.

In the examples, R3Is C substituted by tert-butoxycarbonyl-substituted pyrrolidinyl1-C4An alkyl group. In the examples, R3Is substituted 2-to 8-membered heteroalkyl-substituted pyrrolidinyl-substituted C1-C4An alkyl group. In the examples, R3Is C substituted by a 3-to 6-membered heterocycloalkyl group substituted by a tert-butoxycarbonyl group1-C4An alkyl group.

In the examples, R3Is methyl substituted by unsubstituted pyrrolidinyl. In the examples, R3Is an unsubstituted 3-to 6-membered heterocycloalkyl substituted methyl group.

In the examples, R3Is unsubstituted pyrrolidinyl substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted 3-to 6-membered heterocycloalkyl-substituted C1-C4An alkyl group.

In the examples, R3Is ethyl substituted with unsubstituted morpholinyl. In the examples, R3Is unsubstituted morpholinyl substitutedAnd (4) ethyl. In the examples, R3Is an unsubstituted 5-to 6-membered heterocycloalkyl substituted ethyl group. In the examples, R3Is unsubstituted morpholinyl substituted C1-C4An alkyl group.

In the examples, R3Is ethyl substituted by OH-substituted phenyl. In the examples, R3Is ethyl substituted with an OH substituted aryl. In the examples, R3Is substituted by substituted phenyl1-C4An alkyl group. In the examples, R3Is substituted by substituted aryl1-C4An alkyl group.

In the examples, R3Is unsubstituted piperidinyl substituted methyl. In the examples, R3Is an unsubstituted 5-to 6-membered heterocycloalkyl substituted methyl group. In the examples, R3Is an unsubstituted heterocycloalkyl substituted methyl group. In the examples, R3Is unsubstituted piperidinyl-substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted 5-to 6-membered heterocycloalkyl-substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted heterocycloalkyl-substituted C1-C4An alkyl group.

In the examples, R3Is an ethyl group substituted with an OH-substituted methyl-substituted phenyl group. In the examples, R3Is an ethyl group substituted with an aryl group substituted with an OH-substituted methyl group. In the examples, R3Is a substituted phenyl substituted ethyl group. In the examples, R3Is a substituted aryl substituted ethyl group. In the examples, R3Is substituted by substituted phenyl1-C4An alkyl group. In the examples, R3Is substituted by substituted aryl1-C4An alkyl group.

In the examples, R3Is ethyl substituted with Cl substituted phenyl. In the examples, R3Is an ethyl group substituted with an aryl group substituted with a halogen group. In the examples, R3Is ethyl substituted with phenyl substituted with halo. In the examples, R3Is C substituted by Cl-substituted phenyl1-C4An alkyl group. In the examples, R3Is C substituted by phenyl substituted by halogen1-C4An alkyl group. In the examples, R3Is aryl substituted by halogen1-C4An alkyl group.

In the examples, R3Is methyl substituted with unsubstituted tetrahydrofuranyl. In the examples, R3Is methyl substituted by tetrahydrofuranyl. In the examples, R3Is an unsubstituted 3-to 6-membered heterocycloalkyl substituted methyl group. In the examples, R3Is unsubstituted tetrahydrofuranyl-substituted C1-C4An alkyl group. In the examples, R3Is C substituted by tetrahydrofuranyl1-C4An alkyl group.

In the examples, R3Is an ethyl group substituted with an unsubstituted phenyl group. In the examples, R3Is an unsubstituted aryl substituted ethyl group. In the examples, R3Is unsubstituted phenyl-substituted C1-C4An alkyl group. In the examples, R3Is unsubstituted aryl-substituted C1-C4An alkyl group.

In the examples, R3Is unsubstituted azetidinyl. In the examples, R3Is unsubstituted 3-to 6-membered heterocycloalkyl

In the examples, R3Is methyl substituted by phenoxy substituted by methoxy. In the examples, R3Is methyl substituted with 2 to 4-membered alkoxy substituted phenoxy substituted pyridyl. In the examples, R3Is methyl substituted with 2 to 4-membered alkoxy-substituted aryloxy-substituted pyridyl. In the examples, R3Is methyl substituted with 5 to 6 membered heteroaryl substituted with 2 to 4 membered alkoxy substituted aryloxy. In the examples, R3Is C substituted with a 5-to 6-membered heteroaryl group substituted with a 2-to 4-membered alkoxy-substituted aryloxy group1-C4An alkyl group.

In the examples, R3Is ethyl substituted with methoxy substituted pyridyl. In the examples, R3Is 2 to 4 yuanAlkoxy substituted pyridyl substituted ethyl. In the examples, R3Is ethyl substituted with a 5 to 6 membered heteroaryl substituted with a 2 to 4 membered alkoxy. In the examples, R3Is C substituted with a 5-to 6-membered heteroaryl group substituted with a 2-to 4-membered alkoxy group1-C4An alkyl group. In the examples, R3Is C substituted by 2-to 4-membered alkoxy-substituted heteroaryl1-C4An alkyl group.

In the examples, R3Is ethyl substituted by methoxy substituted phenyl. In the examples, R3Is ethyl substituted with phenyl substituted with 2 to 4 membered alkoxy. In the examples, R3Is ethyl substituted with 2 to 4 membered alkoxy substituted aryl. In the examples, R3Is C substituted by aryl substituted by 2-to 4-membered alkoxy1-C4An alkyl group.

In the examples, R3Is ethyl substituted with phenyl substituted with a 2 to 4 membered heteroalkyl substituted with oxo. In the examples, R3Is a substituted 2 to 4 membered heteroalkyl substituted phenyl substituted ethyl. In the examples, R3Is ethyl substituted with 2 to 4 membered heteroalkyl substituted aryl. In the examples, R3Is substituted 2-to 4-membered heteroalkyl-substituted aryl-substituted C1-C4An alkyl group.

In the examples, R3Is propyl substituted with methoxy substituted phenyl. In the examples, R3Is a propyl group substituted with a phenyl group substituted with a 2 to 4-membered alkoxy group. In the examples, R3Is a propyl group substituted with a 2 to 4-membered alkoxy-substituted aryl group. In the examples, R3Is C substituted by aryl substituted by 2-to 4-membered alkoxy1-C4An alkyl group.

In the examples, R3Is ethyl substituted with phenyl substituted with a 2 to 4 membered heteroalkyl substituted with oxo. In the examples, R3Is a substituted 2 to 4 membered heteroalkyl substituted phenyl substituted ethyl. In the examples, R3Is ethyl substituted with 2 to 4 membered heteroalkyl substituted aryl. In the examples, R3Is substituted with substituted 2-to 4-membered heteroalkyl-substituted arylC1-C4An alkyl group.

In the examples, R3Is an ethyl group substituted with an unsubstituted cyclopentyl group. In the examples, R3Is unsubstituted C3-C6Cycloalkyl-substituted ethyl. In the examples, R3Is unsubstituted C3-C6Cycloalkyl-substituted C1-C4An alkyl group.

In the examples, R3Is ethyl substituted with t-butoxycarbonyl substituted pyrrolidinyl. In the examples, R3Is a pyrrolidinyl substituted ethyl substituted with oxo substituted 4 to 8 membered heteroalkyl substituted. In the examples, R3Is a substituted 4 to 8 membered heteroalkyl substituted pyrrolidinyl substituted ethyl. In the examples, R3Is a 3 to 6 membered heterocycloalkyl substituted ethyl substituted with a substituted 4 to 8 membered heteroalkyl. In the examples, R3Is a 3-to 6-membered heterocycloalkyl substituted with a substituted 4-to 8-membered heteroalkyl1-C4An alkyl group.

In the examples, R3Is ethyl substituted with t-butoxycarbonyl substituted azetidinyl. In the examples, R3Is an ethyl group substituted with an oxo-substituted 4 to 8 membered heteroalkyl-substituted azetidinyl group. In the examples, R3Is a substituted 4 to 8 membered heteroalkyl substituted azetidinyl substituted ethyl. In the examples, R3Is a substituted 4-to 8-membered heteroalkyl-substituted azetidinyl-substituted C1-C4An alkyl group.

In the examples, R3Is an ethyl group substituted with an unsubstituted azetidinyl group. In the examples, R3Is unsubstituted C3-C6Heterocycloalkyl substituted ethyl. In the examples, R3Is unsubstituted C3-C6Heterocycloalkyl-substituted C1-C4An alkyl group.

In the examples, R3Is ethyl substituted with phenyl substituted with CN. In the examples, R3Is a substituted phenyl substituted ethyl group. In the examples, R3Is substituted by CNAryl-substituted ethyl group of (1). In the examples, R3Is aryl substituted by CN1-C4An alkyl group. In the examples, R3Is substituted by substituted aryl1-C4An alkyl group.

In the examples, R3Is an unsubstituted phenyl-substituted ethyl-substituted piperidinyl-substituted methyl group. In the examples, R3Is an unsubstituted aryl-substituted ethyl-substituted piperidinyl-substituted methyl group. In the examples, R3Is unsubstituted aryl-substituted C1-C4Alkyl-substituted piperidinyl-substituted methyl. In the examples, R3Is unsubstituted aryl-substituted C1-C4Alkyl-substituted 3 to 6 membered heterocycloalkyl-substituted methyl. In the examples, R3Is unsubstituted aryl-substituted C1-C4Alkyl substituted 3 to 6 membered heterocycloalkyl substituted C1-C4An alkyl group.

In the examples, R3Is methyl substituted by methoxy substituted pyridyl. In the examples, R3Is methyl substituted with substituted or unsubstituted 2-to 4-membered alkoxy substituted pyridyl. In the examples, R3Is methyl substituted with a substituted or unsubstituted 2-to 4-membered alkoxy substituted 5-to 6-membered heteroaryl. In the examples, R3Is C substituted with a substituted or unsubstituted 2-to 4-membered alkoxy-substituted 5-to 6-membered heteroaryl group1-C4An alkyl group. In the examples, R3Is methyl substituted with substituted 2-to 4-membered alkoxy substituted pyridyl. In the examples, R3Is a substituted 2-to 4-membered alkoxy substituted 5-to 6-membered heteroaryl substituted methyl. In the examples, R3Is a substituted 2-to 4-membered alkoxy-substituted 5-to 6-membered heteroaryl-substituted C1-C4An alkyl group. In the examples, R3Is methyl substituted by unsubstituted 2-to 4-membered alkoxy-substituted pyridyl. In the examples, R3Is an unsubstituted 2-to 4-membered alkoxy-substituted 5-to 6-membered heteroaryl-substituted methyl group. In the examples, R3Is unsubstituted 2-to 4-membered alkoxy-substituted5-to 6-membered heteroaryl substituted C1-C4An alkyl group.

In the examples, R3Is methyl substituted by unsubstituted 2-to 4-membered alkoxy-substituted pyridyl. In the examples, R3Is an unsubstituted 2-to 4-membered alkoxy-substituted 5-to 6-membered heteroaryl-substituted methyl group. In the examples, R3Is unsubstituted 2-to 4-membered alkoxy-substituted 5-to 6-membered heteroaryl-substituted C1-C4An alkyl group.

In the examples, R3Is methyl substituted by unsubstituted pyridyl. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted methyl. In the examples, R3Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group.

In the examples, R3Is ethyl substituted by phenyl substituted by carboxyl. In the examples, R3Is a substituted phenyl substituted ethyl group. In the examples, R3Is ethyl substituted with aryl substituted with carboxyl. In the examples, R3Is aryl substituted by carboxyl1-C4An alkyl group.

In the examples, R3Is by SO2NH2Substituted phenyl substituted ethyl. In the examples, R3Is by SO2NH2Substituted aryl substituted ethyl. In the examples, R3Is by SO2NH2Substituted aryl substituted C1-C4An alkyl group.

In the examples, R3Is hydrogen. In the examples, R3Is ethyl substituted with phenyl substituted with tert-butyl carbamate. In the examples, R3Is an ethyl group substituted with a phenyl group substituted with a 6 to 8 membered heteroalkyl group substituted with an oxo group. In the examples, R3Is a substituted 6 to 8 membered heteroalkyl substituted phenyl substituted ethyl. In the examples, R3Is a substituted 6 to 8 membered heteroalkyl substituted aryl substituted ethyl. In the examples, R3Is substituted 6-to 8-membered heteroalkyl-substituted aryl-substituted C1-C4An alkyl group.

In the examples, R3Is ethyl substituted with tert-butoxycarbonyl substituted piperidinyl. In the examples, R3Is a piperidinyl-substituted ethyl substituted with a 5 to 7 membered heteroalkyl substituted with oxo. In the examples, R3Is a substituted 5 to 7 membered heteroalkyl substituted piperidinyl substituted ethyl. In the examples, R3Is a 5 to 6 membered heterocycloalkyl substituted ethyl substituted with a substituted 5 to 7 membered heteroalkyl. In the examples, R3Is a 5-to 6-membered heterocycloalkyl substituted with a substituted 5-to 7-membered heteroalkyl1-C4An alkyl group.

In the examples, R3Is methyl substituted by unsubstituted thiazolyl. In the examples, R3Is an unsubstituted 5-to 6-membered heteroaryl substituted methyl. In the examples, R3Is unsubstituted 5-to 6-membered heteroaryl substituted C1-C4An alkyl group.

In the examples, R3Is by NH2Substituted phenyl substituted ethyl. In the examples, R3Is by NH2Substituted aryl substituted ethyl. In the examples, R3Is by NH2Substituted aryl substituted C1-C4An alkyl group. In the examples, R3Is substituted by substituted aryl1-C4An alkyl group.

In the examples, R3Is an unsubstituted piperidinyl-substituted ethyl group. In the examples, R3Is an unsubstituted 5-to 6-membered heterocycloalkyl substituted ethyl group. In the examples, R3Is unsubstituted 5-to 6-membered heterocycloalkyl-substituted C1-C4An alkyl group.

In the examples, R3Is ethyl substituted with phenyl substituted with a 2 to 6 membered heteroalkyl substituted with oxo. In the examples, R3Is a substituted 2 to 6 membered heteroalkyl substituted phenyl substituted ethyl. In the examples, R3Is a substituted 2 to 6 membered heteroalkyl substituted aryl substituted ethyl. In the examples, R3Is substituted 2-to 6-membered heteroalkyl-substituted aryl-substituted C1-C4An alkyl group.

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001334

In the examples, R3Is that

Figure BDA0002469898950001335

In the examples, R3Is that

Figure BDA0002469898950001336

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001339

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013315

In the examples, R3Is that

Figure BDA00024698989500013316

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001342

In the examples, R3Is that

Figure BDA0002469898950001343

In the examples, R3Is that

Figure BDA0002469898950001344

In the examples, R3Is that

Figure BDA0002469898950001345

In the examples, R3Is that

Figure BDA0002469898950001346

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001348

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013410

In the examples, R3Is that

Figure BDA00024698989500013411

In the examples, R3Is that

Figure BDA00024698989500013412

In the examples, R3Is that

Figure BDA00024698989500013413

In the examples, R3Is that

Figure BDA00024698989500013414

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013416

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013418

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013420

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013422

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013427

In the examples, R3Is that

Figure BDA00024698989500013428

In the examples, R3Is that

Figure BDA00024698989500013429

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013431

In the examples, R3Is that

Figure BDA00024698989500013432

In the examples, R3Is that

Figure BDA0002469898950001351

In the examples, R3Is that

Figure BDA0002469898950001352

In the examples, R3Is that

Figure BDA0002469898950001353

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001357

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001359

In the examples, R3Is that

Figure BDA00024698989500013510

In the examples, R3Is that

Figure BDA00024698989500013511

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013513

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013515

In the examples, R3Is that

Figure BDA00024698989500013516

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013520

In the examples, R3Is that

Figure BDA00024698989500013521

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013523

In the examples, R3Is that

Figure BDA00024698989500013524

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013528

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001361

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001363

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001366

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001368

In the examples, R3Is that

Figure BDA0002469898950001369

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013614

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013617

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013619

In the examples, R3Is that

Figure BDA00024698989500013620

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013622

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013625

In the examples, R3Is that

Figure BDA00024698989500013626

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001372

In the examples, R3Is thatIn the examples, R3Is thatIn the examplesIn, R3Is that

Figure BDA0002469898950001375

In the examples, R3Is that

Figure BDA0002469898950001376

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001378

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013710

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013713

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013715

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013719

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013721

In the examples, R3Is that

Figure BDA00024698989500013722

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013724

In the examples, R3Is thatIn the examples, R3Is that

Figure BDA00024698989500013726

In the examples, R3Is thatIn the examples, R3Is thatIn the examples, R3Is that

Figure BDA0002469898950001382

In the examples, R3Is that

Figure BDA0002469898950001383

In the examples, R4Is hydrogen, substituted or unsubstituted C1-C6Alkyl, substituted or unsubstituted 2-to 6-membered heteroalkyl, substituted or unsubstituted C3-C6Cycloalkyl, substituted or unsubstituted 3-to 6-membered heterocycloalkyl, substituted or unsubstituted phenyl, or substituted or unsubstituted 5-to 6-membered heteroaryl.

In the examples, R4Independently halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R29Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl) or by R29Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl).

In the examples, R4Is by R29Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4Is by R29Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4Is by R29Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R4Is by R29Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R4Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl).

In the examples, R4A、R4B、R4CAnd R4DIndependently hydrogen, halogen, -CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2Quilt R29Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R29Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl),

By R29Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R29Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R29Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R29Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R4A、R4B、R4CAnd R4DIndependently is by R29Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4A、R4B、R4CAnd R4DIndependently is by R29Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4A、R4B、R4CAnd R4DIndependently is unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4A、R4B、R4CAnd R4DIndependently is by R29Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R4A、R4B、R4CAnd R4DIndependently is by R29Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R4A、R4B、R4CAnd R4DIndependently an unsubstituted heteroalkyl group (e.g., a 2-to 8-membered heteroalkyl group, a 2-to 6-membered heteroalkyl group, or a 2-to 4-membered heteroalkyl group). In the examples, R4A、R4B、R4CAnd R4DIndependently is by R29Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R4A、R4B、R4CAnd R4DIndependently is by R29Substituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R4A、R4B、R4CAnd R4DIndependently is unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R4A、R4B、R4CAnd R4DIndependently is by R29Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R4A、R4B、R4CAnd R4DIndependently is by R29Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R4A、R4B、R4CAnd R4DIndependently an unsubstituted heterocycloalkyl group (e.g., a 3-to 8-membered heterocycloalkyl group, a 3-to 6-membered heterocycloalkyl group, or a 5-to 6-membered heterocycloalkyl group). In the examples, R4A、R4B、R4CAnd R4DIndependently is by R29Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R4A、R4B、R4CAnd R4DIndependently is by R29Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R4A、R4B、R4CAnd R4DIndependently is unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R4A、R4B、R4CAnd R4DIndependently is by R29Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R4A、R4B、R4CAnd R4DIndependently is by R29Substituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R4A、R4B、R4CAnd R4DIndependently unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

R29Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R30Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R30Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R30Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R30Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R30Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R30Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered)Heteroaryl or 5-to 6-membered heteroaryl).

R30Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R31Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R31Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R31Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R31Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R31Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R31Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R4Is by R29Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4Is by R29Substituted alkyl radical(e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4Is by R29Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R4Is by R29Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R4Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R4Is hydrogen, halogen, -CX4 3、-CHX4 2、-CH2X4、-OCX4 3、-OCH2X4、-OCHX4 2、-CN、-SR4D、-NR4AR4BOr substituted or unsubstituted C1-C6An alkyl group. In the examples, R4Is hydrogen, halogen, -CX3、-NR4AR4BOr substituted or unsubstituted C1-C6An alkyl group. In the examples, R4Is hydrogen, halogen, -CF3、-NH2、-NH(CH3) Or unsubstituted C1-C6An alkyl group. In the examples, R4Is hydrogen or unsubstituted methyl.

In the examples, R4Is hydrogen. In the examples, R4is-NH (CH)3). In the examples, R4Is unsubstituted 2-to 3-membered heteroalkyl. In the examples, R4Is a 2 to 3 membered heteroalkyl group. In the examples, R4is-NH2. In the examples, R4is-NH (R)4A). In the examples, R4is-NR4AR4B

In the examples, R4AIs by R29Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical、C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4AIs by R29Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4AIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4AIs unsubstituted C1-C4An alkyl group. In the examples, R4AIs unsubstituted C1-C2An alkyl group. In the examples, R4AIs hydrogen.

In the examples, R4BIs by R29Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4BIs by R29Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4BIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4BIs unsubstituted C1-C4An alkyl group. In the examples, R4BIs unsubstituted C1-C2An alkyl group. In the examples, R4BIs hydrogen.

In the examples, R4CIs by R29Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4CIs by R29Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4CIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4CIs unsubstituted C1-C4An alkyl group. In the examples, R4CIs unsubstituted C1-C2An alkyl group. In the examples, R4CIs hydrogen.

In the examples, R4DIs by R29Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4DIs by R29Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4DIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4DIs unsubstituted C1-C4An alkyl group. In the examples, R4DIs unsubstituted C1-C2An alkyl group. In the examples, R4DIs hydrogen.

In the examples, R4Is unsubstituted methyl. In the examples, R4Is unsubstituted C1-C3An alkyl group. In the examples, R4Is an unsubstituted ethyl group.

In the examples, R4is-CF3. In the examples, R4is-CHF2. In the examples, R4is-CH2F. In the examples, R4is-CX4 3. In the examples, R4is-CHX4 2. In the examples, R4is-CH2X4。X4Independently is-F, -Cl, -Br or-I.

In the examples, R5Is hydrogen, substituted or unsubstituted C1-C6Alkyl, substituted or unsubstituted 2-to 6-membered heteroalkyl, substituted or unsubstituted C3-C6Cycloalkyl, substituted or unsubstituted 3-to 6-membered heterocycloalkyl, substituted or unsubstituted phenyl orSubstituted or unsubstituted 5-to 6-membered heteroaryl.

In the examples, R5Independently halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R32Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl) or by R32Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl).

In the examples, R5Is by R32Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5Is by R32Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5Is by R32Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R5Is by R32Substituted heteroalkyl groups (e.g., 2-to 8-membered heteroalkyl groups,2 to 6 membered heteroalkyl or 2 to 4 membered heteroalkyl). In the examples, R5Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl).

In the examples, R5A、R5B、R5CAnd R5DIndependently of each other is hydrogen, halogen, CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2Quilt R32Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R32Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R32Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R32Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R32Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R32Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R5A、R5B、R5CAnd R5DIndependently is by R32Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5A、R5B、R5CAnd R5DIndependently is by R32Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5A、R5B、R5CAnd R5DIndependently is unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5A、R5B、R5CAnd R5DIndependently is by R32Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R5A、R5B、R5CAnd R5DIndependently is by R32Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R5A、R5B、R5CAnd R5DIndependently an unsubstituted heteroalkyl group (e.g., a 2-to 8-membered heteroalkyl group, a 2-to 6-membered heteroalkyl group, or a 2-to 4-membered heteroalkyl group). In the examples, R5A、R5B、R5CAnd R5DIndependently is by R32Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R5A、R5B、R5CAnd R5DIndependently is by R32Substituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R5A、R5B、R5CAnd R5DIndependently is unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R5A、R5B、R5CAnd R5DIndependently is by R32Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R5A、R5B、R5CAnd R5DIndependently is by R32Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R5A、R5B、R5CAnd R5DIndependently an unsubstituted heterocycloalkyl group (e.g., a 3-to 8-membered heterocycloalkyl group, a 3-to 6-membered heterocycloalkyl group, or a 5-to 6-membered heterocycloalkyl group). In the examples, R5A、R5B、R5CAnd R5DIndependently is by R32Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R5A、R5B、R5CAnd R5DIndependently is by R32Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R5A、R5B、R5CAnd R5DIndependently is unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R5A、R5B、R5CAnd R5DIndependently is by R32Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R5A、R5B、R5CAnd R5DIndependently is by R32Substituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R5A、R5B、R5CAnd R5DIndependently unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

R32Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R33Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R33Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R33Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R33Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R33Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R33Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

R33Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R34Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R34Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R34Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R34Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R34Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R34Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R5Is hydrogen, halogen, -CX5 3、-CHX5 2、-CH2X5、-OCX5 3、-OCH2X5、-OCHX5 2、-CN、-SR5D、-NR5AR5BOr substituted or unsubstituted C1-C6An alkyl group. In the examples, R5Is hydrogen, halogen, -CX5 3、-NR5AR5BOr substituted or unsubstituted C1-C6An alkyl group. In the examples, R5Is hydrogen, halogen, -CF3、-NH2、-NH(CH3) Or unsubstituted C1-C6An alkyl group. In the examples, R5Is hydrogen or unsubstituted methyl. In the examples, R5Is unsubstituted methyl. In the examples, R5Is unsubstituted C1-C3An alkyl group. In the examples, R5Is an unsubstituted ethyl group. In the examples, R5Is unsubstituted methyl.

In the examples, R5Is by R32Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5Is by R32Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5Is by R32Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R5Is by R32Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R5Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R5Is unsubstituted methyl. In the examples, R5Is unsubstituted C1-C2An alkyl group. In the examples, R5Is unsubstituted C1-C3An alkyl group. In the examples, R5Is hydrogen.

In the examples, R6Is a halogen. In the examples, R6is-CX6 3. In the examples, R6is-CHX6 2. In the examples, R6is-CH2X6. In the examples, R6is-OCX6 3. In the examples, R6is-OCH2X6. In the examples, R6is-OCHX6 2. In the examples, R6is-CN. In the examples, R6is-SR6D. In the examples, R6is-SO2R6D. In the examples, R6is-NR6AR6B. In the examples, R6is-C (O) R6C. In the examples, R6is-C (O) OR6C. In the examples, R6is-C (O) NR6AR6B. In the examples, R6is-OR6D. In the examples, R6is-NR6AC(O)R6C. In the examples, R6is-NR6AC(O)OR6C. In the examples, R6is-SO2NR6AR6B. In the examples, R6is-NR6ASO2R6D. In the examples, R6is-C (O) NR6AOR6B

In the examples, R6Is substituted or unsubstituted C1-C6Alkyl, substituted or unsubstituted 2-to 6-membered heteroalkyl, substituted or unsubstituted C3-C6Cycloalkyl, substituted or unsubstituted 3-to 6-membered heterocycloalkyl, substituted or unsubstituted phenyl, or substituted or unsubstituted 5-to 6-membered heteroaryl. In the examples, R6Is hydrogen, substituted or unsubstituted C1-C8Alkyl or substituted or unsubstituted 2 to 8 membered heteroalkyl.

In the examples, R6Independently of one another is halogen, -CX6 3、-CHX6 2、-CH2X6、-OCX6 3、-OCH2X6、-OCHX6 2、-CN、-SR6D、-SO2R6D、-NR6AR6B、-C(O)R6C、-C(O)OR6C、-C(O)NR6AR6B、-OR6D、-NR6AC(O)R6C、-NR6AC(O)OR6CSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl.

In the examples, R6Is by R35Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6Is by R35Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6Is by R35Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6Is by R35Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6is-O- (substituted or unsubstituted C1-C8Alkyl groups). In the examples, R6is-O- (substituted or unsubstituted C1-C6Alkyl groups). In the examples, R6is-O- (substituted or unsubstituted C1-C4Alkyl groups). In the examples, R6is-OCH3. In the examples, R6Is by R35A substituted or unsubstituted 3-to 8-membered heterocycloalkyl group, wherein the heterocycloalkyl group contains an oxygen atom. In the examples, R6Is by R35A substituted or unsubstituted 5-to 6-membered heterocycloalkyl group, wherein the heterocycloalkyl group contains an oxygen atom. In the examples, R6Is by R35A substituted or unsubstituted 5-membered heterocycloalkyl group, wherein the heterocycloalkyl group comprises an oxygen atom. In the examples, R6Is by R35A substituted or unsubstituted 6-membered heterocycloalkyl group, wherein the heterocycloalkyl group comprises an oxygen atom. In the examples, R6Is a substituted or unsubstituted heteroalkyl or substituted or unsubstituted heterocycloalkyl. In the examples, R6Is a substituted or unsubstituted 2-to 8-membered heteroalkyl group. In the examples, R6Is a substituted or unsubstituted 2-to 6-membered heteroalkyl group. In the examples, R6Is a substituted or unsubstituted 2-to 4-membered heteroalkyl group. In the examples, R6Is a substituted or unsubstituted 2-membered heteroalkyl group. In the examples, R6Is a substituted or unsubstituted 3-membered heteroalkyl group. In the examples, R6Is a substituted or unsubstituted 4-membered heteroalkyl group. In the examples, R6Is a substituted or unsubstituted 5-membered heteroalkyl group. In the examples, R6Is a substituted or unsubstituted 6-membered heteroalkyl group. In the examples, R6Is a substituted or unsubstituted 7-membered heteroalkyl group. In the examples, R6Is a substituted or unsubstituted 8-membered heteroalkyl group. In the examples, R6Is a substituted 2-to 8-membered heteroalkyl group. In the examples, R6Is a substituted 2-to 6-membered heteroalkyl group. In the examples, R6Is a substituted 2-to 4-membered heteroalkyl group. In the examples, R6Is a substituted 2-membered heteroalkyl group. In the examples, R6Is a substituted 3-membered heteroalkyl. In the examples, R6Is a substituted 4-membered heteroalkyl group. In the examples, R6Is a substituted 5-membered heteroalkyl group. In the examples, R6Is a substituted 6-membered heteroalkyl group. In the examples, R6Is a substituted 7-membered heteroalkyl group. In the examples, R6Is a substituted 8-membered heteroalkyl group. In the examples, R6Is unsubstituted 2-to 8-membered heteroalkyl. In the examples, R6Is unsubstituted 2-to 6-membered heteroalkyl. In the examples, R6Is unsubstituted 2-to 4-membered heteroalkyl. In the examples, R6Is unsubstituted 2-membered heteroalkyl. In the examples, R6Is unsubstituted 3-membered heteroalkyl. In the examples, R6Is unsubstituted 4-membered heteroalkyl. In the examples, R6Is unsubstituted 5-membered heteroalkyl. In the examples, R6Is unsubstituted 6-membered heteroalkyl. In the examples, R6Is unsubstituted 7-membered heteroalkyl. In the examples, R6Is unsubstituted 8-membered heteroalkyl.

In the examples, R6Is by R35Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6Is by R35Substituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6Is unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups).

In the examples, R6Is by R35Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R6Is by R35Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R6Is unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl).

In the examples, R6Is by R35Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6Is by R35Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6Is unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl).

In the examples, R6Is by R35Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6Is by R35Substituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6Is unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R35Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R36Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R36Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R36Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R36Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R36Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R36Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R35Independently unsubstituted phenyl. In the examples, R35Independently an unsubstituted methyl group. In the examples, R35Independently is-CF3. In the examples, R35Independently is-NH2. In the examples, R35Independently an unsubstituted benzyl group. In the examples, R35Independently an oxo group. In the examples, R35Independently a halogen. In the examples, R35Independently is-CCl3. In the examples, R35Independently is-CBr3. In the examples, R35Independently is-CF3. In the examples, R35Independently is-CI3. In the examples, R35Independently is CHCl2. In the examples, R35Independently is-CHBr2. In the examples, R35Independently is-CHF2. In the examples, R35Independently is-CHI2. In the examples, R35Independently is-CH2And (4) Cl. In the examples, R35Independently is-CH2Br is added. In the examples, R35Independently is-CH2F. In the examples, R35Independently is-CH2I. In the examples, R35Independently is-CN. In the examples, R35Independently is-OH. In the examples, R35Independently is-NH2. In the examples, R35independently-COOH. In the examples, R35Independently is-CONH2. In the examples, R35Independently is-NO2. In the examples, R35Independently is-SH. In the examples, R35Independently is-SO3H. In the examples, R35Independently is-SO4H. In the examples, R35Independently is-SO2NH2. In the examples, R35Independently is-NHNH2. In the examples, R35Independently is-ONH2. In the examples, R35Independently is-NHC (O) NHNH2. In the examples, R35Independently is-NHC (O) NH2. In the examples, R35Independently is-NHSO2H. In the examples, R35independently-NHC (O) H. In the examples, R35independently-NHC (O) OH. In the examples, R35independently-NHOH. In the examples, R35Independently is-OCCl3. In the examples, R35Independently is-OCF3. In the examples, R35Independently is-OCBr3. In the examples, R35Independently is-OCI3. In the examples, R35Independently is-OCHCl2. In the examples, R35Independently is-OCHBr2. In the examples, R35Independently is-OCHI2. In the examples, R35Independently is-OCHF2. In the examples, R35Independently is-OCH2And (4) Cl. In the examples, R35Independently is-OCH2Br is added. In the examples, R35Independently is-OCH2I. In the examples, R35Independently is-OCH2F. In the examples, R35Independently is-O (C)4Alkyl groups). In the examples, R35Independently isIn the examples, R35Independently is

Figure BDA0002469898950001512

In the examples, R35Is by R36Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R35Is by R36Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R35Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups).

In the examples, R35Is by R36Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R35Is by R36Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R35Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R35Is a substituted or unsubstituted 2-to 8-membered heteroalkyl group. In the examples, R35Is a substituted or unsubstituted 2-to 6-membered heteroalkyl group. In the examples, R35Is a substituted or unsubstituted 2-to 4-membered heteroalkyl group. In the examples, R35Is a substituted or unsubstituted 2-membered heteroalkyl group. In the examples, R35Is a substituted or unsubstituted 3-membered heteroalkyl group. In the examples, R35Is a substituted or unsubstituted 4-membered heteroalkyl group. In the examples, R35Is a substituted or unsubstituted 5-membered heteroalkyl group. In the examples, R35Is a substituted or unsubstituted 6-membered heteroalkyl group. In the examples, R35Is a substituted or unsubstituted 7-membered heteroalkyl group. In the examples, R35Is a substituted or unsubstituted 8-membered heteroalkyl group. In the examples, R35Is a substituted 2-to 8-membered heteroalkyl group. In the examples, R35Is a substituted 2-to 6-membered heteroalkyl group. In the examples, R35Is a substituted 2-to 4-membered heteroalkyl group. In the examples, R35Is a substituted 2-membered heteroalkyl group. In the examples, R35Is a substituted 3-membered heteroalkyl. In the examples, R35Is a substituted 4-membered heteroalkyl group. In the examples, R35Is a substituted 5-membered heteroalkyl group. In the examples, R35Is a substituted 6-membered heteroalkyl group. In the examples, R35Is a substituted 7-membered heteroalkyl group. In the examples, R35Is a substituted 8-membered heteroalkyl group. In the examples, R35Is unsubstituted 2-to 8-membered heteroalkyl. In the examples, R35Is unsubstituted 2-to 6-membered heteroalkyl. In the examples, R35Is unsubstituted 2-to 4-membered heteroalkyl. In the examples, R35Is unsubstituted 2-membered heteroalkyl. In the examples, R35Is unsubstituted 3-membered heteroalkyl. In the examples, R35Is unsubstituted 4-membered heteroalkyl. In the examples, R35Is unsubstituted 5-membered heteroalkyl. In the examples, R35Is unsubstituted 6-membered heteroalkyl. In the examples, R35Is unsubstituted 7-membered heteroalkyl. In the examples, R35Is unsubstituted 8-membered heteroalkyl.

In the examples, R35Is by R36Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R35Is by R36Substituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R35Is unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups).

In the examples, R35Is by R36Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R35Is by R36Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R35Is unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R35Is by R36Substituted or unsubstituted 3-to 8-membered heterocycloalkyl. In the examples, R35Is by R36Substituted 3 to 8 membered heterocycloalkyl. In the examples, R35Is unsubstituted 3-to 8-membered heterocycloalkyl. In the examples, R35Is by R36Substituted or unsubstituted 3-to 6-membered heterocycloalkyl. In the examples, R35Is by R36Substituted 3 to 6 membered heterocycloalkyl. In the examples, R35Is unsubstituted 3-to 6-membered heterocycloalkyl. In the examples, R35Is by R36Substituted or unsubstituted 5-to 6-membered heterocycloalkyl. In the examples, R35Is by R36Substituted 5 to 6 membered heterocycloalkyl. In the examples, R35Is unsubstituted 5-to 6-membered heterocycloalkyl.

In the examples, R35Is by R36Substituted or unsubstitutedAryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R35Is by R36Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R35Is unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl).

In the examples, R35Is by R36Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R35Is by R36Substituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R35Is unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R35Is that

In an embodiment, z36 is 0. In an embodiment, z36 is 1. In an embodiment, z36 is 2. In an embodiment, z36 is 3. In an embodiment, z36 is 4. In an embodiment, z36 is 5. In an embodiment, z36 is 6. In an embodiment, z36 is 7. In an embodiment, z36 is 8. In an embodiment, z36 is an integer from 1 to 3. In an embodiment, z36 is an integer from 1 to 2. In an embodiment, z36 is an integer from 1 to 4.

In the examples, R35The method comprises the following steps:

Figure BDA0002469898950001543

Figure BDA0002469898950001551

in the examples, R35The method comprises the following steps:

Figure BDA0002469898950001552

in the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is that

Figure BDA0002469898950001555

In the examples, R35Is thatIn the examples, R35Is that

Figure BDA0002469898950001557

In the examples, R35Is that

Figure BDA0002469898950001558

In the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is that

Figure BDA00024698989500015516

In the examples, R35Is that

Figure BDA00024698989500015517

In the examples, R35Is that

Figure BDA00024698989500015518

In the examples, R35Is that

Figure BDA00024698989500015519

In the examples, R35Is thatIn the examples, R35Is that

Figure BDA0002469898950001562

In the examples, R35Is that

Figure BDA0002469898950001563

In the examples, R35Is thatIn the examples, R35Is that

Figure BDA0002469898950001565

In the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is that

Figure BDA00024698989500015611

In the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is that

Figure BDA00024698989500015614

In the examples, R35Is thatIn the examples, R35Is that

Figure BDA00024698989500015616

In the examples, R35Is that

Figure BDA00024698989500015617

In the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is that

Figure BDA00024698989500015623

In the examples, R35Is that

Figure BDA00024698989500015624

In the examples, R35Is that

Figure BDA00024698989500015625

In the examples, R35Is that

Figure BDA00024698989500015626

In the examples, R35Is that

Figure BDA00024698989500015627

In the examples, R35Is thatIn the examples, R35Is that

Figure BDA0002469898950001571

In the examples, R35Is thatIn the examples, R35Is that

Figure BDA0002469898950001573

In the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is that

Figure BDA0002469898950001577

In the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is that

Figure BDA00024698989500015715

In the examples, R35Is that

Figure BDA00024698989500015716

In the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is thatIn the examples, R35Is that

In the examples, R36The method comprises the following steps:

Figure BDA00024698989500015722

Figure BDA0002469898950001581

wherein R is37Are independent and as described herein. The symbol z37 is an integer from 0 to 10. In an embodiment, z37 is 0. In an embodiment, z37 is 1. In an embodiment, z37 is 2.

In the examples, R36The method comprises the following steps:

Figure BDA0002469898950001583

Figure BDA0002469898950001584

in the examples, R36The method comprises the following steps:

Figure BDA0002469898950001592

in the examples, R36Is that

Figure BDA0002469898950001593

In the examples, R36Is that

Figure BDA0002469898950001594

In the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is that

Figure BDA0002469898950001597

In the examples, R36Is thatIn the examples, R36Is that

Figure BDA0002469898950001599

In the examples, R36Is that

Figure BDA00024698989500015910

In the examples, R36Is that

Figure BDA00024698989500015911

In the examples, R36Is that

Figure BDA00024698989500015912

In the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is that

Figure BDA0002469898950001605

In the examples, R36Is that

Figure BDA0002469898950001606

In the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is that

Figure BDA00024698989500016010

In the examples, R36Is thatIn the examples, R36Is that

Figure BDA00024698989500016012

In the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is that

Figure BDA00024698989500016015

In the examples, R36Is thatIn the examples, R36Is that

Figure BDA00024698989500016017

In the examples, R36Is that

Figure BDA00024698989500016018

In the examples, R36Is thatIn the examples, R36Is that

Figure BDA00024698989500016020

In the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is that

Figure BDA00024698989500016023

In the examples, R36Is that

Figure BDA00024698989500016024

In the examples, R36Is thatIn the examples, R36Is that

Figure BDA00024698989500016026

In the examples, R36Is that

Figure BDA00024698989500016027

In the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is that

Figure BDA0002469898950001611

In the examples, R36Is thatIn the examples, R36Is that

Figure BDA0002469898950001613

In the examples,R36Is thatIn the examples, R36Is thatIn the examples, R36Is that

Figure BDA0002469898950001616

In the examples, R36Is thatIn the examples, R36Is that

Figure BDA0002469898950001618

In the examples, R36Is that

Figure BDA0002469898950001619

In the examples, R36Is that

Figure BDA00024698989500016110

In the examples, R36Is that

Figure BDA00024698989500016111

In the examples, R36Is that

Figure BDA00024698989500016112

In the examples, R36Is thatIn the examples, R36Is that

Figure BDA00024698989500016114

In the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is thatIn the examples, R36Is that

Figure BDA00024698989500016118

In the examples, R36Is thatIn the examples, R36Is that

Figure BDA00024698989500016120

In the examples, R36Is that

Figure BDA00024698989500016121

In the examples, R36Is that

Figure BDA00024698989500016122

In the examples, R6Independently of one another is halogen, -CX6 3、-CHX6 2、-CH2X6、-OCX6 3、-OCH2X6、-OCHX6 2、-NR6AR6B、-C(O)R6CC substituted or unsubstituted1-C6Alkyl, substituted or unsubstituted 2 to 6 membered heteroalkyl. In the examples, R6Independently of one another is halogen, -CX6 3、-CHX6 2、-CH2X6、-OCX6 3、-OCH2X6、-OCHX6 2、-CN、-SR6D、-SO2R6D、-NR6AR6B、-C(O)R6C、-C(O)OR6C、-C(O)NR6AR6B、-OR6D、-NR6AC(O)R6C、-NR6AC(O)OR6CC substituted or unsubstituted1-C6Alkyl, substituted or unsubstituted 2 to 6 membered heteroalkyl. In the examples, R6Independently is-C (O) R6C、-C(O)OR6C、-C(O)NR6AR6B、-OR6D、-NR6AC(O)R6C、-NR6AC(O)OR6CC substituted or unsubstituted1-C6Alkyl, substituted or unsubstituted 2 to 6 membered heteroalkyl. In the examples, R6is-F, -OH, -OCH3、-OCH2CH3、-CH2OH、-CH2OCH3、-NHC(O)CH3、-CH3、-N(CH3)2、-CH2NH2、-CH2N(CH3)2、-NH2、-NHCH3-COOH or-SO2CH3. In the examples, R6is-OH, -OCH3、-OCH2CH3、-CH2OH or-CH2OCH3. In the examples, R6Is substituted or unsubstituted C1-C6Alkyl or substituted or unsubstituted 2 to 6 membered heteroalkyl. In the examples, R6Is by R35Substituted or unsubstituted C1-C6Alkyl or by R35Substituted or unsubstituted 2-to 6-membered heteroalkyl.

In the examples, R6AIs hydrogen, halogen, CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2Quilt R35ASubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R35ASubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R35ASubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R35ASubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R35ASubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R35ASubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6AIs by R35ASubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6AIs by R35ASubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6AIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6AIs by R35ASubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6AIs by R35ASubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6AIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6Ais-O- (substituted or unsubstituted C1-C8Alkyl groups). In the examples, R6Ais-O- (substituted or unsubstituted C1-C6Alkyl groups). In the examples, R6Ais-O- (substituted or unsubstituted C1-C4Alkyl groups). In the examples, R6Ais-OCH3. In the examples, R6AIs by R35AA substituted or unsubstituted 3-to 8-membered heterocycloalkyl group, wherein the heterocycloalkyl group contains an oxygen atom. In the examples, R6AIs by R35AA substituted or unsubstituted 5-to 6-membered heterocycloalkyl group, wherein the heterocycloalkyl group contains an oxygen atom. In the examples, R6AIs by R35AA substituted or unsubstituted 5-membered heterocycloalkyl group, wherein the heterocycloalkyl group comprises an oxygen atom. In the examples, R6AIs by R35AA substituted or unsubstituted 6-membered heterocycloalkyl group, wherein the heterocycloalkyl group comprises an oxygen atom.

In the examples, R6AIs by R35ASubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6AIs by R35ASubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6AIs unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups).

In the examples, R6AIs by R35ASubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R6AIs by R35ASubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R6AIs unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl).

In the examples, R6AIs by R35ASubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6AIs by R35ASubstituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6AIs unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl).

In the examples, R6AIs by R35ASubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6AIs by R35ASubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6AIs unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6AThe method comprises the following steps:

Figure BDA0002469898950001642

in the examples, R6AThe method comprises the following steps:in the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA0002469898950001655

In the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA0002469898950001658

In the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA00024698989500016510

In the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA00024698989500016514

In the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA00024698989500016516

In the examples, R6AIs that

Figure BDA00024698989500016517

In the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA00024698989500016519

In the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA00024698989500016523

In the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA00024698989500016526

In the examples, R6AIs that

Figure BDA00024698989500016527

In the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA0002469898950001662

In the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA0002469898950001664

In the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA0002469898950001667

In the examples, R6AIs that

Figure BDA0002469898950001668

In the examples, R6AIs that

Figure BDA0002469898950001669

In the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA00024698989500016612

In the examples, R6AIs that

Figure BDA00024698989500016613

In the examples, R6AIs that

Figure BDA00024698989500016614

In the examples, R6AIs that

Figure BDA00024698989500016615

In the examples, R6AIs that

Figure BDA00024698989500016616

In the examples, R6AIs that

Figure BDA00024698989500016617

In the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA00024698989500016623

In the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA00024698989500016628

In the examples, R6AIs that

Figure BDA0002469898950001671

In the examples, R6AIs thatIn the examples, R6AIs that

Figure BDA0002469898950001673

In the examples, R6AIs that

Figure BDA0002469898950001674

In the examples, R6AIs that

Figure BDA0002469898950001675

In the examples, R6AIs that

Figure BDA0002469898950001676

In the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs thatIn the examples, R6AIs that

R35AIs oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F. Substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. In the examples, R35AIndependently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R36ASubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R36ASubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R36ASubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R36ASubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl 35} or 5-to 6-membered heterocycloalkyl), with R36ASubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R36ASubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R35AIndependently unsubstituted phenyl. In the examples, R35AIndependently an unsubstituted methyl group. In the examples, R35AIndependently is-CF3. In the examples, R35AIndependently is-NH2. In the examples, R35AIndependently an unsubstituted benzyl group. In the examples, R35AIndependently an oxo group. In the examples, R35AIndependently a halogen. In the examples, R35AIndependently is-CCl3. In the examples, R35AIndependently is-CBr3. In the examples, R35AIndependently is-CF3. In the examples, R35AIndependently is-CI3. In the examples, R35AIndependently is CHCl2. In the examples, R35AIndependently is-CHBr2. In the examples, R35AIndependently is-CHF2. In the examples, R35AIndependently is-CHI2. In the examples, R35AIndependently is-CH2And (4) Cl. In the examples, R35AIndependently is-CH2Br is added. In the examples, R35AIndependently is-CH2F。In the examples, R35AIndependently is-CH2I. In the examples, R35AIndependently is-CN. In the examples, R35AIndependently is-OH. In the examples, R35AIndependently is-NH2. In the examples, R35Aindependently-COOH. In the examples, R35AIndependently is-CONH2. In the examples, R35AIndependently is-NO2. In the examples, R35AIndependently is-SH. In the examples, R35AIndependently is-SO3H. In the examples, R35AIndependently is-SO4H. In the examples, R35AIndependently is-SO2NH2. In the examples, R35AIndependently is-NHNH2. In the examples, R35AIndependently is-ONH2. In the examples, R35AIndependently is-NHC (O) NHNH2. In the examples, R35AIndependently is-NHC (O) NH2. In the examples, R35AIndependently is-NHSO2H. In the examples, R35Aindependently-NHC (O) H. In the examples, R35Aindependently-NHC (O) OH. In the examples, R35Aindependently-NHOH. In the examples, R35AIndependently is-OCCl3. In the examples, R35AIndependently is-OCF3. In the examples, R35AIndependently is-OCBr3. In the examples, R35AIndependently is-OCI3. In the examples, R35AIndependently is-OCHCl2. In the examples, R35AIndependently is-OCHBr2. In the examples, R35AIndependently is-OCHI2. In the examples, R35AIndependently is-OCHF2. In the examples, R35AIndependently is-OCH2And (4) Cl. In the examples, R35AIndependently is-OCH2Br is added. In the examples, R35AIndependently is-OCH2I. In the examples, R35AIndependently is-OCH2F。

R36AIndependently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R37ASubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R37ASubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R37ASubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R37ASubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R37ASubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R37ASubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6BIs hydrogen, halogen, CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2Quilt R35BSubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R35BSubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R35BSubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R35BSubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R35BSubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R35BSubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6BIs by R35BSubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6BIs by R35BSubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6BIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6BIs by R35BSubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6BIs by R35BSubstituted heteroalkyl groups (e.g. 2 to 8 membered)Heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In the examples, R6BIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6Bis-O- (substituted or unsubstituted C1-C8Alkyl groups). In the examples, R6Bis-O- (substituted or unsubstituted C1-C6Alkyl groups). In the examples, R6Bis-O- (substituted or unsubstituted C1-C4Alkyl groups). In the examples, R6Bis-OCH3. In the examples, R6BIs by R35BA substituted or unsubstituted 3-to 8-membered heterocycloalkyl group, wherein the heterocycloalkyl group contains an oxygen atom. In the examples, R6BIs by R35BA substituted or unsubstituted 5-to 6-membered heterocycloalkyl group, wherein the heterocycloalkyl group contains an oxygen atom. In the examples, R6BIs by R35BA substituted or unsubstituted 5-membered heterocycloalkyl group, wherein the heterocycloalkyl group comprises an oxygen atom. In the examples, R6BIs by R35BA substituted or unsubstituted 6-membered heterocycloalkyl group, wherein the heterocycloalkyl group comprises an oxygen atom.

In the examples, R6BIs by R35BSubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6BIs by R35BSubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6BIs unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups).

In the examples, R6BIs by R35BSubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R6BIs by R35BSubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl)Or 5 to 6 membered heterocycloalkyl). In the examples, R6BIs unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl).

In the examples, R6BIs by R35BSubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6BIs by R35BSubstituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6BIs unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl).

In the examples, R6BIs by R35BSubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6BIs by R35BSubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6BIs unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6BThe method comprises the following steps:

Figure BDA0002469898950001712

in the examples, R6BThe method comprises the following steps:in the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA0002469898950001724

In the examples, R6BIs that

Figure BDA0002469898950001725

In the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA0002469898950001727

In the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA00024698989500017210

In the examples, R6BIs that

Figure BDA00024698989500017211

In the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA00024698989500017213

In the examples, R6BIs that

Figure BDA00024698989500017214

In the examples, R6BIs that

Figure BDA00024698989500017215

In the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA00024698989500017219

In the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA00024698989500017221

In the examples, R6BIs that

Figure BDA00024698989500017222

In the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA0002469898950001733

In the examples, R6BIs that

Figure BDA0002469898950001734

In the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA00024698989500017313

In the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA00024698989500017315

In the examples, R6BIs that

Figure BDA00024698989500017316

In the examples, R6BIs that

Figure BDA00024698989500017317

In the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA00024698989500017321

In the examples, R6BIs that

Figure BDA00024698989500017322

In the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA00024698989500017324

In the examples, R6BIs that

Figure BDA00024698989500017325

In the examples, R6BIs that

Figure BDA00024698989500017326

In the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs thatIn an embodiment of the present invention,R6Bis that

Figure BDA0002469898950001743

In the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA0002469898950001747

In the examples, R6BIs that

Figure BDA0002469898950001748

In the examples, R6BIs that

Figure BDA0002469898950001749

In the examples, R6BIs that

Figure BDA00024698989500017410

In the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs that

Figure BDA00024698989500017413

In the examples, R6BIs that

Figure BDA00024698989500017414

In the examples, R6BIs thatIn the examples, R6BIs thatIn the examples, R6BIs that

R35BIs oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F. Substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. In the examples, R35BIndependently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R36BSubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R36BSubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R36BSubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R36BSubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R36BSubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R36BSubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R35BIndependently unsubstituted phenyl. In the examples, R35BIndependently an unsubstituted methyl group. In the examples, R35BIndependently is-CF3. In the examples, R35BIndependently is-NH2. In the examples, R35BIndependently an unsubstituted benzyl group. In the examples, R35BIndependently an oxo group. In the examples, R35BIndependently a halogen. In the examples, R35BIndependently is-CCl3. In the examples, R35BIndependently is-CBr3. In the examples, R35BIndependently is-CF3. In the examples, R35BIndependently is-CI3. In the examples, R35BIndependently is CHCl2. In the examples, R35BIndependently is-CHBr2. In the implementation ofIn the examples, R35BIndependently is-CHF2. In the examples, R35BIndependently is-CHI2. In the examples, R35BIndependently is-CH2And (4) Cl. In the examples, R35BIndependently is-CH2Br is added. In the examples, R35BIndependently is-CH2F. In the examples, R35BIndependently is-CH2I. In the examples, R35BIndependently is-CN. In the examples, R35BIndependently is-OH. In the examples, R35BIndependently is-NH2. In the examples, R35Bindependently-COOH. In the examples, R35BIndependently is-CONH2. In the examples, R35BIndependently is-NO2. In the examples, R35BIndependently is-SH. In the examples, R35BIndependently is-SO3H. In the examples, R35BIndependently is-SO4H. In the examples, R35BIndependently is-SO2NH2. In the examples, R35BIndependently is-NHNH2. In the examples, R35BIndependently is-ONH2. In the examples, R35BIndependently is-NHC (O) NHNH2. In the examples, R35BIndependently is-NHC (O) NH2. In the examples, R35BIndependently is-NHSO2H. In the examples, R35Bindependently-NHC (O) H. In the examples, R35Bindependently-NHC (O) OH. In the examples, R35Bindependently-NHOH. In the examples, R35BIndependently is-OCCl3. In the examples, R35BIndependently is-OCF3. In the examples, R35BIndependently is-OCBr3. In the examples, R35BIndependently is-OCI3. In the examples, R35BIndependently is-OCHCl2. In the examples, R35BIndependently is-OCHBr2. In the examples, R35BIndependently is-OCHI2. In the examples, R35BIndependently is-OCHF2. In the examples, R35BIndependently is-OCH2And (4) Cl. In the examples, R35BIndependently is-OCH2Br is added. In the examples, R35BIndependently is-OCH2I. In the examples, R35BIndependently is-OCH2F。

R36BIndependently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R37BSubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R37BSubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R37BSubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R37BSubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R37BSubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R37BSubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6CIs hydrogen, halogen, CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2Quilt R35CSubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R35CSubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R35CSubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R35CSubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R35CSubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R35CSubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6CIs by R35CSubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6CIs by R35CSubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6CIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6CIs by R35CSubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6CIs by R35CSubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6CIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6Cis-O- (substituted or unsubstituted C1-C8Alkyl groups). In the examples, R6Cis-O- (substituted or unsubstituted C1-C6Alkyl groups). In the examples, R6Cis-O- (substituted or unsubstituted C1-C4Alkyl groups). In the examples, R6Cis-OCH3. In the examples, R6CIs by R35CA substituted or unsubstituted 3-to 8-membered heterocycloalkyl group, wherein the heterocycloalkyl group contains an oxygen atom. In the examples, R6CIs by R35CA substituted or unsubstituted 5-to 6-membered heterocycloalkyl group, wherein the heterocycloalkyl group contains an oxygen atom. In the examples, R6CIs by R35CA substituted or unsubstituted 5-membered heterocycloalkyl group, wherein the heterocycloalkyl group comprises an oxygen atom. In the examples, R6CIs by R35CA substituted or unsubstituted 6-membered heterocycloalkyl group, wherein the heterocycloalkyl group comprises an oxygen atom.

In the examples, R6CIs by R35CSubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6CIs by R35CSubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6CIs unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups).

In the examples, R6CIs by R35CSubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R6CIs by R35CSubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R6CIs unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl).

In the examples, R6CIs by R35CSubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6CIs by R35CSubstituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6CIs unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl).

In the examples, R6CIs by R35CSubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6CIs by R35CSubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6CIs unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6CThe method comprises the following steps:

in the examples, R6CThe method comprises the following steps:

Figure BDA0002469898950001792

in the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA0002469898950001796

In the examples, R6CIs that

Figure BDA0002469898950001797

In the examples, R6CIs that

Figure BDA0002469898950001798

In the examples, R6CIs that

Figure BDA0002469898950001799

In the examples, R6CIs that

Figure BDA00024698989500017910

In the examples, R6CIs that

Figure BDA00024698989500017911

In the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA0002469898950001805

In the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA00024698989500018010

In the examples, R6CIs that

Figure BDA00024698989500018011

In the examples, R6CIs that

Figure BDA00024698989500018012

In the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA00024698989500018014

In the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA00024698989500018016

In the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA00024698989500018018

In the examples, R6CIs that

Figure BDA00024698989500018019

In the examples, R6CIs that

Figure BDA00024698989500018020

In the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA00024698989500018023

In the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA00024698989500018028

In the examples, R6CIs that

Figure BDA00024698989500018029

In the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA0002469898950001813

In the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA0002469898950001815

In the examples, R6CIs that

Figure BDA0002469898950001816

In the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA0002469898950001819

In the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA00024698989500018111

In the examples, R6CIs that

Figure BDA00024698989500018112

In the examples, R6CIs that

Figure BDA00024698989500018113

In the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA00024698989500018115

In the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs thatIn the examples, R6CIs that

Figure BDA00024698989500018125

R35CIs oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F. Substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. In the examples, R35CIndependently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R36CSubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical C1-C6Alkyl or C1-C4Alkyl), by R36CSubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R36CSubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R36CSubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R36CSubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R36CSubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R35CIndependently unsubstituted phenyl. In the examples, R35CIndependently an unsubstituted methyl group. In the examples, R35CIndependently is-CF3. In the examples, R35CIndependently is-NH2. In the examples, R35CIndependently an unsubstituted benzyl group. In the examples, R35CIndependently an oxo group. In the examples, R35CIndependently a halogen. In the examples, R35CIndependently is-CCl3. In factIn the examples, R35CIndependently is-CBr3. In the examples, R35CIndependently is-CF3. In the examples, R35CIndependently is-CI3. In the examples, R35CIndependently is CHCl2. In the examples, R35CIndependently is-CHBr2. In the examples, R35CIndependently is-CHF2. In the examples, R35CIndependently is-CHI2. In the examples, R35CIndependently is-CH2And (4) Cl. In the examples, R35CIndependently is-CH2Br is added. In the examples, R35CIndependently is-CH2F. In the examples, R35CIndependently is-CH2I. In the examples, R35CIndependently is-CN. In the examples, R35CIndependently is-OH. In the examples, R35CIndependently is-NH2. In the examples, R35Cindependently-COOH. In the examples, R35CIndependently is-CONH2. In the examples, R35CIndependently is-NO2. In the examples, R35CIndependently is-SH. In the examples, R35CIndependently is-SO3H. In the examples, R35CIndependently is-SO4H. In the examples, R35CIndependently is-SO2NH2. In the examples, R35CIndependently is-NHNH2. In the examples, R35CIndependently is-ONH2. In the examples, R35CIndependently is-NHC (O) NHNH2. In the examples, R35CIndependently is-NHC (O) NH2. In the examples, R35CIndependently is-NHSO2H. In the examples, R35Cindependently-NHC (O) H. In the examples, R35Cindependently-NHC (O) OH. In the examples, R35Cindependently-NHOH. In the examples, R35CIndependently is-OCCl3. In the examples, R35CIndependently is-OCF3. In the examples, R35CIndependently is-OCBr3. In the examples, R35CIndependently is-OCI3. In the examples, R35CIndependently is-OCHCl2. In the examples, R35CIndependently is-OCHBr2. In the examples, R35CIndependently is-OCHI2. In the examples, R35CIndependently is-OCHF2. In the examples, R35CIndependently is-OCH2And (4) Cl. In the examples, R35CIndependently is-OCH2Br is added. In the examples, R35CIndependently is-OCH2I. In the examples, R35CIndependently is-OCH2F。

R36CIndependently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R37CSubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R37CSubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R37CSubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R37CSubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R37CSubstituted or unsubstituted arylRadical (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl) or by R37CSubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6DIs hydrogen, halogen, CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2Quilt R35DSubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R35DSubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R35DSubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R35DSubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R35DSubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R35DSubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6DIs by R35DSubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6DIs by R35DSubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6DIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6DIs by R35DSubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6DIs by R35DSubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6DIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6Dis-O- (substituted or unsubstituted C1-C8Alkyl groups). In the examples, R6Dis-O- (substituted or unsubstituted C1-C6Alkyl groups). In the examples, R6Dis-O- (substituted or unsubstituted C1-C4Alkyl groups). In the examples, R6Dis-OCH3. In the examples, R6DIs by R35DA substituted or unsubstituted 3-to 8-membered heterocycloalkyl group, wherein the heterocycloalkyl group contains an oxygen atom. In the examples, R6DIs by R35DA substituted or unsubstituted 5-to 6-membered heterocycloalkyl group, wherein the heterocycloalkyl group contains an oxygen atom. In the examples, R6DIs by R35DA substituted or unsubstituted 5-membered heterocycloalkyl group, wherein the heterocycloalkyl group comprises an oxygen atom. In the examples, R6DIs by R35DA substituted or unsubstituted 6-membered heterocycloalkyl group, wherein the heterocycloalkyl group comprises an oxygen atom.

In the examples, R6DIs by R35DSubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6DIs by R35DSubstituted cycloalkyl groups (for example,C3-C8cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6DIs unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups).

In the examples, R6DIs by R35DSubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R6DIs by R35DSubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R6DIs unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl).

In the examples, R6DIs by R35DSubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6DIs by R35DSubstituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6DIs unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl).

In the examples, R6DIs by R35DSubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6DIs by R35DSubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6DIs unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6DThe method comprises the following steps:

in the examples, R6DThe method comprises the following steps:in the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA0002469898950001874

In the examples, R6DIs that

Figure BDA0002469898950001875

In the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA0002469898950001877

In the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA0002469898950001879

In the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA00024698989500018711

In the examples, R6DIs that

Figure BDA00024698989500018712

In the examples, R6DIs that

Figure BDA00024698989500018713

In the examples, R6DIs that

Figure BDA00024698989500018714

In the examples, R6DIs that

Figure BDA00024698989500018715

In the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA00024698989500018718

In the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA00024698989500018720

In the examples, R6DIs that

Figure BDA00024698989500018721

In the examples, R6DIs that

Figure BDA00024698989500018722

In the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA00024698989500018725

In the examples, R6DIs that

Figure BDA00024698989500018726

In the examples, R6DIs that

Figure BDA00024698989500018727

In the examples, R6DIs that

Figure BDA00024698989500018728

In the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA00024698989500018731

In the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs thatIn the examples,R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA0002469898950001885

In the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA0002469898950001887

In the examples, R6DIs that

Figure BDA0002469898950001888

In the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA00024698989500018810

In the examples, R6DIs that

Figure BDA00024698989500018811

In the examples, R6DIs that

Figure BDA00024698989500018812

In the examples, R6DIs that

Figure BDA00024698989500018813

In the examples, R6DIs that

Figure BDA00024698989500018814

In the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA00024698989500018823

In the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA00024698989500018825

In the examples, R6DIs thatIn the examples, R6DIs that

Figure BDA00024698989500018827

In the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs thatIn the examples, R6DIs that

R35DIs oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F. Substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. In the examples, R35DIndependently of one another, oxo, haloElement, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R36DSubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R36DSubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R36DSubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R36DSubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R36DSubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R36DSubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R35DIs unsubstituted phenyl. In the examples, R35DIs unsubstituted methyl. In the examples, R35Dis-CF3. In the examples, R35Dis-NH2. In the examples, R35DIs unsubstituted benzyl. In the examples, R35DIs an oxo group. In the examples, R35DIs a halogen. In the examples, R35Dis-CCl3. In the examples, R35Dis-CBr3. In the examples, R35Dis-CF3. In the examples, R35Dis-CI3. In the examples, R35DIs CHCl2. In the examples, R35Dis-CHBr2. In the examples, R35Dis-CHF2. In the examples, R35Dis-CHI2. In the examples, R35Dis-CH2And (4) Cl. In the examples, R35Dis-CH2Br is added. In the examples, R35Dis-CH2F. In the examples, R35Dis-CH2I. In the examples, R35Dis-CN. In the examples, R35Dis-OH. In the examples, R35Dis-NH2. In the examples, R35Dis-COOH. In the examples, R35Dis-CONH2. In the examples, R35Dis-NO2. In the examples, R35Dis-SH. In the examples, R35Dis-SO3H. In the examples, R35Dis-SO4H. In the examples, R35Dis-SO2NH2. In the examples, R35Dis-NHNH2. In the examples, R35Dis-ONH2. In the examples, R35Dis-NHC (O) NHNH2. In the examples, R35Dis-NHC (O) NH2. In the examples, R35Dis-NHSO2H. In the examples, R35Dis-NHC (O) H. In the examples, R35Dis-NHC (O) OH. In the examples, R35Dis-NHOH. In the examples, R35Dis-OCCl3. In the examples, R35Dis-OCF3. In the examples, R35Dis-OCBr3. In the examples, R35Dis-OCI3. In the examples, R35Dis-OCHCl2. In the examples, R35Dis-OCHBr2. In the examples, R35Dis-OCHI2. In the examples, R35Dis-OCHF2. In the examples, R35Dis-OCH2And (4) Cl. In the examples, R35Dis-OCH2Br is added. In the examples, R35Dis-OCH2I. In the examples, R35Dis-OCH2F。

R36DIndependently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R37DSubstituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R37DSubstituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R37DSubstituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R37DSubstituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R37DSubstituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R37DSubstituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6Is that

Figure BDA0002469898950001912

Figure BDA0002469898950001913

Wherein R is35And z16 as described herein (including the examples).

In the examples, R6Is that

Figure BDA0002469898950001914

Wherein R is35And z16 as described herein (including the examples). In the examples, R6Is thatWherein R is35And z16 as described herein (including the examples). In the examples, R6Is that

Figure BDA0002469898950001916

Wherein R is35And z16 as described herein (including the examples). In the examples, R6Is thatWherein R is35And z16 as described herein (including the examples). In the examples, R6Is that

Figure BDA0002469898950001921

Wherein R is35And z16 as described herein (including the examples). In the examples, R6Is that

Figure BDA0002469898950001922

Wherein R is35And z16 as described herein (including the examples). In the examples, R6Is that

Figure BDA0002469898950001923

Wherein R is35And z16 as described herein (including the examples). In the examples, R6Is that

Figure BDA0002469898950001924

Wherein R is35And z16 as described herein (including the examples). In the examples, R6Is thatWherein R is35And z16 as described herein (including the examples). In the examples, R6Is thatWherein R is35And z16 as described herein (including the examples). In the examples, R6Is thatWherein R is35And z16 as described herein (including the examples). In the examples, R6Is thatWherein R is35And z16 as described herein (including the examples). In the examples, R6Is that

Figure BDA0002469898950001929

Wherein R is35And z16 as described herein (including the examples). In the examples, R6Is that

Figure BDA00024698989500019210

Wherein R is35And z16 as described herein (including the examples).

In the examples, R6Is that Wherein z16 is as described herein, including the examples. In the examples, R6Is that

Figure BDA0002469898950001935

Figure BDA0002469898950001936

In the examples, R6Is that

Figure BDA0002469898950001937

Figure BDA0002469898950001938

In the examples, R6Is thatIn the examples, R6Is that

In an embodiment, z16 is 1. In an embodiment, z16 is 2. In an embodiment, z16 is 3. In an embodiment, z16 is 4. In an embodiment, z16 is 5. In an embodiment, z16 is 6. In an embodiment, z16 is 7. In an embodiment, z16 is 8. In an embodiment, z16 is an integer from 1 to 3. In an embodiment, z16 is an integer from 1 to 2. In an embodiment, z16 is an integer from 1 to 4. In an embodiment, z16 is 0.

In the examples, R6Independently an unsubstituted methyl group. In the examples, R6Independently is unsubstituted C1-C3An alkyl group.

In the examples, R6Independently is-F. In the examples, R6Independently a halogen.

In the examples, R6Independently is-OCH3. In the examples, R6Independently is-OCH2CH3. In the examples, R6Independently is-CH2OCH3. In the examples, R6Independently an unsubstituted 2-to 3-membered heteroalkyl group. In the examples, R6Independently is-OH.

In the examples, R6Independently is-CH2And (5) OH. In the examples, R6Independently a substituted methyl group. In the examples, R6Independently is C substituted by OH1-C3An alkyl group. In the examples, R6Independently is substituted C1-C3An alkyl group.

In the examples, R6Independently an unsubstituted phenyl substituted propyl group. In the examples, R6Independently is unsubstituted phenyl-substituted C2-C6An alkyl group. In the examples, R6Independently is unsubstituted aryl substituted C2-C6An alkyl group.

In the examples, R6Independently is tert-butoxycarbonyl. In the examples, R6Independently a 6-membered heteroalkyl substituted with oxo. In the examples, R6Independently a 4 to 8 membered heteroalkyl substituted with oxo. In the examples, R6Is a substituted 6-membered heteroalkyl group. In the examples, R6Is a substituted 4-to 8-membered heteroalkyl group. In the examples, R6Independently, is tert-butyl carbamate.

In the examples, R6Independently tert-butyl carbamate substituted with N-methyl. In the examples, R6Independently a 6 to 10 membered heteroalkyl substituted with oxo. In the examples, R6Independently a substituted 6 to 10 membered heteroalkyl.

In the examples, R6Independently is-SO2CH3. In thatIn the examples, R6Independently is-SO2- (unsubstituted C)1-C3Alkyl groups). In the examples, R6Independently a 2 to 4 membered heteroalkyl substituted with oxo.

In the examples, R6Independently is-CH2CF3. In the examples, R6Independently an ethyl group substituted with a halo group. In the examples, R6Independently is C substituted by halogen1-C4An alkyl group.

In the examples, R6Independently is-NHC (O) CH3. In the examples, R6Independently a 2 to 4 membered heteroalkyl substituted with-oxo. In the examples, R6Independently is-CH2NH2

In the examples, R6Independently is-NH (CH)3). In the examples, R6Independently is-NR6AR6B. In the examples, R6Independently an unsubstituted 2-to 3-membered heteroalkyl group. In the examples, R6Independently is-NH2

In the examples, R6independently-COOH.

In the examples, R6Independently an 8-membered heteroalkyl substituted with oxo. In the examples, R6Independently a 6 to 10 membered heteroalkyl substituted with oxo. In the examples, R6Independently a substituted 8-membered heteroalkyl group. In the examples, R6Independently a substituted 6 to 10 membered heteroalkyl.

In the examples, R6Independently is-CH2NH2. In the examples, R6Independently by NH2Substituted C1-C3An alkyl group.

In the examples, R6Independently is-OCH2CH3. In the examples, R6Independently an unsubstituted 2-to 4-membered alkoxy group. In the examples, R6Independently an unsubstituted 2-to 4-membered heteroalkyl group. In the examples, R6Independently an unsubstituted 2-to 4-membered heteroalkyl group.

In the examples, R6Independently unsubstituted benzyl carbamate. In the examples, R6Independently a 2 to 5 membered heteroalkyl substituted with OH and unsubstituted phenyl. In the examples, R6Independently a substituted 2-to 5-membered heteroalkyl group.

In the examples, R6Independently is-N (CH)3)2. In the examples, R6Independently is-N (unsubstituted C)1-C3Alkyl radical)2. In the examples, R6Independently an unsubstituted 2-to 6-membered heteroalkyl group.

In the examples, R6Independently is-CH2C(O)NHCH2CH3. In the examples, R6Independently a 4 to 6 membered heteroalkyl substituted with oxo. In the examples, R6Independently a substituted 4-to 6-membered heteroalkyl group.

In the examples, R6Independently is-CH2N(CH3)2. In the examples, R6Independently an unsubstituted 2-to 6-membered heteroalkyl group.

In the examples, R6Independently is-C (O) NH2. In the examples, R6Independently by oxo and by NH2A substituted methyl group. In the examples, R6Independently by oxo and by NH2Substituted C1-C4An alkyl group. In the examples, R6Independently is substituted C1-C4An alkyl group.

In the examples, R6Independently is-N (CH)3)C(O)OCH2CH3. In the examples, R6Independently a 4 to 8 membered heteroalkyl substituted with oxo. In the examples, R6Independently a substituted 4-to 8-membered heteroalkyl group.

In the examples, R6Independently a 4 to 10 membered heteroalkyl substituted with oxo. In the examples, R6Independently a substituted 4-to 10-membered heteroalkyl group. In the examples, R6Independently by oxygenSubstituted 2 to 6 membered heteroalkyl. In the examples, R6Independently a substituted 2-to 6-membered heteroalkyl group. In the examples, R6Independently a 4 to 8 membered heteroalkyl substituted with oxo. In the examples, R6Independently a substituted 4-to 8-membered heteroalkyl group. In the examples, R6Independently a 3 to 8 membered heteroalkyl substituted with oxo and unsubstituted phenyl. In the examples, R6Independently a 3 to 8 membered heteroalkyl substituted with oxo and unsubstituted aryl. In the examples, R6Independently a 4 to 6 membered heteroalkyl substituted with oxo and unsubstituted aryl. In the examples, R6Independently a 4 to 6 membered heteroalkyl substituted with oxo and unsubstituted phenyl. In the examples, R6Independently a substituted 3-to 8-membered heteroalkyl group. In the examples, R6Independently a substituted 4-to 6-membered heteroalkyl group. In the examples, R6Independently an unsubstituted 2-to 4-membered heteroalkyl group.

R6.1And R6.2Each being hydrogen or R in a fixed position on the bonded ring6。R6.1And R6.2R may be as described herein (including any aspect, embodiment, example, figure, or technical scheme)6Any substituent of (1). R6.1Independently hydrogen, halogen, -CX6 3、-CHX6 2、-CH2X6、-OCX6 3、-OCH2X6、-OCHX6 2、-CN、-SR6D、-SO2R6D、-NR6AR6B、-C(O)R6C、-C(O)OR6C、-C(O)NR6AR6B、-OR6D、-NR6AC(O)R6C-、-NR6AC(O)NR6C-、-NR6AC(O)OR6CSubstituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. R6.2Independently of hydrogenHalogen, -CX6 3、-CHX6 2、-CH2X6、-OCX6 3、-OCH2X6、-OCHX6 2、-CN、-SR6D、-SO2R6D、-NR6AR6B、-C(O)R6C、-C(O)OR6C、-C(O)NR6AR6B、-OR6D、-NR6AC(O)R6C-、-NR6AC(O)NR6C-、-NR6AC(O)OR6CSubstituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

In the examples, R6.1Is a halogen. In the examples, R6.1is-CX6 3. In the examples, R6.1is-CHX6 2. In the examples, R6.1is-CH2X6. In the examples, R6.1is-OCX6 3. In the examples, R6.1is-OCH2X6. In the examples, R6.1is-OCHX6 2. In the examples, R6.1is-CN. In the examples, R6.1is-SR6D. In the examples, R6.1is-SO2R6D. In the examples, R6.1is-NR6AR6B. In the examples, R6.1is-C (O) R6C. In the examples, R6.1is-C (O) OR6C. In the examples, R6.1is-C (O) NR6AR6B. In the examples, R6.1is-OR6D. In the examples, R6.1is-NR6AC(O)R6C. In the examples, R6.1is-NR6AC(O)OR6C

In the examples, R6.1Is substituted or unsubstituted C1-C6Alkyl, substituted or unsubstituted 2-to 6-membered heteroalkyl, substituted or unsubstitutedSubstituted C3-C6Cycloalkyl, substituted or unsubstituted 3-to 6-membered heterocycloalkyl, substituted or unsubstituted phenyl, or substituted or unsubstituted 5-to 6-membered heteroaryl. In the examples, R6.1Is hydrogen, substituted or unsubstituted C1-C8Alkyl or substituted or unsubstituted 2 to 8 membered heteroalkyl.

In the examples, R6.1Independently of one another is halogen, -CX6 3、-CHX6 2、-CH2X6、-OCX6 3、-OCH2X6、-OCHX6 2、-CN、-SR6D、-SO2R6D、-NR6AR6B、-C(O)R6C、-C(O)OR6C、-C(O)NR6AR6B、-OR6D、-NR6AC(O)R6C、-NR6AC(O)OR6CSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl.

In the examples, R6.1Is by R35Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6.1Is by R35Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6.1Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6.1Is by R35Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6.1Is by R35Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6.1Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl).

In the examples, R6.1Is by R35Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6.1Is by R35Substituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6.1Is unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups).

In the examples, R6.1Is by R35Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R6.1Is by R35Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R6.1Is unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl).

In the examples, R6.1Is by R35Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6.1Is by R35Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6.1Is unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl).

In the examples, R6.1Is by R35Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6.1Is by R35Substituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6.1Is unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6.2Is a halogen. In the examples, R6.2is-CX6 3. In the examples, R6.2is-CHX6 2. In the examples, R6.2is-CH2X6. In the examples, R6.2is-OCX6 3. In the examples, R6.2is-OCH2X6. In the examples, R6.2is-OCHX6 2. In the examples, R6.2is-CN. In the examples, R6.2is-SR6D. In the examples, R6.2is-SO2R6D. In the examples, R6.2is-NR6AR6B. In the examples, R6.2is-C (O) R6C. In the examples, R6.2is-C (O) OR6C. In the examples, R6.2is-C (O) NR6AR6B. In the examples, R6.2is-OR6D. In the examples, R6.2is-NR6AC(O)R6C. In the examples, R6.2is-NR6AC(O)OR6C

In the examples, R6.2Is substituted or unsubstituted C1-C6Alkyl, substituted or unsubstituted 2-to 6-membered heteroalkyl, substituted or unsubstituted C3-C6Cycloalkyl, substituted or unsubstituted 3-to 6-membered heterocycloalkyl, substituted or unsubstituted phenyl, or substituted or unsubstituted 5-to 6-membered heteroaryl. In the examples, R6.2Is hydrogen, substituted or unsubstituted C1-C8Alkyl or substituted or unsubstituted 2 to 8 membered heteroalkyl.

In the examples, R6.2Independently of one another is halogen, -CX6 3、-CHX6 2、-CH2X6、-OCX6 3、-OCH2X6、-OCHX6 2、-CN、-SR6D、-SO2R6D、-NR6AR6B、-C(O)R6C、-C(O)OR6C、-C(O)NR6AR6B、-OR6D、-NR6AC(O)R6C、-NR6AC(O)OR6CSubstituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl.

In the examples, R6.2Is by R35Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6.2Is by R35Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6.2Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6.2Is by R35Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6.2Is by R35Substituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples, R6.2Is unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl).

In the examples, R6.2Is by R35Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6.2Is by R35Substituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R6.2Is unsubstituted cycloalkyl (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups).

In the examples, R6.2Is by R35Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl or5-to 6-membered heterocycloalkyl). In the examples, R6.2Is by R35Substituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R6.2Is unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl).

In the examples, R6.2Is by R35Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6.2Is by R35Substituted aryl radicals (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R6.2Is unsubstituted aryl (e.g. C)6-C10Aryl radical, C10Aryl, or phenyl).

In the examples, R6.2Is by R35Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6.2Is by R35Substituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R6.2Is unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R6.1Independently is-F. In the examples, R6.1Independently a halogen. In the examples, R6.1Independently is-OCH3. In the examples, R6.1Independently is-OCH2CH3. In the examples, R6.1Independently is-CH2OCH3. In the examples, R6.1Independently an unsubstituted 2-to 3-membered heteroalkyl group. In the examples, R6.1Independently is-OH. In the examples, R6.1Independently is-CH2And (5) OH. In the examples, R6.1Independently a substituted methyl group. In the examples, R6.1Independently is C substituted by OH1-C3An alkyl group. In the examples, R6.1Is independently a quiltSubstituted C1-C3An alkyl group. In the examples, R6.1Independently an unsubstituted phenyl substituted propyl group. In the examples, R6.1Independently is unsubstituted phenyl-substituted C2-C6An alkyl group. In the examples, R6.1Independently is unsubstituted aryl substituted C2-C6An alkyl group. In the examples, R6.1Independently is tert-butoxycarbonyl. In the examples, R6.1Independently a 6-membered heteroalkyl substituted with oxo. In the examples, R6.1Independently a 4 to 8 membered heteroalkyl substituted with oxo. In the examples, R6.1Is a substituted 6-membered heteroalkyl group. In the examples, R6.1Is a substituted 4-to 8-membered heteroalkyl group. In the examples, R6.1Independently, is tert-butyl carbamate. In the examples, R6.1Independently tert-butyl carbamate substituted with N-methyl. In the examples, R6.1Independently a 6 to 10 membered heteroalkyl substituted with oxo. In the examples, R6.1Independently a substituted 6 to 10 membered heteroalkyl. In the examples, R6.1Independently is-SO2CH3. In the examples, R6.1Independently is-SO2- (unsubstituted C)1-C3Alkyl groups). In the examples, R6.1Independently a 2 to 4 membered heteroalkyl substituted with oxo. In the examples, R6.1Independently is-CH2CF3. In the examples, R6.1Independently an ethyl group substituted with a halo group. In the examples, R6.1Independently is C substituted by halogen1-C4An alkyl group. In the examples, R6.1Independently is-NHC (O) CH3. In the examples, R6.1Independently a 2 to 4 membered heteroalkyl substituted with-oxo. In the examples, R6.1Independently is-CH2NH2. In the examples, R6.1Independently is-NH (CH)3). In the examples, R6.1Independently is-NR6.1BR6.1B. In the examples, R6.1Independently an unsubstituted 2-to 3-membered heteroalkyl group. In the examples,R6.1Independently is-NH2. In the examples, R6.1independently-COOH. In the examples, R6.1Independently an 8-membered heteroalkyl substituted with oxo. In the examples, R6.1Independently a 6 to 10 membered heteroalkyl substituted with oxo. In the examples, R6.1Independently a substituted 8-membered heteroalkyl group. In the examples, R6.1Independently a substituted 6 to 10 membered heteroalkyl. In the examples, R6.1Independently is-CH2NH2. In the examples, R6.1Independently by NH2Substituted C1-C3An alkyl group. In the examples, R6.1Independently is-OCH2CH3. In the examples, R6.1Independently an unsubstituted 2-to 4-membered alkoxy group. In the examples, R6.1Independently an unsubstituted 2-to 4-membered heteroalkyl group. In the examples, R6.1Independently an unsubstituted 2-to 4-membered heteroalkyl group. In the examples, R6.1Independently unsubstituted benzyl carbamate. In the examples, R6.1Independently a 2 to 5 membered heteroalkyl substituted with OH and unsubstituted phenyl. In the examples, R6.1Independently a substituted 2-to 5-membered heteroalkyl group. In the examples, R6.1Independently is-N (CH)3)2. In the examples, R6.1Independently is-N (unsubstituted C)1-C3Alkyl radical)2. In the examples, R6.1Independently an unsubstituted 2-to 6-membered heteroalkyl group. In the examples, R6.1Independently is-CH2C(O)NHCH2CH3. In the examples, R6.1Independently a 4 to 6 membered heteroalkyl substituted with oxo. In the examples, R6.1Independently a substituted 4-to 6-membered heteroalkyl group. In the examples, R6.1Independently is-CH2N(CH3)2. In the examples, R6.1Independently an unsubstituted 2-to 6-membered heteroalkyl group. In the examples, R6.1Independently is-C (O) NH2. In the examples, R6.1Independently by oxo and by NH2A substituted methyl group. In the examples, R6.1Independently by oxo and by NH2Substituted C1-C4An alkyl group. In the examples, R6.1Independently is substituted C1-C4An alkyl group. In the examples, R6.1Independently is-N (CH)3)C(O)OCH2CH3. In the examples, R6.1Independently a 4 to 8 membered heteroalkyl substituted with oxo. In the examples, R6.1Independently a substituted 4-to 8-membered heteroalkyl group. In the examples, R6.1Independently a 4 to 10 membered heteroalkyl substituted with oxo. In the examples, R6.1Independently a substituted 4-to 10-membered heteroalkyl group. In the examples, R6.1Independently a 2 to 6 membered heteroalkyl substituted with oxo. In the examples, R6.1Independently a substituted 2-to 6-membered heteroalkyl group. In the examples, R6.1Independently a 4 to 8 membered heteroalkyl substituted with oxo. In the examples, R6.1Independently a substituted 4-to 8-membered heteroalkyl group. In the examples, R6.1Independently a 3 to 8 membered heteroalkyl substituted with oxo and unsubstituted phenyl. In the examples, R6.1Independently a 3 to 8 membered heteroalkyl substituted with oxo and unsubstituted aryl. In the examples, R6.1Independently a 4 to 6 membered heteroalkyl substituted with oxo and unsubstituted aryl. In the examples, R6.1Independently a 4 to 6 membered heteroalkyl substituted with oxo and unsubstituted phenyl. In the examples, R6.1Independently a substituted 3-to 8-membered heteroalkyl group. In the examples, R6.1Independently a substituted 4-to 6-membered heteroalkyl group. In the examples, R6.1Independently an unsubstituted 2-to 4-membered heteroalkyl group.

In the examples, R6.2Independently is-F. In the examples, R6.2Independently a halogen. In the examples, R6.2Independently is-OCH3. In the examples, R6.2Independently is-OCH2CH3. In the examples, R6.2Independently is-CH2OCH3. In the examples, R6.2Independently an unsubstituted 2-to 3-membered heteroalkyl group. In the examples, R6.2Independently is-OH. In the examples, R6.2Independently is-CH2And (5) OH. In the examples, R6.2Independently a substituted methyl group. In the examples, R6.2Independently is C substituted by OH1-C3An alkyl group. In the examples, R6.2Independently is substituted C1-C3An alkyl group. In the examples, R6.2Independently an unsubstituted phenyl substituted propyl group. In the examples, R6.2Independently is unsubstituted phenyl-substituted C2-C6An alkyl group. In the examples, R6.2Independently is unsubstituted aryl substituted C2-C6An alkyl group. In the examples, R6.2Independently is tert-butoxycarbonyl. In the examples, R6.2Independently a 6-membered heteroalkyl substituted with oxo. In the examples, R6.2Independently a 4 to 8 membered heteroalkyl substituted with oxo. In the examples, R6.2Is a substituted 6-membered heteroalkyl group. In the examples, R6.2Is a substituted 4-to 8-membered heteroalkyl group. In the examples, R6.2Independently, is tert-butyl carbamate. In the examples, R6.2Independently tert-butyl carbamate substituted with N-methyl. In the examples, R6.2Independently a 6 to 10 membered heteroalkyl substituted with oxo. In the examples, R6.2Independently a substituted 6 to 10 membered heteroalkyl. In the examples, R6.2Independently is-SO2CH3. In the examples, R6.2Independently is-SO2- (unsubstituted C)1-C3Alkyl groups). In the examples, R6.2Independently a 2 to 4 membered heteroalkyl substituted with oxo. In the examples, R6.2Independently is-CH2CF3. In the examples, R6.2Independently an ethyl group substituted with a halo group. In the examples, R6.2Independently is C substituted by halogen1-C4An alkyl group. In the examples, R6.2Independently is-NHC (O) CH3. In thatIn the examples, R6.2Independently a 2 to 4 membered heteroalkyl substituted with-oxo. In the examples, R6.2Independently is-CH2NH2. In the examples, R6.2Independently is-NH (CH)3). In the examples, R6.2Independently is-NR6.2BR6.2B. In the examples, R6.2Independently an unsubstituted 2-to 3-membered heteroalkyl group. In the examples, R6.2Independently is-NH2. In the examples, R6.2independently-COOH. In the examples, R6.2Independently an 8-membered heteroalkyl substituted with oxo. In the examples, R6.2Independently a 6 to 10 membered heteroalkyl substituted with oxo. In the examples, R6.2Independently a substituted 8-membered heteroalkyl group. In the examples, R6.2Independently a substituted 6 to 10 membered heteroalkyl. In the examples, R6.2Independently is-CH2NH2. In the examples, R6.2Independently by NH2Substituted C1-C3An alkyl group. In the examples, R6.2Independently is-OCH2CH3. In the examples, R6.2Independently an unsubstituted 2-to 4-membered alkoxy group. In the examples, R6.2Independently an unsubstituted 2-to 4-membered heteroalkyl group. In the examples, R6.2Independently an unsubstituted 2-to 4-membered heteroalkyl group. In the examples, R6.2Independently unsubstituted benzyl carbamate. In the examples, R6.2Independently a 2 to 5 membered heteroalkyl substituted with OH and unsubstituted phenyl. In the examples, R6.2Independently a substituted 2-to 5-membered heteroalkyl group. In the examples, R6.2Independently is-N (CH)3)2. In the examples, R6.2Independently is-N (unsubstituted C)1-C3Alkyl radical)2. In the examples, R6.2Independently an unsubstituted 2-to 6-membered heteroalkyl group. In the examples, R6.2Independently is-CH2C(O)NHCH2CH3. In the examples, R6.2Independently is a 4 to 6 membered heteroalkyl substituted with oxo. In the examples, R6.2Independently a substituted 4-to 6-membered heteroalkyl group. In the examples, R6.2Independently is-CH2N(CH3)2. In the examples, R6.2Independently an unsubstituted 2-to 6-membered heteroalkyl group. In the examples, R6.2Independently is-C (O) NH2. In the examples, R6.2Independently by oxo and by NH2A substituted methyl group. In the examples, R6.2Independently by oxo and by NH2Substituted C1-C4An alkyl group. In the examples, R6.2Independently is substituted C1-C4An alkyl group. In the examples, R6.2Independently is-N (CH)3)C(O)OCH2CH3. In the examples, R6.2Independently a 4 to 8 membered heteroalkyl substituted with oxo. In the examples, R6.2Independently a substituted 4-to 8-membered heteroalkyl group. In the examples, R6.2Independently a 4 to 10 membered heteroalkyl substituted with oxo. In the examples, R6.2Independently a substituted 4-to 10-membered heteroalkyl group. In the examples, R6.2Independently a 2 to 6 membered heteroalkyl substituted with oxo. In the examples, R6.2Independently a substituted 2-to 6-membered heteroalkyl group. In the examples, R6.2Independently a 4 to 8 membered heteroalkyl substituted with oxo. In the examples, R6.2Independently a substituted 4-to 8-membered heteroalkyl group. In the examples, R6.2Independently a 3 to 8 membered heteroalkyl substituted with oxo and unsubstituted phenyl. In the examples, R6.2Independently a 3 to 8 membered heteroalkyl substituted with oxo and unsubstituted aryl. In the examples, R6.2Independently a 4 to 6 membered heteroalkyl substituted with oxo and unsubstituted aryl. In the examples, R6.2Independently a 4 to 6 membered heteroalkyl substituted with oxo and unsubstituted phenyl. In the examples, R6.2Independently a substituted 3-to 8-membered heteroalkyl group. In the examples, R6.2Independently a substituted 4-to 6-membered heteroalkyl group. In the examples, R6.2Independently an unsubstituted 2-to 4-membered heteroalkyl group.

In the examples, L1Is by R38Substituted or unsubstituted alkylene (e.g. C)1-C8Alkylene radical, C1-C6Alkylene or C1-C4Alkylene) or by R38Substituted or unsubstituted heteroalkylene groups (e.g., 2-to 8-membered heteroalkylene groups, 2-to 6-membered heteroalkylene groups, or 2-to 4-membered heteroalkylene groups). In the examples, L1Is by R38Substituted or unsubstituted C1-C6Alkylene or by R38Substituted or unsubstituted 2-to 6-membered heteroalkylene. In the examples, L1Is C substituted by methyl1-C6An alkylene group. In the examples, L1Is C substituted by methyl1-C5An alkylene group. In the examples, L1Is C substituted by methyl1-C4An alkylene group. In the examples, L1Is C substituted by methyl1-C3An alkylene group. In the examples, L1Is C substituted by methyl1-C2An alkylene group. In the examples, L1Is methylene substituted by methyl. In the examples, L1Is a bond. In the examples, L1Is substituted or unsubstituted C1-C3Alkylene, substituted or unsubstituted 2 to 3 membered heteroalkylene. In the examples, L1Is a bond. In the examples, L1Is methylene substituted by methyl.

In the examples, L1Is by R38Substituted or unsubstituted alkylene (e.g. C)1-C8Alkylene radical, C1-C6Alkylene or C1-C4Alkylene). In the examples, L1Is by R38Substituted alkylene (e.g. C)1-C8Alkylene radical, C1-C6Alkylene or C1-C4Alkylene). In the examples, L1Is unsubstituted alkylene (e.g. C)1-C8Alkylene radical, C1-C6Alkylene or C1-C4Alkylene).In the examples, L1Is by R38Substituted or unsubstituted heteroalkylene groups (e.g., 2-to 8-membered heteroalkylene groups, 2-to 6-membered heteroalkylene groups, or 2-to 4-membered heteroalkylene groups). In the examples, L1Is by R38Substituted heteroalkylene groups (e.g., 2-to 8-membered heteroalkylene groups, 2-to 6-membered heteroalkylene groups, or 2-to 4-membered heteroalkylene groups). In the examples, L1Is unsubstituted heteroalkylene (e.g., 2-to 8-membered heteroalkylene, 2-to 6-membered heteroalkylene, or 2-to 4-membered heteroalkylene).

R38Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R39Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R39Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R39Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R39Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R39Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) Or by R39Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

R39Independently oxo, halogen, -CCl3、-CBr3、-CF3、-CI3、CHCl2、-CHBr2、-CHF2、-CHI2、-CH2Cl、-CH2Br、-CH2F、-CH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2、-OCH2Cl、-OCH2Br、-OCH2I、-OCH2F、-N3Quilt R40Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), by R40Substituted or unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), with R40Substituted or unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), by R40Substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), with R40Substituted or unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or by R40Substituted or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R39Is by R40Substituted or unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R39Is by R40Substituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R39Is unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups).

In the examples, L1Is substituted or unsubstituted C1-C3An alkylene group. In the examples, L1Is a substituted or unsubstituted methylene group. In the examples, L1Is substituted or unsubstituted C1-C6Alkylene or substituted or unsubstituted 2-to 6-membered heteroalkylene. In the examples, L1Is substituted or unsubstituted C1-C3Alkylene or substituted or unsubstituted 2-to 3-membered heteroalkylene.

In the examples, L1is-CH (CH)3) -. In the examples, L1Is an unsubstituted ethyl group. In the examples, L1Is unsubstituted C1-C3An alkylene group. In the examples, L1Is an unsubstituted methylene group. In the examples, L1Is unsubstituted C2-C3An alkylene group. In the examples, L1is-CH (CH)2CH3) -. In the examples, L1is-C (CH)3)2-. In the examples, L1is-CH2CH2-

In the examples, L1is-CH (CH)2OCH3) -. In the examples, L1Is an unsubstituted 3-membered heteroalkyl-substituted methylene group. In the examples, L1Is an unsubstituted 2-to 4-membered heteroalkyl-substituted methylene group. In the examples, L1is-CH (CH)2OH) -. In the examples, L1Is ethylene substituted by OH. In the examples, L1Is C substituted by OH1-C3An alkylene group. In the examples, L1Is a substituted ethylene group. In an embodiment of the present invention,L1is substituted C1-C3An alkylene group. In the examples, L1Is that

Figure BDA0002469898950002071

In the examples, L1Is that

In the examples, L2Is a bond, -S (O)2-, -C (O) -, -C (O) NH-, -C (O) O-, -OC (O) -, substituted or unsubstituted alkylene, substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene. In the examples, L2Is a bond. In the examples, L2is-S (O)2-. In the examples, L2is-S (O)2NH-. In the examples, L2is-NHS (O)2-. In the examples, L2is-C (O) -. In the examples, L2is-C (O) NH-. In the examples, L2is-NHC (O) -. In the examples, L2is-NHC (O) NH-. In the examples, L2is-C (O) O-. In the examples, L2is-OC (O) -.

In the examples, L2Is a substituted or unsubstituted alkylene (e.g., C)1-C8Alkylene radical, C1-C6Alkylene or C1-C4Alkylene). In the examples, L2Is a substituted alkylene group (e.g. C)1-C8Alkylene radical, C1-C6Alkylene or C1-C4Alkylene). In the examples, L2Is unsubstituted alkylene (e.g. C)1-C8Alkylene radical, C1-C6Alkylene or C1-C4Alkylene). In the examples, L2Is a substituted or unsubstituted heteroalkylene group (e.g., 2-to 8-membered heteroalkylene, 2-to 6-membered heteroalkylene, or 2-to 4-membered heteroalkylene). In the examples, L2Is a substituted heteroalkylene group (e.g., a 2-to 8-membered heteroalkylene group, a 2-to 6-membered heteroalkylene group, or a 2-to 4-membered heteroalkylene group). In the examples, L2Is unsubstituted heteroalkylene (e.g., 2-to 8-membered heteroalkylene, 2-to 6-membered heteroalkylene, or 2-to 4-membered heteroalkylene). In the examples, L2Is substituted or unsubstituted C1-C6An alkylene group. In the examples, L2Is substituted or unsubstituted C1-C4An alkylene group. In the examples, L2Is substituted or unsubstituted C1-C3An alkylene group. In the examples, L2Is substituted or unsubstituted C1-C2An alkylene group.

In embodiments, ring A is C6-C10Aryl or 5 to 10 membered heteroaryl. In embodiments, ring A is C6-C10Aryl or 5 to 10 membered heteroaryl. In embodiments, ring A is C6-C10And (4) an aryl group. In embodiments, ring a is phenyl. In embodiments, ring a is naphthyl. In embodiments, ring a is a 5 to 10 membered heteroaryl. In embodiments, ring a is a 5-to 6-membered heteroaryl. In embodiments, ring a is thienyl. In embodiments, ring a is furyl. In embodiments, ring a is pyrrolyl. In embodiments, ring a is imidazolyl. In an embodiment, ring a is pyrazolyl. In the examples, ring A is oxazolyl. In the examples, ring A is isoxazolyl. In embodiments, ring a is thiazolyl. In embodiments, ring a is pyridyl. In embodiments, ring a is pyridyl. In embodiments, ring a is pyrazinyl. In embodiments, ring a is pyrimidinyl. In an embodiment, ring a is pyridazinyl. In embodiments, ring a is 1,2, 3-triazinyl. In embodiments, ring a is 1,2, 4-triazinyl. In embodiments, ring a is 1,3, 5-triazinyl.

When ring A is substituted (e.g., substituted C)6-C10Aryl), it is understood that z1 is not 0 (i.e., ring A is substituted with R)1Substituted). In embodiments, ring a is substituted C6-C10Aryl or substituted 5-to 10-membered heteroaryl. In embodiments, ring a is substituted C6-C10Aryl radicalsOr substituted 5-to 10-membered heteroaryl. In embodiments, ring a is substituted C6-C10And (4) an aryl group. In embodiments, ring a is substituted phenyl. In embodiments, ring a is substituted naphthyl. In embodiments, ring a is a substituted 5-to 10-membered heteroaryl. In embodiments, ring a is a substituted 5-to 6-membered heteroaryl. In embodiments, ring a is a substituted thienyl group. In embodiments, ring a is a substituted furyl group. In embodiments, ring a is a substituted pyrrolyl. In embodiments, ring a is substituted imidazolyl. In embodiments, ring a is substituted pyrazolyl. In the examples, ring A is a substituted oxazolyl group. In embodiments, ring a is a substituted isoxazolyl. In embodiments, ring a is a substituted thiazolyl. In embodiments, ring a is substituted pyridyl. In embodiments, ring a is substituted pyridyl. In embodiments, ring a is a substituted pyrazinyl. In embodiments, ring a is substituted pyrimidinyl. In an embodiment, ring a is a substituted pyridazinyl group. In embodiments, ring a is a substituted 1,2, 3-triazinyl group. In embodiments, ring a is a substituted 1,2, 4-triazinyl group. In embodiments, ring a is a substituted 1,3, 5-triazinyl group.

In embodiments, ring a is unsubstituted C6-C10Aryl or unsubstituted 5-to 10-membered heteroaryl. In embodiments, ring a is unsubstituted C6-C10Aryl or unsubstituted 5-to 10-membered heteroaryl. In embodiments, ring a is unsubstituted C6-C10And (4) an aryl group. In embodiments, ring a is unsubstituted phenyl. In embodiments, ring a is unsubstituted naphthyl. In embodiments, ring a is an unsubstituted 5-to 10-membered heteroaryl. In embodiments, ring a is an unsubstituted 5-to 6-membered heteroaryl. In embodiments, ring a is unsubstituted thienyl. In embodiments, ring a is unsubstituted furanyl. In embodiments, ring a is unsubstituted pyrrolyl. In embodiments, ring a is unsubstituted imidazolyl. In embodiments, ring a is unsubstituted pyrazolyl. In the examples, ring A is an unsubstituted oxazolyl. In embodiments, ring a is an unsubstituted isoxazolyl. In thatIn embodiments, ring a is unsubstituted thiazolyl. In embodiments, ring a is unsubstituted pyridyl. In embodiments, ring a is unsubstituted pyridyl. In embodiments, ring a is unsubstituted pyrazinyl. In embodiments, ring a is unsubstituted pyrimidinyl. In an embodiment, ring a is unsubstituted pyridazinyl. In embodiments, ring a is unsubstituted 1,2, 3-triazinyl. In embodiments, ring a is unsubstituted 1,2, 4-triazinyl. In embodiments, ring a is unsubstituted 1,3, 5-triazinyl.

In the examples, ring A is substituted by one R1And (4) substitution. In embodiments, ring a is substituted with two optionally different R1And (4) substituent substitution. In embodiments, ring a is substituted with three optionally different R1And (4) substituent substitution. In embodiments, ring a is substituted with four optionally different R1And (4) substituent substitution. In embodiments, ring a is substituted with five optionally different R1And (4) substituent substitution.

In embodiments, ring a is phenyl or 5-to 6-membered heteroaryl. In embodiments, ring a is phenyl. In embodiments, ring a is a 5-to 6-membered heteroaryl. In embodiments, ring a is a 5 membered heteroaryl. In embodiments, ring a is a 5 membered heteroaryl.

In embodiments, ring a is phenyl, pyridyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, furyl, pyrrolyl, thienyl, pyrazinyl, pyridazinyl or pyrimidinyl. In embodiments, ring a is phenyl. In embodiments, ring a is pyridyl. In an embodiment, ring a is pyrazolyl. In embodiments, ring a is imidazolyl. In the examples, ring A is oxazolyl. In the examples, ring A is isoxazolyl. In embodiments, ring a is thiazolyl. In embodiments, ring a is furyl. In embodiments, ring a is pyrrolyl. In embodiments, ring a is thienyl. In embodiments, ring a is pyrazinyl. In an embodiment, ring a is pyridazinyl. In embodiments, ring a is pyrimidinyl. In embodiments, ring a is phenyl or pyridyl. In embodiments, ring a is pyridyl.

In embodiments, ring a is phenyl.

In embodiments, ring a is pyridin-3-yl. In embodiments, ring a is pyridyl. In embodiments, ring a is 6 membered heteroaryl. In embodiments, ring a is pyridin-2-yl. In embodiments, ring a is pyridin-4-yl.

In embodiments, ring a is pyrimidin-5-yl. In embodiments, ring a is pyrimidinyl.

In the examples, ring A is pyridazin-3-yl. In an embodiment, ring a is pyridazinyl.

In embodiments, ring a is pyrazin-2-yl. In embodiments, ring a is pyrazinyl.

In embodiments, ring a is imidazol-1-yl. In embodiments, ring a is imidazolyl. In embodiments, ring a is a 5 membered heteroaryl.

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002113

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002115

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002117

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021111

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021112

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021113

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021117

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021118

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021119

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002122

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002124

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002125

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002126

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002127

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002128

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002129

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021210

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021212

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021213

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021214

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002132

Wherein R is1.2And R1.3Each being R at a fixed position on the bonded ring1。R1.2And R1.3Can independently be R as described herein (including any aspect, embodiment, example, drawing, or technical scheme)1OfAnd (c) which substituents are defined herein. In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002135

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002137

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002139

In the examples, - (Ring A) - (R)1)z1Is thatWherein R is1.2And R1.4Each being R at a fixed position on the bonded ring1。R1.2And R1.4Can independently be R as described herein (including any aspect, embodiment, example, drawing, or technical scheme)1Any substituent of (1). In the examples, - (Ring A) - (R)1)z1Is that

In the embodiment, - (Ring A) -(R1)z1Is that

Figure BDA00024698989500021312

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021313

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021314

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021316

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002141

In the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002142

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002144

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002146

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA00024698989500021410

In the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is thatIn the examples, - (Ring A) - (R)1)z1Is that

Figure BDA0002469898950002155

In the examples, - (Ring A) - (R)1)z1Is that

In embodiments, ring B is a 4-to 8-membered heterocycloalkyl. In embodiments, ring B is a 4-membered heterocycloalkyl. In embodiments, ring B is a 5-membered heterocycloalkyl. In embodiments, ring B is a 6-membered heterocycloalkyl. In embodiments, ring B is a 7-membered heterocycloalkyl. In embodiments, ring B is an 8 membered heteroA cycloalkyl group. In embodiments, ring B is a 4-to 6-membered heterocycloalkyl. In embodiments, ring B is azetidinyl. When ring B is substituted (e.g., substituted 4-to 8-membered heterocycloalkyl), it is understood that z6 is other than 0 (i.e., ring B is substituted with R)6Substituted ring B).

In embodiments, ring B is a substituted or unsubstituted heterocycloalkyl. In embodiments, ring B is a substituted heterocycloalkyl. In embodiments, ring B is unsubstituted heterocycloalkyl. In embodiments, ring B is a substituted or unsubstituted 3-to 10-membered heterocycloalkyl. In embodiments, ring B is a substituted 3-to 10-membered heterocycloalkyl. In embodiments, ring B is unsubstituted 3-to 10-membered heterocycloalkyl. In embodiments, ring B is substituted with R6Substituted or unsubstituted 5-to 10-membered heterocycloalkyl. In embodiments, ring B is substituted with R6Substituted 5 to 10 membered heterocycloalkyl. In embodiments, ring B is an unsubstituted 5-to 10-membered heterocycloalkyl.

In embodiments, ring B is a substituted or unsubstituted 3-membered heterocycloalkyl. In embodiments, ring B is a substituted or unsubstituted 4-membered heterocycloalkyl. In embodiments, ring B is a substituted or unsubstituted 5-membered heterocycloalkyl. In embodiments, ring B is a substituted or unsubstituted 6-membered heterocycloalkyl. In embodiments, ring B is a substituted 3-membered heterocycloalkyl. In embodiments, ring B is a substituted 4-membered heterocycloalkyl. In embodiments, ring B is a substituted 5-membered heterocycloalkyl. In embodiments, ring B is a substituted 6-membered heterocycloalkyl. In embodiments, ring B is unsubstituted 3-membered heterocycloalkyl. In embodiments, ring B is unsubstituted 4-membered heterocycloalkyl. In embodiments, ring B is an unsubstituted 5-membered heterocycloalkyl. In embodiments, ring B is unsubstituted 6-membered heterocycloalkyl.

In embodiments, ring B is substituted or unsubstituted aziridinyl, aziridinyl (azirinyl), azetidinyl, dihydroazetidinyl (dihydroazetyl), diazacyclobutanyl, azetidinyl, pyrrolidinyl, pyrrolinyl, pyrrolyl, pyrazolidinyl, imidazolinyl, pyrazolinyl, pyrazolyl, thiazolidinyl, thiazolyl, isothiazolyl, piperidinyl, piperazinyl, morpholinyl, oxazinyl, thiomorpholinyl, thiazinyl, decahydroquinolinyl, dihydroazepinyl, azepinyl, azepanyl, or azoctyl. In embodiments, ring B is a substituted aziridinyl, azetidinyl, dihydroazetidinyl, diazacyclobutanyl, azetidinyl, pyrrolidinyl, pyrrolinyl, pyrrolyl, pyrazolidinyl, imidazolidinyl, pyrazolinyl, pyrazolyl, thiazolidinyl, thiazolyl, isothiazolyl, piperidinyl, piperazinyl, morpholinyl, oxazinyl, thiomorpholinyl, thiazinyl, decahydroquinolinyl, dihydroazepinyl, azepanyl, or azocyclooctyl. In embodiments, ring B is unsubstituted aziridinyl, azetidinyl, dihydroazetidinyl, diazacyclobutanyl, azetidinyl, pyrrolidinyl, pyrrolinyl, pyrrolyl, pyrazolidinyl, imidazolidinyl, pyrazolinyl, pyrazolyl, thiazolidinyl, thiazolyl, isothiazolyl, piperidinyl, piperazinyl, morpholinyl, oxazinyl, thiomorpholinyl, thiazinyl, decahydroquinolinyl, dihydroazepinyl, azepanyl, or azocyclooctyl.

In the examples, ring B is substituted by one R6And (4) substitution. In embodiments, ring B is substituted with two optionally different R6And (4) substituent substitution. In embodiments, ring B is substituted with three optionally different R6And (4) substituent substitution. In embodiments, ring B is substituted with four optionally different R6And (4) substituent substitution. In embodiments, ring B is substituted with five optionally different R6And (4) substituent substitution. In embodiments, ring B is substituted with six optionally different R6And (4) substituent substitution. In embodiments, ring B is optionally substituted with seven optionally different R6And (4) substituent substitution. In embodiments, ring B is substituted with eight optionally different R6And (4) substituent substitution. In embodiments, ring B is substituted with nine optionally different R6And (4) substituent substitution. In embodiments, ring B is substituted with ten optionally different R6And (4) substituent substitution.

In embodiments, ring B is azetidinyl. In embodiments, ring B is a 4-membered heterocycloalkyl. In embodiments, ring B is a 3 to 5 membered heterocycloalkyl. In embodiments, ring B is a 3-to 6-membered heterocycloalkyl. In embodiments, ring B is pyrrolidinyl. In embodiments, ring B is a 5-membered heterocycloalkyl. In embodiments, ring B is a 4-to 6-membered heterocycloalkyl. In embodiments, ring B is morpholino. In embodiments, ring B is a 6-membered heterocycloalkyl. In embodiments, ring B is a 5-to 7-membered heterocycloalkyl. In an embodiment, ring B is a 2-oxa-6-azaspiro [3.3] heptyl group. In the examples, ring B is 2-oxa-6-azaspiro [3.3] hept-6-yl. In embodiments, ring B is a 7-membered heterocycloalkyl. In embodiments, ring B is a 6 to 8 membered heterocycloalkyl. In embodiments, ring B is a 7-membered spiroheterocycloalkyl. In embodiments, ring B is a 6 to 8 membered spiroheterocycloalkyl. In embodiments, ring B is piperidin-1-yl. In embodiments, ring B is piperidinyl. In embodiments, ring B is piperazin-1-yl. In embodiments, ring B is piperazinyl. In the examples, ring B is oxazolidin-3-yl. In embodiments, ring B is an oxazolinyl group. In embodiments, ring B is an imidazolidyl. In embodiments, ring B is a 1, 3-oxazacyclohexanyl group. In embodiments, ring B is an oxazacyclohexanyl group.

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002171

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002174

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002176

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002177

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500021711

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002183

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn factIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500021810

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500021811

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500021812

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500021820

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500021821

In the examples, - (Ring B) - (R)6)z6Is. In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500021823

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002191

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002193

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002196

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002198

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500021911

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (A)Ring B) - (R6)z6Is that

Figure BDA00024698989500021915

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500021916

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500021918

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002201

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002209

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500022013

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500022014

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500022015

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500022016

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500022020

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500022021

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002212

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002214

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002215

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002217

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002219

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500022111

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500022115

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA00024698989500022118

In the examples, - (Ring B) - (R)6)z6Is thatIn an embodiment, ring B is

In embodiments, ring C is substituted or unsubstituted C3-C6Cycloalkyl, substituted or unsubstituted 3-to 6-membered heterocycloalkyl, substituted or unsubstituted phenyl, or substituted or unsubstituted 5-to 6-membered heteroaryl. In embodiments, ring C is a substituted or unsubstituted 5-to 6-membered heteroaryl. When ring C is substituted (e.g., substituted C3-C6Cycloalkyl), it is understood that z24 is not 0 (i.e., ring C is substituted with R)24Substituted).

In embodiments, ring C is substituted or unsubstituted cycloalkyl. In embodiments, ring C is a substituted or unsubstituted heterocycloalkyl. In embodiments, ring C is substituted or unsubstituted aryl. In embodiments, ring C is substituted or unsubstituted heteroaryl. In embodiments, ring C is substituted or unsubstituted (C)3-C10) Cycloalkyl, substituted or unsubstituted 3-to 10-membered heterocycloalkyl, substituted or unsubstituted (C)6-C10) Aryl or substituted or unsubstituted 5 to 10 membered heteroaryl. In embodiments, ring C is substituted or unsubstituted (C)3-C10) A cycloalkyl group. In embodiments, ring C is a substituted or unsubstituted 3-to 10-membered heterocycloalkyl. In embodiments, ring C is substituted or unsubstituted (C)6-C10) And (4) an aryl group. In embodiments, ring C is a substituted or unsubstituted 5-to 10-membered heteroaryl. In embodiments, ring C is substituted or unsubstituted (C)3-C6) A cycloalkyl group. In embodiments, ring C is a substituted or unsubstituted 3-to 6-membered heterocycloalkyl. In an embodiment, ring C is takenSubstituted or unsubstituted phenyl. In embodiments, ring C is substituted or unsubstituted naphthyl. In embodiments, ring C is a substituted or unsubstituted 5-to 9-membered heteroaryl. In embodiments, ring C is a substituted or unsubstituted 5-to 6-membered heteroaryl. In embodiments, ring C is an unsubstituted 5-to 6-membered heteroaryl. In embodiments, ring C is a substituted or unsubstituted 5-membered heteroaryl. In embodiments, ring C is a substituted 5-membered heteroaryl. In embodiments, ring C is an unsubstituted 5-membered heteroaryl.

In embodiments, ring C is substituted with R24Substituted or unsubstituted (C)3-C10) Cycloalkyl radicals, by R24Substituted or unsubstituted 5-to 10-membered heterocycloalkyl, substituted or unsubstituted by R24Substituted or unsubstituted (C)6-C10) Aryl or by R24Substituted or unsubstituted 5-to 10-membered heteroaryl. In embodiments, ring C is substituted with R24Substituted or unsubstituted (C)3-C10) Cycloalkyl radicals or by R24Substituted or unsubstituted 5-to 10-membered heterocycloalkyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted (C)3-C10) A cycloalkyl group. In embodiments, ring C is substituted with R24Substituted or unsubstituted 3 to 10 membered heterocycloalkyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted (C)6-C10) And (4) an aryl group. In embodiments, ring C is substituted with R24Substituted or unsubstituted 5-to 10-membered heteroaryl. In embodiments, ring C is substituted with R24Substituted or unsubstituted (C)3-C6) A cycloalkyl group. In embodiments, ring C is substituted with R24Substituted or unsubstituted 3-to 6-membered heterocycloalkyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted phenyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted naphthyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted 5-to 9-membered heteroaryl. In embodiments, ring C is substituted with R24Substituted or unsubstituted 5-to 6-membered heteroaryl.

In embodiments, ring C is substituted with R24Substituted or unsubstituted thienyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted phenyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted benzothienyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted naphthyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted benzofuranyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted furyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted pyrrolyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted oxazolyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted oxadiazolyl group. In embodiments, ring C is substituted with R24A substituted or unsubstituted triazolyl. In embodiments, ring C is substituted with R24Substituted or unsubstituted thiazolyl.

In embodiments, ring C is substituted cycloalkyl. In embodiments, ring C is a substituted heterocycloalkyl. In embodiments, ring C is substituted aryl. In embodiments, ring C is substituted heteroaryl. In embodiments, ring C is substituted (C)3-C10) Cycloalkyl, substituted 3-to 10-membered heterocycloalkyl, substituted (C)6-C10) Aryl or substituted 5-to 10-membered heteroaryl. In embodiments, ring C is substituted (C)3-C10) A cycloalkyl group. In embodiments, ring C is a substituted 3-to 10-membered heterocycloalkyl. In embodiments, ring C is substituted (C)6-C10) And (4) an aryl group. In embodiments, ring C is a substituted 5-to 10-membered heteroaryl. In embodiments, ring C is substituted (C)3-C6) A cycloalkyl group. In embodiments, ring C is a substituted 3-to 6-membered heterocycloalkyl. In embodiments, ring C is substituted phenyl. In embodiments, ring C is substituted naphthyl. In embodiments, ring C is a substituted 5-to 9-membered heteroaryl. In embodiments, ring C is a substituted 5-to 6-membered heteroaryl. In embodiments, ring C is substituted with R24Substituted (C)3-C10) Cycloalkyl radicals, by R24Substituted 5-to 10-membered heterocycloalkyl, by R24Substituted (C)6-C10) Aryl or by R24Substituted 5 to 10A membered heteroaryl group. In embodiments, ring C is substituted with R24Substituted (C)3-C10) Cycloalkyl radicals or by R24Substituted 5 to 10 membered heterocycloalkyl. In embodiments, ring C is substituted with R24Substituted (C)3-C10) A cycloalkyl group. In embodiments, ring C is substituted with R24Substituted 3 to 10 membered heterocycloalkyl. In embodiments, ring C is substituted with R24Substituted (C)6-C10) And (4) an aryl group. In embodiments, ring C is substituted with R24Substituted 5 to 10 membered heteroaryl. In embodiments, ring C is substituted with R24Substituted (C)3-C6) A cycloalkyl group. In embodiments, ring C is substituted with R24Substituted 3 to 6 membered heterocycloalkyl. In embodiments, ring C is substituted with R24A substituted phenyl group. In embodiments, ring C is substituted with R24Substituted naphthyl. In embodiments, ring C is substituted with R24Substituted 5 to 9 membered heteroaryl. In embodiments, ring C is substituted with R24Substituted 5 to 6 membered heteroaryl. In embodiments, ring C is substituted with R24Substituted thienyl. In embodiments, ring C is substituted with R24A substituted phenyl group. In embodiments, ring C is substituted with R24Substituted benzothienyl. In embodiments, ring C is substituted with R24Substituted naphthyl. In embodiments, ring C is substituted with R24Substituted benzofuranyl. In embodiments, ring C is substituted with R24A substituted furyl group. In embodiments, ring C is substituted with R24A substituted pyrrolyl group. In embodiments, ring C is substituted with R24Substituted oxazolyl. In embodiments, ring C is substituted with R24Substituted oxadiazolyl groups. In embodiments, ring C is substituted with R24A substituted triazolyl group. In embodiments, ring C is substituted with R24A substituted thiazolyl group.

In embodiments, ring C is unsubstituted cycloalkyl. In embodiments, ring C is unsubstituted heterocycloalkyl. In embodiments, ring C is unsubstituted aryl. In embodiments, ring C is unsubstituted heteroaryl. In embodiments, ring C is unsubstituted (C)3-C10) Cycloalkyl, unsubstituted 3-to 10-membered heterocycloalkyl, unsubstituted (C)6-C10) Aryl radicals or unsubstitutedThe 5 to 10 membered heteroaryl of (a). In embodiments, ring C is unsubstituted (C)3-C10) A cycloalkyl group. In embodiments, ring C is unsubstituted 3-to 10-membered heterocycloalkyl. In embodiments, ring C is unsubstituted (C)6-C10) And (4) an aryl group. In embodiments, ring C is an unsubstituted 5-to 10-membered heteroaryl. In embodiments, ring C is unsubstituted (C)3-C6) A cycloalkyl group. In embodiments, ring C is unsubstituted 3-to 6-membered heterocycloalkyl. In embodiments, ring C is unsubstituted phenyl. In embodiments, ring C is unsubstituted naphthyl. In embodiments, ring C is an unsubstituted 5-to 9-membered heteroaryl. In embodiments, ring C is an unsubstituted 5-to 6-membered heteroaryl. In embodiments, ring C is unsubstituted (C)3-C10) Cycloalkyl, unsubstituted 5-to 10-membered heterocycloalkyl, unsubstituted (C)6-C10) Aryl or unsubstituted 5-to 10-membered heteroaryl. In embodiments, ring C is unsubstituted (C)3-C10) Cycloalkyl or unsubstituted 5-to 10-membered heterocycloalkyl. In embodiments, ring C is unsubstituted (C)3-C10) A cycloalkyl group. In embodiments, ring C is unsubstituted 3-to 10-membered heterocycloalkyl. In embodiments, ring C is unsubstituted (C)6-C10) And (4) an aryl group. In embodiments, ring C is an unsubstituted 5-to 10-membered heteroaryl. In embodiments, ring C is unsubstituted (C)3-C6) A cycloalkyl group. In embodiments, ring C is unsubstituted 3-to 6-membered heterocycloalkyl. In embodiments, ring C is unsubstituted phenyl. In embodiments, ring C is unsubstituted naphthyl. In embodiments, ring C is an unsubstituted 5-to 9-membered heteroaryl. In embodiments, ring C is an unsubstituted 5-to 6-membered heteroaryl. In embodiments, ring C is unsubstituted thienyl. In embodiments, ring C is unsubstituted phenyl. In embodiments, ring C is unsubstituted benzothienyl. In embodiments, ring C is unsubstituted naphthyl. In embodiments, ring C is unsubstituted benzofuranyl. In embodiments, ring C is unsubstituted furanyl. In embodiments, ring C is unsubstituted pyrrolyl. In embodiments, ring C is notA substituted oxazolyl group. In embodiments, ring C is unsubstituted phenyl. In embodiments, ring C is unsubstituted oxadiazolyl. In embodiments, ring C is an unsubstituted triazolyl. In embodiments, ring C is unsubstituted thiazolyl.

In embodiments, ring C is C6-C10Aryl or 5 to 10 membered heteroaryl. In embodiments, ring C is C6-C10Aryl or 5 to 10 membered heteroaryl. In embodiments, ring C is C6-C10And (4) an aryl group. In embodiments, ring C is phenyl. In embodiments, ring C is naphthyl. In embodiments, ring C is a 5 to 10 membered heteroaryl. In embodiments, ring C is a 5-to 6-membered heteroaryl. In embodiments, ring C is thienyl. In embodiments, ring C is furyl. In embodiments, ring C is pyrrolyl. In embodiments, ring C is imidazolyl. In an embodiment, ring C is pyrazolyl. In the examples, ring C is oxazolyl. In embodiments, ring C is isoxazolyl. In embodiments, ring C is thiazolyl. In embodiments, ring C is pyridyl. In embodiments, ring C is pyridyl. In embodiments, ring C is pyrazinyl. In embodiments, ring C is pyrimidinyl. In an embodiment, ring C is pyridazinyl. In embodiments, ring C is 1,2, 3-triazinyl. In embodiments, ring C is 1,2, 4-triazinyl. In embodiments, ring C is 1,3, 5-triazinyl.

In embodiments, ring C is substituted C6-C10Aryl or substituted 5-to 10-membered heteroaryl. In embodiments, ring C is substituted C6-C10Aryl or substituted 5-to 10-membered heteroaryl. In embodiments, ring C is substituted C6-C10And (4) an aryl group. In embodiments, ring C is substituted phenyl. In embodiments, ring C is substituted naphthyl. In embodiments, ring C is a substituted 5-to 10-membered heteroaryl. In embodiments, ring C is a substituted 5-to 6-membered heteroaryl. In embodiments, ring C is a substituted thienyl group. In embodiments, ring C is a substituted furyl group. In embodiments, ring C is a substituted pyrrolyl. In embodiments, ring C is substituted imidazolyl. In embodiments, ring C is substituted pyrazolyl. In factIn the examples, ring C is a substituted oxazolyl group. In embodiments, ring C is a substituted isoxazolyl. In embodiments, ring C is a substituted thiazolyl. In embodiments, ring C is substituted pyridyl. In embodiments, ring C is substituted pyridyl. In embodiments, ring C is a substituted pyrazinyl. In embodiments, ring C is substituted pyrimidinyl. In an embodiment, ring C is a substituted pyridazinyl group. In embodiments, ring C is a substituted 1,2, 3-triazinyl group. In embodiments, ring C is a substituted 1,2, 4-triazinyl group. In embodiments, ring C is a substituted 1,3, 5-triazinyl group.

In embodiments, ring C is unsubstituted C6-C10Aryl or unsubstituted 5-to 10-membered heteroaryl. In embodiments, ring C is unsubstituted C6-C10Aryl or unsubstituted 5-to 10-membered heteroaryl. In embodiments, ring C is unsubstituted C6-C10And (4) an aryl group. In embodiments, ring C is unsubstituted phenyl. In embodiments, ring C is unsubstituted naphthyl. In embodiments, ring C is an unsubstituted 5-to 10-membered heteroaryl. In embodiments, ring C is an unsubstituted 5-to 6-membered heteroaryl. In embodiments, ring C is unsubstituted thienyl. In embodiments, ring C is unsubstituted furanyl. In embodiments, ring C is unsubstituted pyrrolyl. In embodiments, ring C is unsubstituted imidazolyl. In embodiments, ring C is unsubstituted pyrazolyl. In embodiments, ring C is an unsubstituted oxazolyl. In embodiments, ring C is an unsubstituted isoxazolyl. In embodiments, ring C is unsubstituted thiazolyl. In embodiments, ring C is unsubstituted pyridyl. In embodiments, ring C is unsubstituted pyridyl. In embodiments, ring C is unsubstituted pyrazinyl. In embodiments, ring C is unsubstituted pyrimidinyl. In an embodiment, ring C is unsubstituted pyridazinyl. In embodiments, ring C is unsubstituted 1,2, 3-triazinyl. In embodiments, ring C is unsubstituted 1,2, 4-triazinyl. In embodiments, ring C is unsubstituted 1,3, 5-triazinyl.

In embodiments, ring C is a 4 to 8 membered heterocycloalkyl. In embodiments, ring C is a 4-membered heterocycloalkyl. In embodiments, ring C is a 5-membered heterocycloalkyl. In embodiments, ring C is a 6-membered heterocycloalkyl. In embodiments, ring C is a 7-membered heterocycloalkyl. In embodiments, ring C is an 8-membered heterocycloalkyl. In embodiments, ring C is a 4 to 6 membered heterocycloalkyl. In embodiments, ring C is azetidinyl.

In embodiments, ring C is a substituted or unsubstituted heterocycloalkyl. In embodiments, ring C is a substituted heterocycloalkyl. In embodiments, ring C is unsubstituted heterocycloalkyl. In embodiments, ring C is a substituted or unsubstituted 3-to 10-membered heterocycloalkyl. In embodiments, ring C is a substituted 3-to 10-membered heterocycloalkyl. In embodiments, ring C is unsubstituted 3-to 10-membered heterocycloalkyl. In embodiments, ring C is substituted with R6Substituted or unsubstituted 5-to 10-membered heterocycloalkyl. In embodiments, ring C is substituted with R6Substituted 5 to 10 membered heterocycloalkyl. In embodiments, ring C is an unsubstituted 5-to 10-membered heterocycloalkyl.

In embodiments, ring C is a substituted or unsubstituted 3-membered heterocycloalkyl. In embodiments, ring C is a substituted or unsubstituted 4-membered heterocycloalkyl. In embodiments, ring C is a substituted or unsubstituted 5-membered heterocycloalkyl. In embodiments, ring C is a substituted or unsubstituted 6-membered heterocycloalkyl. In embodiments, ring C is a substituted 3-membered heterocycloalkyl. In embodiments, ring C is a substituted 4-membered heterocycloalkyl. In embodiments, ring C is a substituted 5-membered heterocycloalkyl. In embodiments, ring C is a substituted 6-membered heterocycloalkyl. In embodiments, ring C is unsubstituted 3-membered heterocycloalkyl. In embodiments, ring C is unsubstituted 4-membered heterocycloalkyl. In embodiments, ring C is an unsubstituted 5-membered heterocycloalkyl. In embodiments, ring C is unsubstituted 6-membered heterocycloalkyl.

In embodiments, ring C is substituted or unsubstituted aziridinyl, azetidinyl, dihydroazetidinyl, diazacyclobutanyl, azetidinyl, pyrrolidinyl, pyrrolinyl, pyrrolyl, pyrazolidinyl, imidazolinyl, pyrazolinyl, pyrazolyl, thiazolidinyl, thiazolyl, isothiazolyl, piperidinyl, piperazinyl, morpholinyl, oxazinyl, thiomorpholinyl, thiazinyl, decahydroquinolinyl, dihydroazepinyl, azepanyl, or azocyclooctyl. In embodiments, ring C is a substituted aziridinyl, azetidinyl, dihydroazetidinyl, diazacyclobutanyl, azetidinyl, pyrrolidinyl, pyrrolinyl, pyrrolyl, pyrazolidinyl, imidazolidinyl, pyrazolinyl, pyrazolyl, thiazolidinyl, thiazolyl, isothiazolyl, piperidinyl, piperazinyl, morpholinyl, oxazinyl, thiomorpholinyl, thiazinyl, decahydroquinolinyl, dihydroazepinyl, azepanyl, or azocyclooctyl. In embodiments, ring C is unsubstituted aziridinyl, azetidinyl, dihydroazetidinyl, diazacyclobutanyl, azetidinyl, pyrrolidinyl, pyrrolinyl, pyrrolyl, pyrazolidinyl, imidazolidinyl, pyrazolinyl, pyrazolyl, thiazolidinyl, thiazolyl, isothiazolyl, piperidinyl, piperazinyl, morpholinyl, oxazinyl, thiomorpholinyl, thiazinyl, decahydroquinolinyl, dihydroazepinyl, azepanyl, or azocyclooctyl.

Ring C may be substituted by one R24And (4) substitution. Ring C may be substituted by two optionally different R24And (4) substituent substitution. Ring C may be substituted by three optionally different R24And (4) substituent substitution. Ring C may be substituted by four optionally different R24And (4) substituent substitution. Ring C may be substituted by five optionally different R24And (4) substituent substitution. Ring C may be substituted by six optionally different R24And (4) substituent substitution. Ring C may be optionally substituted with seven optionally different R24And (4) substituent substitution. Ring C may be substituted by eight optionally different R24And (4) substituent substitution. Ring C may be substituted by nine optionally different R24And (4) substituent substitution. Ring C may be optionally substituted by ten R24And (4) substituent substitution.

In embodiments, ring C is a substituted cyclopropyl. In embodiments, ring C is a substituted cyclobutyl. In embodiments, ring C is a substituted cyclohexyl. In embodiments, ring C is a substituted cyclopentyl. In an embodiment, ring C is OH substituted cyclopentyl. In embodiments, ring C is cyclobutyl substituted by OH. In embodiments, ring C is an unsubstituted cyclobutyl. In embodiments, ring C is unsubstituted cyclohexyl. In embodiments, ring C is an unsubstituted cyclopentyl. In embodiments, ring C is phenyl substituted with OH. In embodiments, ring C is substituted phenyl. In embodiments, ring C is unsubstituted phenyl. In embodiments, ring C is unsubstituted tetrahydropyranyl. In embodiments, ring C is a substituted tetrahydropyranyl. In embodiments, ring C is unsubstituted tetrahydrofuranyl. In embodiments, ring C is substituted tetrahydrofuranyl. In embodiments, ring C is unsubstituted cyclopropyl. In embodiments, ring C is unsubstituted pyridyl. In embodiments, ring C is substituted pyridyl. In embodiments, ring C is-OCH3A substituted pyridyl group. In embodiments, ring C is substituted piperidinyl. In embodiments, ring C is unsubstituted piperidinyl. In embodiments, ring C is a substituted thiazolyl. In embodiments, ring C is unsubstituted thiazolyl. In embodiments, ring C is substituted pyrrolidinyl. In embodiments, ring C is unsubstituted pyrrolidinyl. In embodiments, ring C is a substituted oxetanyl group. In embodiments, ring C is unsubstituted oxetanyl. In embodiments, ring C is a substituted azetidinyl. In embodiments, ring C is unsubstituted azetidinyl. In embodiments, ring C is a substituted morpholinyl. In embodiments, ring C is unsubstituted morpholinyl. In embodiments, ring C is substituted imidazolyl. In embodiments, ring C is unsubstituted imidazolyl. In embodiments, ring C is substituted pyrimidinyl. In embodiments, ring C is unsubstituted pyrimidinyl. In an embodiment, ring C is a substituted pyridazinyl group. In an embodiment, ring C is unsubstituted pyridazinyl.

In the examples, each R1A、R1B、R1C、R1D、R4A、R4B、R4C、R4D、R5A、R5B、R5C、R5D、R6A、R6B、R6CAnd R6DIndependently of each other is hydrogen, halogen, CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H. -NHC (O) H, -NHC (O) OH, -NHOH, unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R1AIs hydrogen. In the examples, R1BIs hydrogen. In the examples, R1CIs hydrogen. In the examples, R1DIs hydrogen. In the examples, R4AIs hydrogen. In the examples, R4BIs hydrogen. In the examples, R4CIs hydrogen. In the examples, R4DIs hydrogen. In the examples, R5AIs hydrogen. In the examples, R5BIs hydrogen. In the examples, R5CIs hydrogen. In the examples, R5DIs hydrogen. In the examples, R1AIs a halogen. In the examples, R1BIs a halogen. In the examples, R1CIs a halogen. In the examples, R1DIs a halogen. In the examples, RABIs a halogen. In the examples, R4BIs a halogen. In the examples, R4CIs a halogen. In the examples, R4DIs a halogen. In the examples, R5AIs a halogen. In the examples, R5BIs a halogen. In the examples, R5CIs a halogen. In the examples, R5DIs a halogen. In the examples, R6AIs a halogen. In the examples, R6BIs a halogen. In the examples, R6CIs a halogen. In the examples, R6DIs a halogen.

In the examples, R1AIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R1BIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R1CIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R1DIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4AIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4BIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4CIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R4DIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5AIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5BIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5CIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R5DIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6AIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6BIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6CIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R6DIs unsubstituted alkyl (e.g. C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups).

In the examples R1AIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R1BIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R1CIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R1DIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R4AIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R4BIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R4CIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R4DIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R5AIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R5BIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R5CIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R5DIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R6AIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R6BIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R6CIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl). In the examples R6DIs unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl).

In the examples, R bonded to the same nitrogen atom1AAnd R1BSubstituents may optionally join to form a substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R bonded to the same nitrogen atom4AAnd R4BSubstituents may optionally join to form a substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, the same asR bound to a nitrogen atom5AAnd R5BSubstituents may optionally join to form a substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R bonded to the same nitrogen atom6AAnd R6BSubstituents may optionally join to form a substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R bonded to the same nitrogen atom1AAnd R1BSubstituents may optionally join to form substituted heterocycloalkyl groups (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R bonded to the same nitrogen atom4AAnd R4BSubstituents may optionally join to form substituted heterocycloalkyl groups (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R bonded to the same nitrogen atom5AAnd R5BSubstituents may optionally join to form substituted heterocycloalkyl groups (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R bonded to the same nitrogen atom6AAnd R6BSubstituents may optionally join to form substituted heterocycloalkyl groups (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R bonded to the same nitrogen atom1AAnd R1BSubstituents may optionally join to form unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R bonded to the same nitrogen atom4AAnd R4BSubstituents may optionally join to form unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R bonded to the same nitrogen atom5AAnd R5BSubstituents may optionally join to form unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl). In the examples, R bonded to the same nitrogen atom6AAnd R6BThe substituent can be anyOptionally joined to form an unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl).

In the examples, each R1A、R1B、R1C、R1D、R4A、R4B、R4C、R4D、R5A、R5B、R5CAnd R5DIndependently hydrogen, halogen, -CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H. -NHC (O) H, -NHC (O) OH, -NHOH, unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

R22、R25、R28、R31、R34、R37And R40Independently an oxo group,Halogen, -CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2Unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl, 2-to 6-membered heteroalkyl, or 2-to 4-membered heteroalkyl), unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl), unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R22、R25、R28、R31、R34、R37And R40Independently an oxo group. In the examples, R22、R25、R28、R31、R34、R37And R40Independently a halogen. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CF3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CBr3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CCl3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CI3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CHF2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CHBr2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CHCl2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CHI2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CH2F. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CH2Br is added. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CH2And (4) Cl. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CH2I. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCF3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCBr3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCCl3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCI3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCHF2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCHBr2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCHCl2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCHI2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCH2F. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCH2Br is added. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCH2And (4) Cl. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCH2I. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CN. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OH. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-NH2. In the examples, R22、R25、R28、R31、R34、R37And R40independently-COOH. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CONH2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-NO2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-SH. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-SO3H. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-SO4H. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-SO2NH2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-NHNH2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-ONH2、-NHC(O)NHNH2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-NHC (O) NH2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-NHSO2H. In the examples, R22、R25、R28、R31、R34、R37And R40independently-NHC (O) H. In the examples, R22、R25、R28、R31、R34、R37And R40independently-NHC (O) OH. In the examples, R22、R25、R28、R31、R34、R37And R40independently-NHOH. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCCl3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCF3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCBr3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCI3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCHCl2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCHBr2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCHI2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-OCHF2. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl groups). In the examples, R22、R25、R28、R31、R34、R37And R40Independently an unsubstituted heteroalkyl group (e.g., a 2-to 8-membered heteroalkyl group, a 2-to 6-membered heteroalkyl group, or a 2-to 4-membered heteroalkyl group). In the examples, R22、R25、R28、R31、R34、R37And R40Independently is unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R22、R25、R28、R31、R34、R37And R40Independently an unsubstituted heterocycloalkyl group (e.g., a 3-to 8-membered heterocycloalkyl group, a 3-to 6-membered heterocycloalkyl group, or a 5-to 6-membered heterocycloalkyl group). In the examples, R22、R25、R28、R31、R34、R37And R40Independently is unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl). In the examples, R22、R25、R28、R31、R34、R37And R40Independently unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl). In the examples, R22、R25、R28、R31、R34、R37And R40Independently is-CH3. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is unsubstituted C2An alkyl group. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is unsubstituted C3An alkyl group. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is unsubstituted C4An alkyl group. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is unsubstituted C5An alkyl group. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is unsubstituted C6An alkyl group. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is unsubstituted C7An alkyl group. In the examples, R22、R25、R28、R31、R34、R37And R40Independently is unsubstituted C8An alkyl group.

R37A、R37B、R37CAnd R37DIndependently oxo, halogen, -CF3、-CBr3、-CCl3、-CI3、-CHF2、-CHBr2、-CHCl2、-CHI2、-CH2F、-CH2Br、-CH2Cl、-CH2I、-OCF3、-OCBr3、-OCCl3、-OCI3、-OCHF2、-OCHBr2、-OCHCl2、-OCHI2、-OCH2F、-OCH2Br、-OCH2Cl、-OCH2I、-CN、-OH、-NH2、-COOH、-CONH2、-NO2、-SH、-SO3H、-SO4H、-SO2NH2、-NHNH2、-ONH2、-NHC(O)NHNH2、-NHC(O)NH2、-NHSO2H、-NHC(O)H、-NHC(O)OH、-NHOH、-OCCl3、-OCF3、-OCBr3、-OCI3、-OCHCl2、-OCHBr2、-OCHI2、-OCHF2Unsubstituted alkyl (e.g., C)1-C8Alkyl radical, C1-C6Alkyl or C1-C4Alkyl), unsubstituted heteroalkyl (e.g., 2-to 8-membered heteroalkyl)6-membered heteroalkyl or 2-to 4-membered heteroalkyl), unsubstituted cycloalkyl (e.g., C)3-C8Cycloalkyl radical, C3-C6{86 cycloalkyl or C5-C6Cycloalkyl), unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl), unsubstituted aryl (e.g., C)6-C10Aryl radical, C10Aryl, or phenyl) or unsubstituted heteroaryl (e.g., 5-to 10-membered heteroaryl, 5-to 9-membered heteroaryl, or 5-to 6-membered heteroaryl).

In the examples, R25is-OH. In the examples, R25is-OCH3. In the examples, R25is-OCH2CH3. In the examples, R25is-F. In the examples, R25is-NHC (O) CH3. In the examples, R25is-COOH. In the examples, R25is-SO2NH2

In the examples, R28is-OH. In the examples, R28is-OCH3. In the examples, R28is-OCH2CH3. In the examples, R28is-F. In the examples, R28is-NHC (O) CH3. In the examples, R28is-COOH. In the examples, R28is-SO2NH2

In the examples, X1is-F. In the examples, X1is-Cl. In the examples, X1is-Br. In the examples, X1is-I. In the examples, X4is-F. In the examples, X4is-Cl. In the examples, X4is-Br. In the examples, X4is-I. In the examples, X5is-F. In the examples, X5is-Cl. In the examples, X5is-Br. In the examples, X5is-I. In the examples, X6is-F. In the examples, X6is-Cl. In the examples, X6is-Br. In the examples, X6is-I.

In an embodiment, z1 is an integer from 0 to 5. In an embodiment, z1 is an integer from 0 to 2. In an embodiment, z1 is 0. In an embodiment, z1 is 1. In an embodiment, z1 is 2. In an embodiment, z1 is 3. In an embodiment, z1 is 4. In an embodiment, z1 is 5. In an embodiment, z6 is an integer from 0 to 5. In an embodiment, z6 is an integer from 0 to 2. In an embodiment, z6 is 0. In an embodiment, z6 is 1. In an embodiment, z6 is 2. In an embodiment, z6 is 3. In an embodiment, z6 is 4. In an embodiment, z6 is 5. In an embodiment, z6 is 6. In an embodiment, z6 is 7. In an embodiment, z6 is 8. In an embodiment, z6 is 9. In an embodiment, z6 is 10. In an embodiment, z16 is 1. In an embodiment, z16 is 2. In an embodiment, z16 is 3. In an embodiment, z16 is 4. In an embodiment, z16 is 5. In an embodiment, z16 is 6. In an embodiment, z16 is 7. In an embodiment, z16 is 8. In an embodiment, z24 is 0. In an embodiment, z24 is 1. In an embodiment, z24 is 2. In an embodiment, z24 is 3. In an embodiment, z24 is 4. In an embodiment, z24 is 5. In an embodiment, z24 is 6. In an embodiment, z24 is 7. In an embodiment, z24 is 8. In an embodiment, z24 is 9. In an embodiment, z24 is 10.

In an embodiment, the compound is Z1. In an embodiment, the compound is Z2. In an embodiment, the compound is Z3. In an embodiment, the compound is Z4. In an embodiment, the compound is Z5. In an embodiment, the compound is Z6. In an embodiment, the compound is Z7. In an embodiment, the compound is Z8. In an embodiment, the compound is Z9. In an embodiment, the compound is Z10. In an embodiment, the compound is Z11. In an embodiment, the compound is Z12. In an embodiment, the compound is Z13. In an embodiment, the compound is Z14. In an embodiment, the compound is Z15. In an embodiment, the compound is Z16. In an embodiment, the compound is Z17. In an embodiment, the compound is Z18. In an embodiment, the compound is Z19. In an embodiment, the compound is Z20. In an embodiment, the compound is Z21. In an embodiment, the compound is Z22. In an embodiment, the compound is Z23. In an embodiment, the compound is Z24. In an embodiment, the compound is Z25. In an embodiment, the compound is Z26. In an embodiment, the compound is Z27. In an embodiment, the compound is Z28. In an embodiment, the compound is Z29. In an embodiment, the compound is Z30. In an embodiment, the compound is Z31. In an embodiment, the compound is Z32. In an embodiment, the compound is Z33. In an embodiment, the compound is Z34. In an embodiment, the compound is Z35. In an embodiment, the compound is Z36. In an embodiment, the compound is Z37. In an embodiment, the compound is Z38. In an embodiment, the compound is Z39. In an embodiment, the compound is Z40. In an embodiment, the compound is Z41. In an embodiment, the compound is Z42. In an embodiment, the compound is Z43. In an embodiment, the compound is Z44. In an embodiment, the compound is Z45. In an embodiment, the compound is Z46. In an embodiment, the compound is Z47. In an embodiment, the compound is Z48. In an embodiment, the compound is Z49. In an embodiment, the compound is Z50. In an embodiment, the compound is Z51. In an embodiment, the compound is Z52. In an embodiment, the compound is Z53. In an embodiment, the compound is Z54. In an embodiment, the compound is Z55. In an embodiment, the compound is Z56. In an embodiment, the compound is Z57. In an embodiment, the compound is Z58. In an embodiment, the compound is Z59. In an embodiment, the compound is Z60. In an embodiment, the compound is Z61. In an embodiment, the compound is Z62. In an embodiment, the compound is Z63. In an embodiment, the compound is Z64. In an embodiment, the compound is Z65. In an embodiment, the compound is Z66. In an embodiment, the compound is Z67. In an embodiment, the compound is Z68. In an embodiment, the compound is Z69. In an embodiment, the compound is Z70. In an embodiment, the compound is Z71. In an embodiment, the compound is Z72. In an embodiment, the compound is Z73. In an embodiment, the compound is Z74. In an embodiment, the compound is Z75. In an embodiment, the compound is Z76. In an embodiment, the compound is Z77. In an embodiment, the compound is Z78. In an embodiment, the compound is Z79. In an embodiment, the compound is Z80. In an embodiment, the compound is Z81. In an embodiment, the compound is Z82. In an embodiment, the compound is Z83. In an embodiment, the compound is Z84. In an embodiment, the compound is Z85. In an embodiment, the compound is Z86. In an embodiment, the compound is Z87. In an embodiment, the compound is Z88. In an embodiment, the compound is Z89. In an embodiment, the compound is Z90. In an embodiment, the compound is Z91. In an embodiment, the compound is Z92. In an embodiment, the compound is Z93. In an embodiment, the compound is Z94. In an embodiment, the compound is Z95. In an embodiment, the compound is Z96. In an embodiment, the compound is Z97. In an embodiment, the compound is Z98. In an embodiment, the compound is Z99. In an embodiment, the compound is Z100. In an embodiment, the compound is Z101. In an embodiment, the compound is Z102. In an embodiment, the compound is Z103. In an embodiment, the compound is Z104. In an embodiment, the compound is Z105. In an embodiment, the compound is Z106. In an embodiment, the compound is Z107. In an embodiment, the compound is Z108. In an embodiment, the compound is Z109. In an embodiment, the compound is Z110. In an embodiment, the compound is Z111. In an embodiment, the compound is Z112. In an embodiment, the compound is Z113. In an embodiment, the compound is Z114. In an embodiment, the compound is Z115. In an embodiment, the compound is Z116. In an embodiment, the compound is Z117. In an embodiment, the compound is Z118. In an embodiment, the compound is Z119. In an embodiment, the compound is Z120. In an embodiment, the compound is Z121. In an embodiment, the compound is Z122. In an embodiment, the compound is Z123. In an embodiment, the compound is Z124. In an embodiment, the compound is Z125. In an embodiment, the compound is Z126. In an embodiment, the compound is Z127. In an embodiment, the compound is Z128. In an embodiment, the compound is Z129. In an embodiment, the compound is Z130. In an embodiment, the compound is Z131. In an embodiment, the compound is Z132. In an embodiment, the compound is Z133. In an embodiment, the compound is Z134. In an embodiment, the compound is Z135. In an embodiment, the compound is Z136. In an embodiment, the compound is Z137. In an embodiment, the compound is Z138. In an embodiment, the compound is Z139. In an embodiment, the compound is Z140. In an embodiment, the compound is Z141. In an embodiment, the compound is Z142. In an embodiment, the compound is Z143. In an embodiment, the compound is Z144. In an embodiment, the compound is Z145. In an embodiment, the compound is Z146. In an embodiment, the compound is Z147. In an embodiment, the compound is Z148. In an embodiment, the compound is Z149. In an embodiment, the compound is Z150. In an embodiment, the compound is Z151. In an embodiment, the compound is Z152. In an embodiment, the compound is Z153. In an embodiment, the compound is Z154. In an embodiment, the compound is Z155. In an embodiment, the compound is Z156. In an embodiment, the compound is Z157. In an embodiment, the compound is Z158. In an embodiment, the compound is Z159. In an embodiment, the compound is Z160. In an embodiment, the compound is Z161. In an embodiment, the compound is Z162. In an embodiment, the compound is Z163. In an embodiment, the compound is Z164. In an embodiment, the compound is Z165. In an embodiment, the compound is Z166. In an embodiment, the compound is Z167. In an embodiment, the compound is Z168. In an embodiment, the compound is Z169. In an embodiment, the compound is Z170. In an embodiment, the compound is Z171. In an embodiment, the compound is Z172. In an embodiment, the compound is Z173. In an embodiment, the compound is Z174. In an embodiment, the compound is Z175. In an embodiment, the compound is Z176. In an embodiment, the compound is Z177. In an embodiment, the compound is Z178. In an embodiment, the compound is Z179. In an embodiment, the compound is Z180. In an embodiment, the compound is Z181. In an embodiment, the compound is Z182. In an embodiment, the compound is Z183. In an embodiment, the compound is Z184. In an embodiment, the compound is Z185. In an embodiment, the compound is Z186. In an embodiment, the compound is Z187. In an embodiment, the compound is Z188. In an embodiment, the compound is Z189. In an embodiment, the compound is Z190. In an embodiment, the compound is Z191. In an embodiment, the compound is Z192. In an embodiment, the compound is Z193. In an embodiment, the compound is Z194. In an embodiment, the compound is Z195. In an embodiment, the compound is Z196. In an embodiment, the compound is Z197. In an embodiment, the compound is Z198. In an embodiment, the compound is Z199. In an embodiment, the compound is Z200. In an embodiment, the compound is Z201. In an embodiment, the compound is Z202. In an embodiment, the compound is Z203. In an embodiment, the compound is Z204. In an embodiment, the compound is Z205. In an embodiment, the compound is Z206. In an embodiment, the compound is Z207. In an embodiment, the compound is Z208. In an embodiment, the compound is Z209. In an embodiment, the compound is Z210. In an embodiment, the compound is Z211. In an embodiment, the compound is Z212. In an embodiment, the compound is Z213. In an embodiment, the compound is Z214. In an embodiment, the compound is Z215. In an embodiment, the compound is Z216. In an embodiment, the compound is Z217. In an embodiment, the compound is Z218. In an embodiment, the compound is Z219. In an embodiment, the compound is Z220. In an embodiment, the compound is Z221. In an embodiment, the compound is Z222. In an embodiment, the compound is Z223. In an embodiment, the compound is Z224. In an embodiment, the compound is Z225. In an embodiment, the compound is Z226. In an embodiment, the compound is Z227. In an embodiment, the compound is Z228. In an embodiment, the compound is Z229. In an embodiment, the compound is Z230. In an embodiment, the compound is Z231. In an embodiment, the compound is Z232. In an embodiment, the compound is Z233. In an embodiment, the compound is Z234. In an embodiment, the compound is Z235. In an embodiment, the compound is Z236. In an embodiment, the compound is Z237. In an embodiment, the compound is Z238. In an embodiment, the compound is Z239. In an embodiment, the compound is Z240. In an embodiment, the compound is Z241. In an embodiment, the compound is Z242. In an embodiment, the compound is Z243. In an embodiment, the compound is Z244. In an embodiment, the compound is Z245. In an embodiment, the compound is Z246. In an embodiment, the compound is Z247. In an embodiment, the compound is Z248. In an embodiment, the compound is Z249. In an embodiment, the compound is Z250. In an embodiment, the compound is Z251. In an embodiment, the compound is Z252. In an embodiment, the compound is Z253. In an embodiment, the compound is Z254. In an embodiment, the compound is Z255. In an embodiment, the compound is Z256. In an embodiment, the compound is Z257. In an embodiment, the compound is Z258. In an embodiment, the compound is Z259. In an embodiment, the compound is Z260. In an embodiment, the compound is Z261. In an embodiment, the compound is Z262. In an embodiment, the compound is Z263. In an embodiment, the compound is Z264. In an embodiment, the compound is Z265. In an embodiment, the compound is Z266. In an embodiment, the compound is Z267. In an embodiment, the compound is Z268. In an embodiment, the compound is Z269. In an embodiment, the compound is Z270. In an embodiment, the compound is Z271. In an embodiment, the compound is Z272. In an embodiment, the compound is Z273. In an embodiment, the compound is Z274. In an embodiment, the compound is Z275. In an embodiment, the compound is Z276. In an embodiment, the compound is Z277. In an embodiment, the compound is Z278. In an embodiment, the compound is Z279. In an embodiment, the compound is Z280. In an embodiment, the compound is Z281. In an embodiment, the compound is Z282. In an embodiment, the compound is Z283. In an embodiment, the compound is Z284. In an embodiment, the compound is Z285. In an embodiment, the compound is Z286. In an embodiment, the compound is Z287. In an embodiment, the compound is Z288. In an embodiment, the compound is Z289. In an embodiment, the compound is Z290. In an embodiment, the compound is Z291. In an embodiment, the compound is Z292. In an embodiment, the compound is Z293. In an embodiment, the compound is Z294. In an embodiment, the compound is Z295. In an embodiment, the compound is Z296. In an embodiment, the compound is Z297. In an embodiment, the compound is Z298. In an embodiment, the compound is Z299. In an embodiment, the compound is Z300. In an embodiment, the compound is Z301. In an embodiment, the compound is Z302. In an embodiment, the compound is Z303. In an embodiment, the compound is Z304. In an embodiment, the compound is Z305. In an embodiment, the compound is Z306. In an embodiment, the compound is Z307. In an embodiment, the compound is Z308. In an embodiment, the compound is Z309. In an embodiment, the compound is Z310. In an embodiment, the compound is Z311. In an embodiment, the compound is Z312. In an embodiment, the compound is Z313. In an embodiment, the compound is Z314. In an embodiment, the compound is Z315. In an embodiment, the compound is Z316. In an embodiment, the compound is Z317. In an embodiment, the compound is Z318. In an embodiment, the compound is Z319. In an embodiment, the compound is Z320. In an embodiment, the compound is Z321. In an embodiment, the compound is Z322. In an embodiment, the compound is Z323. In an embodiment, the compound is Z324. In an embodiment, the compound is Z325. In an embodiment, the compound is Z326. In an embodiment, the compound is Z327. In an embodiment, the compound is Z328. In an embodiment, the compound is Z329. In an embodiment, the compound is Z330. In an embodiment, the compound is Z331. In an embodiment, the compound is Z332. In an embodiment, the compound is Z333. In an embodiment, the compound is Z334. In an embodiment, the compound is Z335. In an embodiment, the compound is Z336. In an embodiment, the compound is Z337. In an embodiment, the compound is Z338. In an embodiment, the compound is Z339. In an embodiment, the compound is Z340. In an embodiment, the compound is Z341. In an embodiment, the compound is Z342. In an embodiment, the compound is Z343. In an embodiment, the compound is Z344. In an embodiment, the compound is Z345. In an embodiment, the compound is Z346. In an embodiment, the compound is Z347. In an embodiment, the compound is Z348. In an embodiment, the compound is Z349. In an embodiment, the compound is Z350. In an embodiment, the compound is Z351. In an embodiment, the compound is Z352. In an embodiment, the compound is Z353. In an embodiment, the compound is Z354. In an embodiment, the compound is Z355. In an embodiment, the compound is Z356. In an embodiment, the compound is Z357. In an embodiment, the compound is Z358. In an embodiment, the compound is Z359. In an embodiment, the compound is Z360. In an embodiment, the compound is Z361. In an embodiment, the compound is Z362. In an embodiment, the compound is Z363. In an embodiment, the compound is Z364. In an embodiment, the compound is Z365. In an embodiment, the compound is Z366. In an embodiment, the compound is Z367. In an embodiment, the compound is Z368. In the examples, the compound is Z369. In an embodiment, the compound is Z370. In an embodiment, the compound is Z371. In an embodiment, the compound is Z372. In embodiments, the compound is Z373. In an embodiment, the compound is Z374. In an embodiment, the compound is Z375. In an embodiment, the compound is Z376. In an embodiment, the compound is Z377. In an embodiment, the compound is Z378. In an embodiment, the compound is Z379. In an embodiment, the compound is Z380. In an embodiment, the compound is Z381. In an embodiment, the compound is Z382. In an embodiment, the compound is Z383. In an embodiment, the compound is Z384. In an embodiment, the compound is Z385. In an embodiment, compound is Z386. In an embodiment, the compound is Z387. In an embodiment, the compound is Z388. In an embodiment, the compound is Z389. In an embodiment, the compound is Z390. In an embodiment, the compound is Z391. In an embodiment, the compound is Z392. In an embodiment, the compound is Z393. In an embodiment, the compound is Z394. In an embodiment, the compound is Z395. In an embodiment, the compound is Z396. In an embodiment, the compound is Z397. In an embodiment, the compound is Z398. In an embodiment, the compound is Z399. In an embodiment, the compound is Z400. In an embodiment, the compound is Z401. In an embodiment, the compound is Z402. In an embodiment, the compound is Z403. In an embodiment, the compound is Z404. In an embodiment, the compound is Z405. In an embodiment, the compound is Z406. In an embodiment, the compound is Z407. In an embodiment, the compound is Z408. In an embodiment, the compound is Z409. In an embodiment, the compound is Z410. In an embodiment, the compound is Z411. In an embodiment, the compound is Z412. In an embodiment, the compound is Z413. In an embodiment, the compound is Z414. In an embodiment, the compound is Z415. In an embodiment, the compound is Z416. In an embodiment, the compound is Z417. In an embodiment, the compound is Z418. In an embodiment, the compound is Z419. In an embodiment, the compound is Z420. In an embodiment, the compound is Z421. In an embodiment, the compound is Z422. In an embodiment, the compound is Z423. In an embodiment, the compound is Z424. In an embodiment, the compound is Z425. In an embodiment, the compound is Z426. In an embodiment, the compound is Z427. In an embodiment, the compound is Z428. In an embodiment, the compound is Z429. In an embodiment, the compound is Z430. In an embodiment, the compound is Z431. In an embodiment, the compound is Z432. In an embodiment, the compound is Z433. In an embodiment, the compound is Z434. In an embodiment, the compound is Z435. In an embodiment, the compound is Z436. In an embodiment, the compound is Z437. In an embodiment, the compound is Z438. In an embodiment, the compound is Z439. In an embodiment, the compound is Z440. In an embodiment, the compound is Z441. In an embodiment, the compound is Z442. In an embodiment, the compound is Z443. In an embodiment, the compound is Z444. In an embodiment, the compound is Z445. In an embodiment, the compound is Z446. In an embodiment, the compound is Z447. In an embodiment, the compound is Z448. In an embodiment, the compound is Z449. In an embodiment, the compound is Z450. In an embodiment, the compound is Z451. In an embodiment, the compound is Z452. In an embodiment, the compound is Z453. In an embodiment, the compound is Z454. In an embodiment, the compound is Z455. In an embodiment, the compound is Z456. In an embodiment, the compound is Z457. In an embodiment, the compound is Z458. In an embodiment, the compound is Z459. In an embodiment, the compound is Z460. In an embodiment, the compound is Z461. In an embodiment, the compound is Z462. In an embodiment, the compound is Z463. In an embodiment, the compound is Z464. In an embodiment, the compound is Z465. In an embodiment, the compound is Z466. In an embodiment, the compound is Z467. In an embodiment, the compound is Z468. In an embodiment, the compound is Z469. In an embodiment, the compound is Z470. In an embodiment, the compound is Z471. In an embodiment, the compound is Z472. In an embodiment, the compound is Z473. In an embodiment, the compound is Z474. In an embodiment, the compound is Z475. In an embodiment, the compound is Z476. In an embodiment, the compound is Z477. In an embodiment, the compound is Z478. In an embodiment, the compound is Z479. In an embodiment, the compound is Z480. In an embodiment, the compound is Z481. In an embodiment, the compound is Z482. In an embodiment, the compound is Z483. In an embodiment, the compound is Z484. In an embodiment, the compound is Z485. In an embodiment, the compound is Z486. In an embodiment, the compound is Z487. In embodiments, the compound is Z488. In an embodiment, the compound is Z489. In an embodiment, the compound is Z490. In an embodiment, the compound is Z491. In an embodiment, the compound is Z492. In an embodiment, the compound is Z493. In an embodiment, the compound is Z494. In an embodiment, the compound is Z495. In an embodiment, the compound is Z496. In an embodiment, the compound is Z497. In an embodiment, the compound is Z498. In the examples, the compound is Z499. In an embodiment, the compound is Z500. In an embodiment, the compound is Z501. In an embodiment, the compound is Z502. In an embodiment, the compound is Z503. In an embodiment, the compound is Z504. In an embodiment, the compound is Z505. In an embodiment, the compound is Z506. In an embodiment, the compound is Z507. In an embodiment, the compound is Z508. In an embodiment, the compound is Z509. In an embodiment, the compound is Z510. In an embodiment, the compound is Z511. In an embodiment, the compound is Z512. In an embodiment, the compound is Z513. In an embodiment, the compound is Z514. In an embodiment, the compound is Z515. In an embodiment, the compound is Z516. In an embodiment, the compound is Z517. In an embodiment, the compound is Z518. In an embodiment, the compound is Z519. In an embodiment, the compound is Z520. In an embodiment, the compound is Z521. In an embodiment, the compound is Z522. In an embodiment, the compound is Z523. In an embodiment, the compound is Z524. In an embodiment, the compound is Z525. In an embodiment, the compound is Z526. In an embodiment, the compound is Z527. In an embodiment, the compound is Z528. In an embodiment, the compound is Z529. In an embodiment, the compound is Z530. In an embodiment, the compound is Z531. In an embodiment, the compound is Z532. In an embodiment, the compound is Z533. In an embodiment, the compound is Z534. In an embodiment, the compound is Z535. In an embodiment, the compound is Z536. In an embodiment, the compound is Z537. In an embodiment, the compound is Z538. In an embodiment, the compound is Z539. In an embodiment, the compound is Z540. In an embodiment, the compound is Z541. In an embodiment, the compound is Z542. In an embodiment, the compound is Z543. In an embodiment, the compound is Z544. In an embodiment, the compound is Z545. In an embodiment, the compound is Z546. In an embodiment, the compound is Z547. In an embodiment, the compound is Z548. In an embodiment, the compound is Z549. In an embodiment, the compound is Z550. In an embodiment, the compound is Z551. In an embodiment, the compound is Z552. In an embodiment, the compound is Z553. In an embodiment, the compound is Z554. In an embodiment, the compound is Z555. In an embodiment, the compound is Z556. In an embodiment, the compound is Z557. In an embodiment, the compound is Z558. In an embodiment, the compound is Z559. In an embodiment, the compound is Z560. In an embodiment, the compound is Z561. In an embodiment, the compound is Z562. In an embodiment, the compound is Z563. In an embodiment, the compound is Z564. In an embodiment, the compound is Z565. In an embodiment, the compound is Z566. In an embodiment, the compound is Z567. In an embodiment, the compound is Z568. In an embodiment, the compound is Z569. In an embodiment, the compound is Z570. In an embodiment, the compound is Z571. In an embodiment, the compound is Z572. In an embodiment, the compound is Z573. In an embodiment, the compound is Z574. In an embodiment, the compound is Z575. In an embodiment, the compound is Z576. In an embodiment, the compound is Z577. In an embodiment, the compound is Z578. In an embodiment, the compound is Z579. In an embodiment, the compound is Z580. In an embodiment, the compound is Z581. In an embodiment, the compound is Z582. In an embodiment, the compound is Z583. In an embodiment, the compound is Z584. In an embodiment, the compound is Z585. In an embodiment, the compound is Z586. In an embodiment, the compound is Z587. In an embodiment, the compound is Z588. In an embodiment, the compound is Z589. In an embodiment, the compound is Z590. In an embodiment, the compound is Z591. In an embodiment, the compound is Z592. In an embodiment, the compound is Z593. In an embodiment, the compound is Z594. In an embodiment, the compound is Z595. In an embodiment, the compound is Z596. In an embodiment, the compound is Z597. In an embodiment, the compound is Z598. In an embodiment, the compound is Z599. In an embodiment, the compound is Z600. In an embodiment, the compound is Z601. In an embodiment, the compound is Z602. In an embodiment, the compound is Z603. In an embodiment, the compound is Z604. In an embodiment, the compound is Z605. In an embodiment, the compound is Z606. In an embodiment, the compound is Z607. In an embodiment, the compound is Z608. In an embodiment, the compound is Z609. In an embodiment, the compound is Z610. In an embodiment, the compound is Z611. In an embodiment, the compound is Z612. In an embodiment, the compound is Z613. In an embodiment, the compound is Z614. In an embodiment, the compound is Z615. In an embodiment, the compound is Z616. In an embodiment, the compound is Z617. In an embodiment, the compound is Z618. In an embodiment, the compound is Z619. In an embodiment, the compound is Z620. In an embodiment, the compound is Z621. In an embodiment, the compound is Z622. In an embodiment, the compound is Z623. In an embodiment, the compound is Z624. In an embodiment, the compound is Z625. In an embodiment, the compound is Z626. In an embodiment, the compound is Z627. In an embodiment, the compound is Z628. In an embodiment, the compound is Z629. In an embodiment, the compound is Z630. In an embodiment, the compound is Z631. In an embodiment, the compound is Z632. In an embodiment, the compound is Z633. In an embodiment, the compound is Z634. In an embodiment, the compound is Z635. In an embodiment, the compound is Z636. In an embodiment, the compound is Z637. In an embodiment, the compound is Z638. In an embodiment, the compound is Z639. In an embodiment, the compound is Z640. In an embodiment, the compound is Z641. In an embodiment, the compound is Z642. In an embodiment, the compound is Z643. In an embodiment, the compound is Z644. In the examples, the compound is Z645. In an embodiment, the compound is Z646. In an embodiment, the compound is Z647.

In the examples, the compound is not:

in the examples, the compounds are notIn the examples, the compounds are notIn the examples, the compounds are not

Figure BDA0002469898950002492

In the examples, the compounds are notIn the examples, the compounds are not

Figure BDA0002469898950002494

In the examples, the compounds are notIn the examples, the compounds are notIn the examples, the compounds are not

Figure BDA0002469898950002497

In the examples, the compounds are notIn the examples, the compounds are notIn the examples, the compounds are notIn the examples, the compounds are notIn the examples, the compounds are not

Figure BDA00024698989500024912

In the examples, the compounds are not

Figure BDA00024698989500024913

In the examples, when R2And R3R forms unsubstituted heterocycloalkyl and z1 is 04Is not hydrogen. In the examples, when R2Or R3Is hydrogen and L1When it is an unsubstituted methylene group, R4Is not hydrogen. In the examples, when R2When is hydrogen, R3Is not unsubstituted cyclopropyl.

In the examples, when R2And R3R forms unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl) and z1 is 04Is not hydrogen. In the examples, when R2And R3R when unsubstituted 3-to 8-membered heterocycloalkyl is formed and z1 is 04Is not hydrogen. In the examples, when R2And R3R when unsubstituted 5-to 6-membered heterocycloalkyl is formed and z1 is 04Is not hydrogen. In the examples, when R2And R3R forms an unsubstituted 5-membered heterocycloalkyl group and z1 is 04Is not hydrogen. In the examples, when R2And R3Form an unsubstituted 6-membered heterocycloalkyl group and z1 is 0,R4Is not hydrogen. In the examples, R2And R3Unsubstituted 6-membered heterocycloalkyl is not formed. In the examples, R2And R3Unsubstituted 5-membered heterocycloalkyl is not formed.

In the examples, when R2And R3R when R forms a substituted or unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl) and z1 is 04Is not hydrogen. In the examples, when R2And R3R when forming a substituted or unsubstituted 3-to 8-membered heterocycloalkyl group and z1 is 04Is not hydrogen. In the examples, when R2And R3R when forming a substituted or unsubstituted 5-to 6-membered heterocycloalkyl group and z1 is 04Is not hydrogen. In the examples, when R2And R3R forms a substituted or unsubstituted 5-membered heterocycloalkyl group and z1 is 04Is not hydrogen. In the examples, when R2And R3R forms a substituted or unsubstituted 6-membered heterocycloalkyl group and z1 is 04Is not hydrogen. In the examples, R2And R3A substituted or unsubstituted 6-membered heterocycloalkyl group is not formed. In the examples, R2And R3A substituted or unsubstituted 5-membered heterocycloalkyl group is not formed.

In the examples, when R2Or R3Is hydrogen and L1Is unsubstituted alkylene (e.g. C)1-C8Alkylene radical, C1-C6Alkylene or C1-C4Alkylene) of R4Is not hydrogen. In the examples, when R2Or R3Is hydrogen and L1Is unsubstituted C1-C8When it is alkylene, R4Is not hydrogen. In the examples, when R2Or R3Is hydrogen and L1Is unsubstituted C1-C6When it is alkylene, R4Is not hydrogen. In the examples, when R2Or R3Is hydrogen and L1Is unsubstituted C1-C4When it is alkylene, R4Is not hydrogen. In the examples, when R2Or R3Is hydrogen and L1Is unsubstituted C1-C2When it is alkylene, R4Is not hydrogen. In the examples, when R2Or R3When is hydrogen, L1C not unsubstituted1-C2An alkylene group. In the examples, when R2Or R3When is hydrogen, L1C not unsubstituted1-C4An alkylene group.

In the examples, when R2Or R3Is hydrogen and L1Is a substituted or unsubstituted alkylene (e.g., C)1-C8Alkylene radical, C1-C6Alkylene or C1-C4Alkylene) of R4Is not hydrogen. In the examples, when R2Or R3Is hydrogen and L1Is substituted or unsubstituted C1-C8When it is alkylene, R4Is not hydrogen. In the examples, when R2Or R3Is hydrogen and L1Is substituted or unsubstituted C1-C6When it is alkylene, R4Is not hydrogen. In the examples, when R2Or R3Is hydrogen and L1Is substituted or unsubstituted C1-C4When it is alkylene, R4Is not hydrogen. In the examples, when R2Or R3Is hydrogen and L1Is substituted or unsubstituted C1-C2When it is alkylene, R4Is not hydrogen. In the examples, when R2Or R3When is hydrogen, L1C which is not substituted or unsubstituted1-C2An alkylene group. In the examples, when R2Or R3When is hydrogen, L1C which is not substituted or unsubstituted1-C4An alkylene group.

In the examples, when R2When is hydrogen, R3Is not unsubstituted cyclopropyl. In the examples, when R2When is hydrogen, R3Cycloalkyl other than unsubstituted (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, when R2When is hydrogen, R3Is not provided withUnsubstituted C3-C8A cycloalkyl group. In the examples, when R2When is hydrogen, R3C not unsubstituted3-C6A cycloalkyl group. In the examples, when R2When is hydrogen, R3C not unsubstituted5-C6A cycloalkyl group.

In the examples, when R2When is hydrogen, R3Is not a substituted or unsubstituted cyclopropyl group. In the examples, when R2When is hydrogen, R3Cycloalkyl which is not substituted or unsubstituted (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, when R2When is hydrogen, R3C which is not substituted or unsubstituted3-C8A cycloalkyl group. In the examples, when R2When is hydrogen, R3C which is not substituted or unsubstituted3-C6A cycloalkyl group. In the examples, when R2When is hydrogen, R3C which is not substituted or unsubstituted5-C6A cycloalkyl group.

In the examples, R4Is not hydrogen. In the examples, R2Or R3Is not hydrogen. In the examples, L1Is not an unsubstituted methylene group. In the examples, R3Is not unsubstituted cyclopropyl.

In the examples, when R2And R3When unsubstituted heterocycloalkyl (e.g., 3-to 8-membered heterocycloalkyl, 3-to 6-membered heterocycloalkyl, or 5-to 6-membered heterocycloalkyl) is formed, R4Is not hydrogen. In the examples, when R2And R3When unsubstituted 3-to 8-membered heterocycloalkyl is formed, R4Is not hydrogen. In the examples, when R2And R3When unsubstituted 5-to 6-membered heterocycloalkyl is formed, R4Is not hydrogen. In the examples, when R2And R3When unsubstituted 5-membered heterocycloalkyl is formed, R4Is not hydrogen. In the examples, when R2And R3When unsubstituted 6-membered heterocycloalkyl is formed, R4Is not hydrogen. In the examples, R2And R3Unsubstituted 6-membered heterocycloalkyl is not formed. In the examples, R2And R3Unsubstituted 5-membered heterocycloalkyl is not formed.

In the examples, when L1Is unsubstituted alkylene (e.g. C)1-C8Alkylene radical, C1-C6Alkylene or C1-C4Alkylene) of R4Is not hydrogen. In the examples, when L1Is unsubstituted C1-C8When it is alkylene, R4Is not hydrogen. In the examples, when L1Is unsubstituted C1-C6When it is alkylene, R4Is not hydrogen. In the examples, when L1Is unsubstituted C1-C4When it is alkylene, R4Is not hydrogen. In the examples, when L1Is unsubstituted C1-C2When it is alkylene, R4Is not hydrogen. In the examples, L1C not unsubstituted1-C2An alkylene group. In the examples, L1C not unsubstituted1-C4An alkylene group.

In the examples, R3Is not unsubstituted cyclopropyl. In the examples, R3Cycloalkyl other than unsubstituted (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R3C not unsubstituted3-C8A cycloalkyl group. In the examples, R3C not unsubstituted3-C6A cycloalkyl group. In the examples, R3C not unsubstituted5-C6A cycloalkyl group. In the examples, R2Is not unsubstituted cyclopropyl. In the examples, R2Cycloalkyl other than unsubstituted (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R2C not unsubstituted3-C8A cycloalkyl group. In the examples, R2C not unsubstituted3-C6A cycloalkyl group. In the examples, R2C not unsubstituted5-C6A cycloalkyl group.

In the examples, R3Is not a substituted or unsubstituted cyclopropyl group. In the examples, R3Cycloalkyl which is not substituted or unsubstituted (e.g. C)3-C8Cycloalkyl radical, C3-C6Cycloalkyl or C5-C6Cycloalkyl groups). In the examples, R3C which is not substituted or unsubstituted3-C8A cycloalkyl group. In the examples, R3C which is not substituted or unsubstituted3-C6A cycloalkyl group. In the examples, R3C which is not substituted or unsubstituted5-C6A cycloalkyl group.

In an embodiment, the compound is not Z1. In an embodiment, the compound is not Z2. In an embodiment, the compound is not Z3. In an embodiment, the compound is not Z4. In an embodiment, the compound is not Z5. In an embodiment, the compound is not Z6. In an embodiment, the compound is not Z7. In an embodiment, the compound is not Z8. In an embodiment, the compound is not Z9. In an embodiment, the compound is not Z10. In an embodiment, the compound is not Z11. In an embodiment, the compound is not Z12. In an embodiment, the compound is not Z13. In an embodiment, the compound is not Z14. In an embodiment, the compound is not Z15. In an embodiment, the compound is not Z16. In an embodiment, the compound is not Z17. In an embodiment, the compound is not Z18. In an embodiment, the compound is not Z19. In an embodiment, the compound is not Z20. In an embodiment, the compound is not Z21. In an embodiment, the compound is not Z22. In an embodiment, the compound is not Z23. In an embodiment, the compound is not Z24. In an embodiment, the compound is not Z25. In an embodiment, the compound is not Z26. In an embodiment, the compound is not Z27. In an embodiment, the compound is not Z28. In an embodiment, the compound is not Z29. In an embodiment, the compound is not Z30. In an embodiment, the compound is not Z31. In an embodiment, the compound is not Z32. In an embodiment, the compound is not Z33. In an embodiment, the compound is not Z34. In an embodiment, the compound is not Z35. In an embodiment, the compound is not Z36. In an embodiment, the compound is not Z37. In an embodiment, the compound is not Z38. In an embodiment, the compound is not Z39. In an embodiment, the compound is not Z40. In an embodiment, the compound is not Z41. In an embodiment, the compound is not Z42. In an embodiment, the compound is not Z43. In an embodiment, the compound is not Z44. In an embodiment, the compound is not Z45. In an embodiment, the compound is not Z46. In an embodiment, the compound is not Z47. In an embodiment, the compound is not Z48. In an embodiment, the compound is not Z49. In an embodiment, the compound is not Z50. In an embodiment, the compound is not Z51. In an embodiment, the compound is not Z52. In an embodiment, the compound is not Z53. In an embodiment, the compound is not Z54. In an embodiment, the compound is not Z55. In an embodiment, the compound is not Z56. In an embodiment, the compound is not Z57. In an embodiment, the compound is not Z58. In an embodiment, the compound is not Z59. In an embodiment, the compound is not Z60. In an embodiment, the compound is not Z61. In an embodiment, the compound is not Z62. In an embodiment, the compound is not Z63. In an embodiment, the compound is not Z64. In an embodiment, the compound is not Z65. In an embodiment, the compound is not Z66. In an embodiment, the compound is not Z67. In an embodiment, the compound is not Z68. In an embodiment, the compound is not Z69. In an embodiment, the compound is not Z70. In an embodiment, the compound is not Z71. In an embodiment, the compound is not Z72. In an embodiment, the compound is not Z73. In an embodiment, the compound is not Z74. In an embodiment, the compound is not Z75. In an embodiment, the compound is not Z76. In an embodiment, the compound is not Z77. In an embodiment, the compound is not Z78. In an embodiment, the compound is not Z79. In an embodiment, the compound is not Z80. In an embodiment, the compound is not Z81. In an embodiment, the compound is not Z82. In an embodiment, the compound is not Z83. In an embodiment, the compound is not Z84. In an embodiment, the compound is not Z85. In an embodiment, the compound is not Z86. In an embodiment, the compound is not Z87. In an embodiment, the compound is not Z88. In an embodiment, the compound is not Z89. In an embodiment, the compound is not Z90. In an embodiment, the compound is not Z91. In an embodiment, the compound is not Z92. In an embodiment, the compound is not Z93. In an embodiment, the compound is not Z94. In an embodiment, the compound is not Z95. In an embodiment, the compound is not Z96. In an embodiment, the compound is not Z97. In an embodiment, the compound is not Z98. In an embodiment, the compound is not Z99. In embodiments, the compound is not Z100. In an embodiment, the compound is not Z101. In embodiments, the compound is not Z102. In embodiments, the compound is not Z103. In embodiments, the compound is not Z104. In an embodiment, the compound is not Z105. In an embodiment, the compound is not Z106. In an embodiment, the compound is not Z107. In an embodiment, the compound is not Z108. In an embodiment, the compound is not Z109. In an embodiment, the compound is not Z110. In embodiments, the compound is not Z111. In an embodiment, the compound is not Z112. In an embodiment, the compound is not Z113. In an embodiment, the compound is not Z114. In an embodiment, the compound is not Z115. In embodiments, the compound is not Z116. In an embodiment, the compound is not Z117. In embodiments, the compound is not Z118. In an embodiment, the compound is not Z119. In embodiments, the compound is not Z120. In an embodiment, the compound is not Z121. In an embodiment, the compound is not Z122. In an embodiment, the compound is not Z123. In an embodiment, the compound is not Z124. In embodiments, the compound is not Z125. In an embodiment, the compound is not Z126. In an embodiment, the compound is not Z127. In embodiments, the compound is not Z128. In an embodiment, the compound is not Z129. In an embodiment, the compound is not Z130. In an embodiment, the compound is not Z131. In an embodiment, the compound is not Z132. In an embodiment, the compound is not Z133. In an embodiment, the compound is not Z134. In an embodiment, the compound is not Z135. In an embodiment, the compound is not Z136. In an embodiment, the compound is not Z137. In an embodiment, the compound is not Z138. In an embodiment, the compound is not Z139. In an embodiment, the compound is not Z140. In an embodiment, the compound is not Z141. In an embodiment, the compound is not Z142. In an embodiment, the compound is not Z143. In an embodiment, the compound is not Z144. In embodiments, the compound is not Z145. In an embodiment, the compound is not Z146. In the examples, the compound is not Z147. In an embodiment, the compound is not Z148. In an embodiment, the compound is not Z149. In an embodiment, the compound is not Z150. In an embodiment, the compound is not Z151. In embodiments, the compound is not Z152. In an embodiment, the compound is not Z153. In an embodiment, the compound is not Z154. In an embodiment, the compound is not Z155. In an embodiment, the compound is not Z156. In an embodiment, the compound is not Z157. In an embodiment, the compound is not Z158. In an embodiment, the compound is not Z159. In an embodiment, the compound is not Z160. In an embodiment, the compound is not Z161. In an embodiment, the compound is not Z162. In an embodiment, the compound is not Z163. In embodiments, the compound is not Z164. In an embodiment, the compound is not Z165. In an embodiment, the compound is not Z166. In embodiments, the compound is not Z167. In an embodiment, the compound is not Z168. In an embodiment, the compound is not Z169. In an embodiment, the compound is not Z170. In an embodiment, the compound is not Z171. In embodiments, the compound is not Z172. In an embodiment, the compound is not Z173. In embodiments, the compound is not Z174. In an embodiment, the compound is not Z175. In embodiments, the compound is not Z176. In the examples, the compound is not Z177. In an embodiment, the compound is not Z178. In the examples, the compound is not Z179. In an embodiment, the compound is not Z180. In an embodiment, the compound is not Z181. In an embodiment, the compound is not Z182. In an embodiment, the compound is not Z183. In an embodiment, the compound is not Z184. In an embodiment, the compound is not Z185. In an embodiment, the compound is not Z186. In an embodiment, the compound is not Z187. In an embodiment, the compound is not Z188. In an embodiment, the compound is not Z189. In an embodiment, the compound is not Z190. In an embodiment, the compound is not Z191. In an embodiment, the compound is not Z192. In an embodiment, the compound is not Z193. In an embodiment, the compound is not Z194. In an embodiment, the compound is not Z195. In an embodiment, the compound is not Z196. In an embodiment, the compound is not Z197. In an embodiment, the compound is not Z198. In an embodiment, the compound is not Z199. In an embodiment, the compound is not Z200. In an embodiment, the compound is not Z201. In an embodiment, the compound is not Z202. In an embodiment, the compound is not Z203. In an embodiment, the compound is not Z204. In an embodiment, the compound is not Z205. In an embodiment, the compound is not Z206. In an embodiment, the compound is not Z207. In an embodiment, the compound is not Z208. In an embodiment, the compound is not Z209. In an embodiment, the compound is not Z210. In an embodiment, the compound is not Z211. In an embodiment, the compound is not Z212. In an embodiment, the compound is not Z213. In embodiments, the compound is not Z214. In an embodiment, the compound is not Z215. In an embodiment, the compound is not Z216. In an embodiment, the compound is not Z217. In an embodiment, the compound is not Z218. In an embodiment, the compound is not Z219. In an embodiment, the compound is not Z220. In an embodiment, the compound is not Z221. In an embodiment, the compound is not Z222. In an embodiment, the compound is not Z223. In an embodiment, the compound is not Z224. In an embodiment, the compound is not Z225. In an embodiment, the compound is not Z226. In an embodiment, the compound is not Z227. In an embodiment, the compound is not Z228. In an embodiment, the compound is not Z229. In an embodiment, the compound is not Z230. In embodiments, the compound is not Z231. In an embodiment, the compound is not Z232. In an embodiment, the compound is not Z233. In an embodiment, the compound is not Z234. In an embodiment, the compound is not Z235. In an embodiment, the compound is not Z236. In embodiments, the compound is not Z237. In an embodiment, the compound is not Z238. In embodiments, the compound is not Z239. In an embodiment, the compound is not Z240. In an embodiment, the compound is not Z241. In an embodiment, the compound is not Z242. In an embodiment, the compound is not Z243. In an embodiment, the compound is not Z244. In an embodiment, the compound is not Z245. In an embodiment, the compound is not Z246. In an embodiment, the compound is not Z247. In embodiments, the compound is not Z248. In the examples, the compound is not Z249. In an embodiment, the compound is not Z250. In an embodiment, the compound is not Z251. In an embodiment, the compound is not Z252. In an embodiment, the compound is not Z253. In an embodiment, the compound is not Z254. In an embodiment, the compound is not Z255. In an embodiment, the compound is not Z256. In the examples, the compound is not Z257. In an embodiment, the compound is not Z258. In an embodiment, the compound is not Z259. In embodiments, the compound is not Z260. In an embodiment, the compound is not Z261. In an embodiment, the compound is not Z262. In an embodiment, the compound is not Z263. In an embodiment, the compound is not Z264. In an embodiment, the compound is not Z265. In an embodiment, the compound is not Z266. In an embodiment, the compound is not Z267. In an embodiment, the compound is not Z268. In an embodiment, the compound is not Z269. In an embodiment, the compound is not Z270. In an embodiment, the compound is not Z271. In embodiments, the compound is not Z272. In embodiments, the compound is not Z273. In an embodiment, the compound is not Z274. In an embodiment, the compound is not Z275. In an embodiment, the compound is not Z276. In an embodiment, the compound is not Z277. In an embodiment, the compound is not Z278. In an embodiment, the compound is not Z279. In an embodiment, the compound is not Z280. In an embodiment, the compound is not Z281. In an embodiment, the compound is not Z282. In an embodiment, the compound is not Z283. In an embodiment, the compound is not Z284. In an embodiment, the compound is not Z285. In embodiments, the compound is not Z286. In embodiments, the compound is not Z287. In embodiments, the compound is not Z288. In the examples, the compound is not Z289. In an embodiment, the compound is not Z290. In an embodiment, the compound is not Z291. In an embodiment, the compound is not Z292. In an embodiment, the compound is not Z293. In embodiments, the compound is not Z294. In an embodiment, the compound is not Z295. In an embodiment, the compound is not Z296. In an embodiment, the compound is not Z297. In an embodiment, the compound is not Z298. In embodiments, the compound is not Z299. In an embodiment, the compound is not Z300. In an embodiment, the compound is not Z301. In an embodiment, the compound is not Z302. In an embodiment, the compound is not Z303. In an embodiment, the compound is not Z304. In an embodiment, the compound is not Z305. In an embodiment, the compound is not Z306. In an embodiment, the compound is not Z307. In an embodiment, the compound is not Z308. In an embodiment, the compound is not Z309. In an embodiment, the compound is not Z310. In embodiments, the compound is not Z311. In an embodiment, the compound is not Z312. In an embodiment, the compound is not Z313. In an embodiment, the compound is not Z314. In an embodiment, the compound is not Z315. In an embodiment, the compound is not Z316. In an embodiment, the compound is not Z317. In an embodiment, the compound is not Z318. In embodiments, the compound is not Z319. In an embodiment, the compound is not Z320. In an embodiment, the compound is not Z321. In embodiments, the compound is not Z322. In an embodiment, the compound is not Z323. In an embodiment, the compound is not Z324. In an embodiment, the compound is not Z325. In an embodiment, the compound is not Z326. In an embodiment, the compound is not Z327. In an embodiment, the compound is not Z328. In an embodiment, the compound is not Z329. In an embodiment, the compound is not Z330. In an embodiment, the compound is not Z331. In an embodiment, the compound is not Z332. In an embodiment, the compound is not Z333. In an embodiment, the compound is not Z334. In an embodiment, the compound is not Z335. In an embodiment, the compound is not Z336. In an embodiment, the compound is not Z337. In an embodiment, the compound is not Z338. In an embodiment, the compound is not Z339. In an embodiment, the compound is not Z340. In an embodiment, the compound is not Z341. In an embodiment, the compound is not Z342. In an embodiment, the compound is not Z343. In an embodiment, the compound is not Z344. In an embodiment, the compound is not Z345. In an embodiment, the compound is not Z346. In an embodiment, the compound is not Z347. In an embodiment, the compound is not Z348. In embodiments, the compound is not Z349. In an embodiment, the compound is not Z350. In an embodiment, the compound is not Z351. In an embodiment, the compound is not Z352. In the examples, the compound is not Z353. In an embodiment, the compound is not Z354. In an embodiment, the compound is not Z355. In an embodiment, the compound is not Z356. In embodiments, the compound is not Z357. In an embodiment, the compound is not Z358. In an embodiment, the compound is not Z359. In an embodiment, the compound is not Z360. In an embodiment, the compound is not Z361. In an embodiment, the compound is not Z362. In embodiments, the compound is not Z363. In an embodiment, the compound is not Z364. In an embodiment, the compound is not Z365. In an embodiment, the compound is not Z366. In an embodiment, the compound is not Z367. In an embodiment, the compound is not Z368. In the examples, the compound is not Z369. In an embodiment, the compound is not Z370. In an embodiment, the compound is not Z371. In an embodiment, the compound is not Z372. In embodiments, the compound is not Z373. In an embodiment, the compound is not Z374. In an embodiment, the compound is not Z375. In an embodiment, the compound is not Z376. In an embodiment, the compound is not Z377. In an embodiment, the compound is not Z378. In an embodiment, the compound is not Z379. In an embodiment, the compound is not Z380. In an embodiment, the compound is not Z381. In an embodiment, the compound is not Z382. In an embodiment, the compound is not Z383. In an embodiment, the compound is not Z384. In an embodiment, the compound is not Z385. In an embodiment, the compound is not Z386. In an embodiment, the compound is not Z387. In an embodiment, the compound is not Z388. In an embodiment, the compound is not Z389. In embodiments, the compound is not Z390. In an embodiment, the compound is not Z391. In embodiments, the compound is not Z392. In the examples, the compound is not Z393. In an embodiment, the compound is not Z394. In embodiments, the compound is not Z395. In the examples, the compound is not Z396. In embodiments, the compound is not Z397. In an embodiment, the compound is not Z398. In embodiments, the compound is not Z399. In an embodiment, the compound is not Z400. In an embodiment, the compound is not Z401. In an embodiment, the compound is not Z402. In an embodiment, the compound is not Z403. In an embodiment, the compound is not Z404. In an embodiment, the compound is not Z405. In an embodiment, the compound is not Z406. In an embodiment, the compound is not Z407. In an embodiment, the compound is not Z408. In an embodiment, the compound is not Z409. In an embodiment, the compound is not Z410. In an embodiment, the compound is not Z411. In an embodiment, the compound is not Z412. In an embodiment, the compound is not Z413. In an embodiment, the compound is not Z414. In embodiments, the compound is not Z415. In embodiments, the compound is not Z416. In embodiments, the compound is not Z417. In embodiments, the compound is not Z418. In an embodiment, the compound is not Z419. In an embodiment, the compound is not Z420. In an embodiment, the compound is not Z421. In an embodiment, the compound is not Z422. In an embodiment, the compound is not Z423. In an embodiment, the compound is not Z424. In embodiments, the compound is not Z425. In an embodiment, the compound is not Z426. In an embodiment, the compound is not Z427. In an embodiment, the compound is not Z428. In the examples, the compound is not Z429. In an embodiment, the compound is not Z430. In an embodiment, the compound is not Z431. In an embodiment, the compound is not Z432. In an embodiment, the compound is not Z433. In an embodiment, the compound is not Z434. In an embodiment, the compound is not Z435. In an embodiment, the compound is not Z436. In embodiments, the compound is not Z437. In an embodiment, the compound is not Z438. In embodiments, the compound is not Z439. In an embodiment, the compound is not Z440. In an embodiment, the compound is not Z441. In an embodiment, the compound is not Z442. In an embodiment, the compound is not Z443. In an embodiment, the compound is not Z444. In an embodiment, the compound is not Z445. In an embodiment, the compound is not Z446. In an embodiment, the compound is not Z447. In an embodiment, the compound is not Z448. In an embodiment, the compound is not Z449. In embodiments, the compound is not Z450. In an embodiment, the compound is not Z451. In an embodiment, the compound is not Z452. In an embodiment, the compound is not Z453. In an embodiment, the compound is not Z454. In an embodiment, the compound is not Z455. In an embodiment, the compound is not Z456. In an embodiment, the compound is not Z457. In an embodiment, the compound is not Z458. In an embodiment, the compound is not Z459. In an embodiment, the compound is not Z460. In an embodiment, the compound is not Z461. In an embodiment, the compound is not Z462. In embodiments, the compound is not Z463. In an embodiment, the compound is not Z464. In an embodiment, the compound is not Z465. In an embodiment, the compound is not Z466. In embodiments, the compound is not Z467. In an embodiment, the compound is not Z468. In the examples, the compound is not Z469. In an embodiment, the compound is not Z470. In an embodiment, the compound is not Z471. In an embodiment, the compound is not Z472. In an embodiment, the compound is not Z473. In an embodiment, the compound is not Z474. In embodiments, the compound is not Z475. In an embodiment, the compound is not Z476. In an embodiment, the compound is not Z477. In an embodiment, the compound is not Z478. In an embodiment, the compound is not Z479. In an embodiment, the compound is not Z480. In an embodiment, the compound is not Z481. In an embodiment, the compound is not Z482. In an embodiment, the compound is not Z483. In an embodiment, the compound is not Z484. In an embodiment, the compound is not Z485. In an embodiment, the compound is not Z486. In an embodiment, the compound is not Z487. In embodiments, the compound is not Z488. In the examples, the compound is not Z489. In an embodiment, the compound is not Z490. In an embodiment, the compound is not Z491. In an embodiment, the compound is not Z492. In embodiments, the compound is not Z493. In an embodiment, the compound is not Z494. In the examples, the compound is not Z495. In an embodiment, the compound is not Z496. In an embodiment, the compound is not Z497. In embodiments, the compound is not Z498. In the examples, the compound is not Z499. In an embodiment, the compound is not Z500. In an embodiment, the compound is not Z501. In an embodiment, the compound is not Z502. In an embodiment, the compound is not Z503. In an embodiment, the compound is not Z504. In an embodiment, the compound is not Z505. In an embodiment, the compound is not Z506. In an embodiment, the compound is not Z507. In an embodiment, the compound is not Z508. In an embodiment, the compound is not Z509. In an embodiment, the compound is not Z510. In an embodiment, the compound is not Z511. In an embodiment, the compound is not Z512. In an embodiment, the compound is not Z513. In an embodiment, the compound is not Z514. In an embodiment, the compound is not Z515. In an embodiment, the compound is not Z516. In an embodiment, the compound is not Z517. In an embodiment, the compound is not Z518. In an embodiment, the compound is not Z519. In an embodiment, the compound is not Z520. In an embodiment, the compound is not Z521. In an embodiment, the compound is not Z522. In an embodiment, the compound is not Z523. In an embodiment, the compound is not Z524. In an embodiment, the compound is not Z525. In an embodiment, the compound is not Z526. In the examples, the compound is not Z527. In an embodiment, the compound is not Z528. In an embodiment, the compound is not Z529. In an embodiment, the compound is not Z530. In an embodiment, the compound is not Z531. In an embodiment, the compound is not Z532. In an embodiment, the compound is not Z533. In an embodiment, the compound is not Z534. In embodiments, the compound is not Z535. In an embodiment, the compound is not Z536. In an embodiment, the compound is not Z537. In an embodiment, the compound is not Z538. In the examples, the compound is not Z539. In an embodiment, the compound is not Z540. In an embodiment, the compound is not Z541. In an embodiment, the compound is not Z542. In an embodiment, the compound is not Z543. In an embodiment, the compound is not Z544. In an embodiment, the compound is not Z545. In an embodiment, the compound is not Z546. In an embodiment, the compound is not Z547. In an embodiment, the compound is not Z548. In an embodiment, the compound is not Z549. In an embodiment, the compound is not Z550. In an embodiment, the compound is not Z551. In an embodiment, the compound is not Z552. In an embodiment, the compound is not Z553. In an embodiment, the compound is not Z554. In embodiments, the compound is not Z555. In an embodiment, the compound is not Z556. In an embodiment, the compound is not Z557. In an embodiment, the compound is not Z558. In an embodiment, the compound is not Z559. In an embodiment, the compound is not Z560. In an embodiment, the compound is not Z561. In an embodiment, the compound is not Z562. In an embodiment, the compound is not Z563. In an embodiment, the compound is not Z564. In an embodiment, the compound is not Z565. In an embodiment, the compound is not Z566. In an embodiment, the compound is not Z567. In an embodiment, the compound is not Z568. In an embodiment, the compound is not Z569. In an embodiment, the compound is not Z570. In an embodiment, the compound is not Z571. In an embodiment, the compound is not Z572. In an embodiment, the compound is not Z573. In an embodiment, the compound is not Z574. In an embodiment, the compound is not Z575. In an embodiment, the compound is not Z576. In embodiments, the compound is not Z577. In an embodiment, the compound is not Z578. In embodiments, the compound is not Z579. In an embodiment, the compound is not Z580. In an embodiment, the compound is not Z581. In an embodiment, the compound is not Z582. In the examples, the compound is not Z583. In an embodiment, the compound is not Z584. In an embodiment, the compound is not Z585. In an embodiment, the compound is not Z586. In the examples, the compound is not Z587. In an embodiment, the compound is not Z588. In the examples, the compound is not Z589. In embodiments, the compound is not Z590. In an embodiment, the compound is not Z591. In an embodiment, the compound is not Z592. In an embodiment, the compound is not Z593. In an embodiment, the compound is not Z594. In an embodiment, the compound is not Z595. In an embodiment, the compound is not Z596. In an embodiment, the compound is not Z597. In an embodiment, the compound is not Z598. In an embodiment, the compound is not Z599. In an embodiment, the compound is not Z600. In an embodiment, the compound is not Z601. In an embodiment, the compound is not Z602. In the examples, the compound is not Z603. In an embodiment, the compound is not Z604. In an embodiment, the compound is not Z605. In an embodiment, the compound is not Z606. In an embodiment, the compound is not Z607. In an embodiment, the compound is not Z608. In an embodiment, the compound is not Z609. In an embodiment, the compound is not Z610. In an embodiment, the compound is not Z611. In an embodiment, the compound is not Z612. In an embodiment, the compound is not Z613. In an embodiment, the compound is not Z614. In an embodiment, the compound is not Z615. In an embodiment, the compound is not Z616. In an embodiment, the compound is not Z617. In an embodiment, the compound is not Z618. In an embodiment, the compound is not Z619. In an embodiment, the compound is not Z620. In an embodiment, the compound is not Z621. In embodiments, the compound is not Z622. In an embodiment, the compound is not Z623. In an embodiment, the compound is not Z624. In an embodiment, the compound is not Z625. In an embodiment, the compound is not Z626. In embodiments, the compound is not Z627. In an embodiment, the compound is not Z628. In an embodiment, the compound is not Z629. In an embodiment, the compound is not Z630. In an embodiment, the compound is not Z631. In an embodiment, the compound is not Z632. In an embodiment, the compound is not Z633. In an embodiment, the compound is not Z634. In an embodiment, the compound is not Z635. In embodiments, the compound is not Z636. In an embodiment, the compound is not Z637. In an embodiment, the compound is not Z638. In an embodiment, the compound is not Z639. In an embodiment, the compound is not Z640. In an embodiment, the compound is not Z641. In an embodiment, the compound is not Z642. In an embodiment, the compound is not Z643. In an embodiment, the compound is not Z644. In the examples, the compound is not Z645. In an embodiment, the compound is not Z646. In an embodiment, the compound is not Z647.

In embodiments, the compound has the formula:

Figure BDA0002469898950002631

ring A, ring B, L1、R1、R4、R5、R6Z1 and z6 are as described herein. In the examples, R5Is unsubstituted alkyl. In the examples, R5Is unsubstituted C1-C4An alkyl group. In the examples, R5Is unsubstituted C1-C3An alkyl group. In the examples, R5Is unsubstituted C1-C2An alkyl group. In the examples, R5Is unsubstituted tert-butyl. In the examples, R5Is unsubstituted isobutyl. In the examples, R5Is unsubstituted sec-butyl. In the examples, R5Is unsubstituted n-butyl. In the examples, R5Is unsubstituted isopropyl. In the examples, R5Is unsubstituted n-propyl. In the examples, R5Is an unsubstituted ethyl group. In the examples, R5Is unsubstituted methyl. In the examples, R5Is unsubstituted hydrogen. In the examples, R4Is unsubstituted alkyl. In the examples, R4Is unsubstituted C1-C4An alkyl group. In the examples, R4Is unsubstituted C1-C3An alkyl group. In the examples, R4Is unsubstituted C1-C2An alkyl group. In the examples, R4Is unsubstituted tert-butyl. In the examples, R4Is unsubstituted isobutyl. In the examples, R4Is unsubstituted sec-butyl. In the examples, R4Is unsubstituted n-butyl. In the examples, R4Is unsubstituted isopropyl. In the examples, R4Is unsubstituted n-propyl. In the examples, R4Is an unsubstituted ethyl group. In the examples, R4Is unsubstituted methyl. In the examples, R4Is unsubstituted hydrogen. In the examples, L1Is an unsubstituted alkylene group. In the implementation ofIn the examples, L1Is unsubstituted C1-C4An alkylene group. In the examples, L1Is unsubstituted C1-C3An alkylene group. In the examples, L1Is unsubstituted C1-C2An alkylene group. In the examples, L1Is unsubstituted tert-butylidene. In the examples, L1Is unsubstituted isobutylene. In the examples, L1Is unsubstituted sec-butylene. In the examples, L1Is unsubstituted n-butylene. In the examples, L1Is unsubstituted isopropylidene. In the examples, L1Is unsubstituted n-propylene. In the examples, L1Is an unsubstituted ethylene group. In the examples, L1Is an unsubstituted methylene group. In the examples, L1Is a bond. In the examples, L1Is that

Figure BDA0002469898950002641

In the examples, L1Is thatIn the examples, L1Is thatIn the examples, L1Is thatIn the examples, L1Is thatIn the examples, L1Is thatIn the examples, L1Is that

Figure BDA0002469898950002647

In the examples, L1Is thatIn the examples, L1Is thatIn the examples, L1Is that

Figure BDA00024698989500026410

In the examples, L1Is thatIn the examples, L1Is that

Figure BDA0002469898950002652

In the examples, L1Is that

Figure BDA0002469898950002653

In the examples, L1Is that

Figure BDA0002469898950002654

In the examples, L1Is that

Figure BDA0002469898950002655

In the examples, L1Is that

Figure BDA0002469898950002656

In the examples, L1Is that

Figure BDA0002469898950002657

In the examples, L1Is thatIn the examples, L1Is thatIn the examples, L1Is thatIn the examples, L1Is thatIn the examples, L1Is that

Figure BDA00024698989500026512

In the examples, L1Is thatIn the examples, L1Is that

Figure BDA00024698989500026514

In embodiments, ring a is pyridyl. In embodiments, ring a is 2-pyridyl. In embodiments, ring a is 3-pyridyl. In embodiments, ring a is 4-pyridyl. In embodiments, ring a is pyrrolyl. In embodiments, ring A is 2-pyrrolyl. In embodiments, ring A is 3-pyrrolyl. In embodiments, ring a is azetidinyl. In embodiments, ring a is 2-azetidinyl. In embodiments, ring A is 3-azetidinyl. In the examples, R1Independently is-OH. In the examples, R1Independently is-OCH3. In the examples, R1Independently is-OCH2CH3. In the examples, R1Independently is unsubstituted C1-C4An alkoxy group. In the examples, R1Independently is-Cl. In the examples, R1Independently is-F. In the examples, R1Independently a halogen. In the examples, R1Independently is-CH3. In the examples, R1Independently is-CH2CH3. In the examples, R1Independently is unsubstituted C1-C4An alkyl group. In the examples, R1Independently is-CF3. In the examples, R1Independently is-CX1 3. In an embodiment, z1 is an integer from 0 to 5. In an embodiment, z1 is an integer from 0 to 2. In an embodiment, z1 is 0. In an embodiment, z1Is 1. In an embodiment, z1 is 2. In an embodiment, z1 is 3. In an embodiment, z1 is 4. In an embodiment, z1 is 5. In the examples, R6Independently is-OH. In the examples, R6Independently is-OCH3. In the examples, R6Independently is-OCH2CH3. In the examples, R6Independently is unsubstituted C1-C4An alkoxy group. In the examples, R6Independently is-Cl. In the examples, R6Independently is-F. In the examples, R6Independently is-Br. In the examples, R6Independently is-I. In the examples, R6Independently a halogen. In the examples, R6Independently is-CH3. In the examples, R6Independently is-CH2CH3. In the examples, R6Independently is unsubstituted C1-C4An alkyl group. In the examples, R6Independently is-CF3. In the examples, R6Independently is-CCl3. In the examples, R6Independently is-CBr3. In the examples, R6Independently is-CI3. In the examples, R6Independently is-CX6 3. In embodiments, ring B is heterocycloalkyl. In embodiments, ring B is a 4-to 6-membered heterocycloalkyl. In embodiments, ring B is a 4-membered heterocycloalkyl. In embodiments, ring B is a 5-membered heterocycloalkyl. In embodiments, ring B is a 6-membered heterocycloalkyl. In embodiments, ring B is azetidinyl. In embodiments, ring B is pyrrolidinyl. In embodiments, ring B is piperidinyl. In an embodiment, z6 is an integer from 0 to 8. In an embodiment, z6 is an integer from 0 to 2. In an embodiment, z6 is 0. In an embodiment, z6 is 1. In an embodiment, z6 is 2. In an embodiment, z6 is 3. In an embodiment, z6 is 4. In an embodiment, z6 is 5. In an embodiment, z6 is 6. In an embodiment, z6 is 7. In an embodiment, z6 is 8. In an embodiment, z6 is 9. In an embodiment, z6 is 10. In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002661

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002663

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002664

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002665

In the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002666

In the examples, - (Ring B) - (R)6)z6Is thatIn the examples, - (Ring B) - (R)6)z6Is that

Figure BDA0002469898950002668

In an embodiment, the compound is Z297.

Pharmaceutical composition

In one aspect, there is provided a pharmaceutical composition comprising a compound as described herein and a pharmaceutically acceptable excipient.

In an embodiment of the pharmaceutical composition, a therapeutically effective amount of the compound, or a pharmaceutically acceptable salt thereof, is included.

In an embodiment of the pharmaceutical composition, the pharmaceutical composition comprises a second agent (e.g., a therapeutic agent). In an embodiment of the pharmaceutical composition, the pharmaceutical composition comprises a therapeutically effective amount of a second agent (e.g., a therapeutic agent). In an embodiment of the pharmaceutical composition, the second agent is an agent for treating cancer. In embodiments, the second agent is an anti-cancer agent. In an embodiment, the second agent is chemotherapy. In embodiments, the second agent is an anti-inflammatory agent. In embodiments, administration does not comprise administration of any active agent other than the recited active agent (e.g., a compound described herein). In embodiments, the second agent is an anti-fibrotic agent. In embodiments, the second agent is an anti-neurodegenerative disease agent. In an embodiment, the second agent is an agent for treating fibrosis. In an embodiment, the second agent is an agent for treating a neurodegenerative disease.

Method of use

In one aspect, there is provided a method of inhibiting adenosine A2B receptor activity and adenosine A2A receptor activity, the method comprising contacting the adenosine A2B receptor and adenosine A2A receptor with a compound as described herein (including the examples). In embodiments, the compounds contact the adenosine A2B receptor. In embodiments, the compounds contact the adenosine A2A receptor. In embodiments, the compounds are capable of contacting the adenosine A2A receptor and the adenosine A2B receptor independently. In embodiments, the compound does not contact the adenosine A2A receptor and the adenosine A2B receptor simultaneously.

In one aspect, there is provided a method of inhibiting adenosine A2B receptor activity and adenosine A2A receptor activity, the method comprising contacting the adenosine A2B receptor or adenosine A2A receptor with a compound as described herein (including the examples). In the examples, the methods inhibit adenosine A2B receptor activity and adenosine A2A receptor activity relative to controls.

In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 1: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 2: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 3: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 4: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 5: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 6: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 7: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 8: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 9: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 10: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 20: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 25: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 30: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 40: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 50: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 100: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 200: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 300: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 400: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 500: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 600: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 700: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 800: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 900: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A2A receptor activity at a ratio of about 1000: about 1.

In another aspect, there is provided a method of inhibiting the activity of the adenosine A2B receptor, which method comprises contacting the adenosine A2B receptor with a compound as described herein (including the examples). In embodiments, the methods inhibit adenosine A2B receptor activity relative to a control. In embodiments, the method inhibits adenosine A2B receptor activity greater than adenosine A3 receptor activity. In embodiments, the method inhibits adenosine A2B receptor activity greater than adenosine a1 receptor activity.

In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 1: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 2: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 3: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 4: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 5: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 6: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 7: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 8: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 9: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 10: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 20: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 25: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 30: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 40: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 50: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 100: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 200: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 300: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 400: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 500: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 600: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 700: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 800: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 900: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine A3 receptor activity at a ratio of about 1000: about 1.

In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 1: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 2: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 3: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 4: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 5: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 6: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 7: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 8: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 9: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 10: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 20: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 25: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 30: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 40: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 50: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 100: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 200: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 300: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 400: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 500: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 600: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 700: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 800: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 900: about 1. In embodiments, the method inhibits adenosine A2B receptor activity to adenosine a1 receptor activity at a ratio of about 1000: about 1.

In embodiments, the methods inhibit adenosine A2B receptor activity and do not inhibit adenosine A3 receptor activity.

In one aspect, there is provided a method of inhibiting the activity of the adenosine A2B receptor, which method comprises contacting the adenosine A2B receptor with a compound as described herein (including the examples).

In one aspect, there is provided a method of inhibiting the activity of the adenosine A2A receptor, which method comprises contacting the adenosine A2A receptor with a compound as described herein (including the examples).

In one aspect, there is provided a method of treating cancer, the method comprising administering to a subject in need thereof an effective amount of a compound as described herein (including the examples). In embodiments, the cancer is breast, lung, colon, bladder, kidney, liver, pancreas, melanoma, leukemia, lymphoma, or prostate cancer. In an embodiment, the cancer is breast cancer. In an embodiment, the cancer is lung cancer. In an embodiment, the cancer is colon cancer. In an embodiment, the cancer is bladder cancer. In an embodiment, the cancer is renal cancer. In embodiments, the cancer is liver cancer. In an embodiment, the cancer is pancreatic cancer. In an embodiment, the cancer is melanoma. In an embodiment, the cancer is leukemia. In an embodiment, the cancer is lymphoma. In an embodiment, the cancer is prostate cancer.

In one aspect, there is provided a method of treating a fibrotic disease, the method comprising administering to a subject in need thereof an effective amount of a compound as described herein (including the examples). In embodiments, the fibrotic disease is pulmonary fibrosis. In embodiments, the fibrotic disease is Idiopathic Pulmonary Fibrosis (IPF). In embodiments, the fibrotic disease is Idiopathic Pulmonary Fibrosis (IPF), myocardial infarction, myocardial hypertrophy, heart failure, cirrhosis, acetaminophen (paracetamol) hepatotoxicity, hepatitis C liver disease, fatty liver (hepatosteatosis/fatty liver disease), or liver fibrosis. In the examples, the fibrotic disease is nonalcoholic steatohepatitis (NASH). In the examples, the fibrotic disease is non-alcoholic fatty liver disease (NAFLD).

In one aspect, there is provided a method of treating a neurodegenerative disease, the method comprising administering to a subject in need thereof an effective amount of a compound as described herein (including the examples). In embodiments, the neurodegenerative disease is alzheimer's disease, huntington's disease, multiple sclerosis, parkinson's disease, retinitis pigmentosa, amyotrophic lateral sclerosis, retinal degeneration, macular degeneration, prion disease, creutzfeldt-jakob disease, or kuru. In an embodiment, the neurodegenerative disease is alzheimer's disease. In an embodiment, the neurodegenerative disease is huntington's disease. In an embodiment, the neurodegenerative disease is multiple sclerosis. In an embodiment, the neurodegenerative disease is parkinson's disease. In an embodiment, the neurodegenerative disease is amyotrophic lateral sclerosis.

In embodiments, the method comprises administering a second agent (e.g., a therapeutic agent). In embodiments, the method comprises administering a therapeutically effective amount of a second agent (e.g., a therapeutic agent). In an embodiment, the second agent is an agent for treating cancer. In embodiments, the second agent is an anti-cancer agent. In an embodiment, the second agent is chemotherapy. In embodiments, the second agent is an anti-inflammatory agent. In an embodiment, the second agent is an agent for treating fibrosis. In an embodiment, the second agent is an agent for treating a neurodegenerative disease.

In one aspect, there is provided a method of inhibiting adenosine receptor activity, the method comprising contacting the adenosine receptor (e.g. a1, A2A, A2B or A3) with a compound as described herein (including the examples).

It is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and scope of the appended claims. All publications, patents, and patent applications cited herein are hereby incorporated by reference in their entirety for all purposes.

589页详细技术资料下载
上一篇:一种医用注射器针头装配设备
下一篇:治疗癌症的方法及组合疗法

网友询问留言

已有0条留言

还没有人留言评论。精彩留言会获得点赞!

精彩留言,会给你点赞!